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The VapA-VapB-VipC trimeric complex is part of an epigenetic developmental control 
pathway of A. nidulans. VeA-interacting protein (VipC) and VipC-associated protein B 
(VapB) are methyltransferases, and VapA is a zinc-finger membrane protein. This complex 
integrates and translocates environmental signals from the membrane to the nucleus for the 
control of development through changes in gene expression. Genome analysis of several 
Aspergillus species revealed the presence of different Vap-Vip pathways variants not only 
among the Aspergilli but also within the strains of the human opportunistic pathogen A. 
fumigatus. Some strains, such as A1160, a gene duplication event resulted in two paralogues 
genes coding for AfVipC1 and AfVipC2. There are also strains, such as AfS35, that have 
lost AfvapB gene and carry an AfvapA, AfvipC1 and AfvipC2 genotype, which is much more 
abundant in nature. This work introduces a novel and highly dynamic mechanism by which 
A. fumigatus can adapt to changing environmental conditions. This fungus has a gene loss 
or gene duplication system to adapt to different niches. In A. fumigatus AfS35, VapA, 
VipC1 and VipC2 present similar features to their homologues in A. nidulans and are 
interacting under vegetative and asexual conditions. The loss of at least one of the 
methyltransferases, vipC1 or vipC2, promotes resistance against the menadione-induced 
oxidative stress. In contrast, deletion of vipC2 alone or together with vapA increase the 
sensitivity to sorbic acid. In the A1160 strain with the Vap-Vip configuration of all four 
genes (vapA, vapB, vipC1 and vipC2), loss of vipC2 has the opposite effect and increases 
the sensitivity against menadione and the resistance to sorbic acid. In the AfS35 strain, 
deletion of vipC2 leads to an overexpression of the master regulator of asexual 
development, brlA, and two genes involved in the fumiquinazolines synthesis, fmqA and 
fmqC, which results in an accumulation of fumiquinazoline intermediates (FQA, FQC/D, 
FQF). VipC2 also affects the production of pigments and other secondary metabolites, 
especially under blue-light conditions. Loss of vipC2 results in an upregulation of the drug 
efflux transporter genes, abcA and abcB, which leads to an increased resistance against 
voriconazole and itraconazole in the AfS35 strain. In summary, this study presents 
experimental evidences that homologues of VapA, VapB and VipC proteins in A. fumigatus 
AfS35 interact and play a role in the control of stress response, secondary metabolism and 






Der VapA-VapB-VipC trimerische Komplex ist Teil einer epigenetischen Kontrolle für die 
Entwicklung in A. nidulans. VipC (VeA-interacting protein C) und VapB (VipC-associated 
protein B) sind Methyltransferasen und VapA ist ein Zink-finger-enthaltendes 
Membraneprotein. Dieser Komplex integriert Umweltsignale und leitet sie von der 
Membran an den Zellkern weiter. Er kontrolliert so die Entwicklung durch Änderungen in 
der Genexpression. Genomanalysen mehrerer Aspergillus Arten zeigten, dass unter ihnen 
und speziell in verschiedenen A. fumigatus Stämmen verschiedene Vap-Vip Varianten 
existieren. Stämme dieses Pilzes, etwa A1160, haben eine seltene Variante, welche neben 
den Genen für AfVapA, AfVapB und AfVipC, wie in A  nidulans, eine Genduplikation 
aufweisen, die in zwei paralogen Genen für AfVipC1 und AfVipC2 resultiert. Andere 
Stämme, wie etwa AfS35, haben das Gen AfvapB verloren und tragen die Gene AfvapA, 
AfvipC1 und AfvipC2. Diese Variante ist in der Natur weit verbreitet. Die vorliegende 
Arbeit stellt einen neuen, sehr dynamischen Mechanismus vor, durch welchen sich 
A. fumigatus an wechselhafte Umweltbedingungen anpassen kann. Durch ein Genverlust- 
oder Genverdopplungssystem kann sich der Pilz an unterschiedliche Nischen anpassen. 
VapA, VipC1 und VipC2 in A. fumigatus AfS35 haben ähnliche Eigenschaften, wie ihre 
Homologe in A. nidulans und interagieren unter vegetativen und asexuellen Bedingungen. 
Der Verlust mindestens einer dieser Methyltransferasen, vipC1 oder vipC2, verleiht 
Resistenz gegen Menadion-induzierten oxidativen Stress. Dagegen erhöht die Deletion von 
vipC2 oder von vipC2/vapA die Sensititvität für Sorbinsäure. In A1160, einem Stamm mit 
der Vap-Vip Konfiguration aller vier Gene, bewirkt der Verlust von vipC2 den 
gegenteiligen Effekt und erhöht die Sensitivität für Menadion und die Sorbinsäureresistenz. 
Deletion von vipC2 in dem Stamm AfS35 führt zur Überexpression von brlA, fmqA und 
fmqC, was in einer Akkumulation von Intermediaten von Fumiquinazoline (FQA, FQC/D, 
FQF) resultiert. VipC2 hat Einfluss auf die Produktion von Pigmenten und anderen 
Sekundärmetaboliten, besonders während des Wachstums in blauem Licht. Verlust von 
vipC2 resultiert zu der Hochregulation von abcA und abcB drug efflux transporter Genen, 
was zu einer erhöhten Resistenz gegen Voriconazole und Itraconazole in dem AfS35 
Stamm führt. Diese Studie zeigt, dass die homologen VapA, VapB und VipC Proteine in 
A. fumigatus AfS35 miteinander interagieren und eine Rolle in der Kontrolle von 
Stressantwort, Sekundärmetabolismus und Azol-Antimykotika Resistenz spielen. Diese 







1.1.1 Aspergillus: general concepts 
Fungi is a term used to name a group of organisms composed by microorganisms and 
moulds, as well as the typical mushrooms. These organisms build up the fungal kingdom, 
separated from the plant and animal kingdom, and it contains up to 5.1 million species. 
Fungi live in almost every kind of environment on this planet, including soil, water and 
other organisms, only surpassed by bacteria in their ability to resist and stand extremes in 
temperature, water activity, and carbon and nitrogen sources (Raspor et al., 2006). Out of 
all these fungal species, only about 100.000 are known. They have a very complex 
taxonomy and more than half of these discovered species belong to the phylum 
Ascomycota. It is the largest phylum of fungi, representing several hundreds of genera, 
including Aspergillus (Hawksworth et al., 1997; Blackwell, 2011). 
Aspergillus is one of the oldest named genera of fungi, and by the beginning of the 
19th century, it had become one of the best-known and most studied mould groups. This 
widely spread and diverse group of fungi is one of the most abundant in the world. It is so 
diverse that, for example, genomic analyses between A. nidulans and A  fumigatus revealed 
that, even belonging to the same genus, they are as close related as fish to humans (Galagan 
et al., 2005; Bennett, 2010). 
The genus Aspergillus refers to its asexual reproductive stage, often mould-like, by 
which it produces conidiospores (‘conidia’) via mitosis, and it comprises a few hundred 
species. This ‘anamorph’ genus is connected to approximately ten different ‘teleomorph’ 
genera, which corresponds to the sexual reproductive stage, typically a fruiting body, and 
produces the ascospores via meiosis (Geiser, 2009). 
Their success as cosmopolitan organisms is explained in part, by the fact that they are 
very versatile concerning their abiotic growth conditions, thus, they can degrade a wide 
variety of organic compounds and molecules. Furthermore, they are massive producers of 
sexual and asexual spores (ascospores and conidiospores, respectively) that are easily 
dispersed over long and short distances. In fact, spores of this genus are among the most 
common fungal structures present in the air (Bennett, 2010; Krijgsheld et al., 2013). They 





role in the recycling of nutrients and in the carbon and nitrogen cycles of natural 
ecosystems. They are usually found decomposing complex plant polymers into simpler 
ones that are then absorbed by the fungal cell, indeed, they are considered to be common 
food spoilage fungi. They are also important contributors to human ecology and economy 
as key elements of several industrial processes. This common moulds are also professional 
producers of extracellular enzymes, such as xylanases and cellulases. Also, they produce a 
great variety of secondary metabolites, and compounds of different nature. Some of them 
can be toxic molecules, like the aflatoxin produced by Aspergillus flavus, that can 
contaminate grains and other foods. These metabolites can be even a threat for human 
health, but also, there are some others that have important benefits for human society and 
other animals (Bennett, 2010). 
Apart from the secondary metabolites produced by these fungi, also other processes 
and biological transformations performed by these organisms are of high relevance for 
industry. Fungi belonging to this genus have been extensively used in the agroalimentary 
industry to produce food derivatives, taking advantage of their metabolic versatility and 
fermentation capacity. For example, A. oryzae is widely used in Japanese bioindustries. 
Dozens of examples in the Asian cuisine rely on a large repertoire of fermented foods and 
enzymatic machinery of this fungus (Abe K., 2008; Machida et al., 2008; Ichishima, 2016; 
Park et al., 2017).  
More recently, new aspects of their fermenting potential have been investigated in 
contemporary biotechnology trying to focus more and more in new ‘green’ alternatives 
methods of biomass transformation. Regarding to this, Aspergilli possess a huge 
prospective for finding new enzymes that could be utilized to convert plant biomass into 
fuels and other industrially useful products (Baker et al., 2008). 
Another important aspect of their biology is the infective character of some species 
belonging to this genus, including plant and animal pathogens.  
 
1.1.2 Aspergillus nidulans vs. Aspergillus fumigatus: features and development 
One of the most broadly used Aspergillus species in classical fungal genetics is the 





develop asexually and produce conidiospores, or it can also grow and mate with itself to 
produce sexual cleistothecia that contain the ascospores. 
Sexual development occurs after conidiophore formation. These are produced three 
days after spore germination whereas the sexual fruiting bodies takes at least seven days, 
although the developmental programs are triggered much earlier (Braus et al., 2002; 
Pöggeler et al., 2006). Vegetative mycelia are enabled to induce the formation of the 
reproductive structures 12-20 hours after germination depending on external signals 
(Bayram et al., 2010) (Figure 1). 
Figure 1: Schematic depiction of the life cycle of Aspergillus nidulans 
A. nidulans can undergo sexual or asexual development resulting in the formation of the sexual 
fruiting body (cleistothecia) or the conidiophore, respectively. Environmental conditions that 
regulate both developmental programs are interpreted to control gene expression and promote 
differentiation. Whereas cleistothecia formation occurs predominantly in the dark under low oxygen 
supply, asexual conidiophores are formed in light when oxygen is present. Modified from Casselton 





A. fumigatus is a heterothallic fungi that needs a partner from the opposite mating 
type to undergo sexual development under very specific and controlled environmental 
conditions (Krijgsheld et al., 2013) (Figure 2). Apart from this physiological and 
developmental aspect, there exist additional features that differentiates both fungi. For 
example, at the morphological level, asexual spores of A. nidulans are 1.5 times larger than 
A. fumigatus conidia. Also, the conidiophore of A. nidulans, presents an extra layer of cells, 
the metulae, that is absent in A. fumigatus (Figure 1 and 2) (Yu, 2010). 
 
Figure 2: Schematic depiction of the life cycle of Aspergillus fumigatus 
A. fumigatus can undergo sexual or asexual development resulting in the formation of the sexual 
fruiting body (cleistothecia) or the conidiophore, respectively. The formation of sexual mature 
cleistothecia requires the conjugation of two strains of opposite mating types (MAT1-1 and 
MAT1-2) together with very strict environmental conditions: darkness, 30°C, nutrients supply, 







1.1.3 A. fumigatus: from soil to lungs 
Until 2009, it was thought that A. fumigatus is an asexual fungus, lacking a full proper 
sexual developmental program. However, genomic analysis revealed the presence of 
functional determinants of sexual development, such as putative mating type idiomorphs 
and regulators, suggesting that it is able to reproduce sexually (Dyer et al., 2005; Große et 
al., 2008). These evidences were confirmed when the cryptic sexual cycle was discovered 
(O’Gorman et al., 2009). 
Since A. fumigatus undergoes sexual development only in the presence of a mating 
partner and under strict environmental conditions, the fungus performs asexual 
development under almost any condition. A. fumigatus is a massive producer of 
conidiospores that can colonise a wide variety of habitats, even human epitheliums. Most 
human pathogens normally live in soil or compost, and acquire nutrients from decaying 
material. The infection is acquired via the lung when airborne spores are inhaled by hosts 
with deficiencies in their immune system capacity (Pitt, 1994; Brakhage, 2005) (Figure 3). 
 
Figure 3: Life cycle and infection process of Aspergillus fumigatus 
A. fumigatus grows profusely as environmental saprophyte over the decomposing matter. 
Airborne conidia can easily spread and can be inhaled by human hosts. In 
immunosuppressed individuals, due to the absence of sufficient pulmonary defences, these 
spores can germinate and invade tissue, disseminating through the blood stream to the brain 
and other organs. Modified from Dagenais et al., 2009. 
 
Infections can range from allergies to life-threatening infections. Repeated exposure 





characterized by the absence of mycelial colonization, and in most cases, removal of the 
patient from the environmental source results in clinical improvement. Inside an 
immunocompromised host, inhaled spores can germinate causing three of the most severe 
infections, also known as aspergilloma, allergic bronchopulmonary aspergillosis (ABPA) 
and invasive aspergillosis (IA). These syndromes involve mycelial growth inside the body, 
and usually require therapeutic intervention (Latgé, 1999). Among the different species of 
Aspergilli, A. fumigatus, is the most common agent of human invasive fungal infections 
which mortality is more than 60 % rate in immunocompromised individuals even with 
treatment (Tekaia et al., 2005; Gauthier et al., 2013). This is due to an increasing prevalence 
of azole-resistance strains and, in part, to the use of pesticides in the agricultural industry 
(Berger et al., 2017). 
1.2 Responses to environmental signals of A. fumigatus 
The duality of A. fumigatus as saprophyte but at the same time as one of the most 
hazardous fungal opportunistic pathogens has driven its capacity of adaptation and response 
to a wide variety of potentially toxic environmental challenges. Adaptation and resistance 
to stressful scenarios have contributed to its development as human pathogen. The 
susceptible immunocompromised hosts represent a specific ecological niche that 
constitutes different kind of stresses to the fungus during the course of infection (Hartmann 
et al., 2011). 
1.2.1 Oxidative stress response 
Living organisms are always exposed to environmental and endogenous oxidative 
stress. Fungi have mechanisms to protect themselves against the damage that ROS (reactive 
oxygen species) can inflict to their biomolecules (Sato et al., 2009; Breitenbach et al., 
2015). Intracellular ROS are common by-products wherever oxygen is metabolically 
involved and they accumulate mostly as a result of cellular respiration. ROS are also 
produced as a part of protection mechanisms of animals and plants. One known example of 
these defence strategies to which fungi should rise is the high levels of ROS produced by 
neutrophil cells during the oxidative burst (Moye-Rowley, 2003; Camejo et al., 2016; 
Shlezinger et al., 2017). 
Pathogenic fungi, like A. fumigatus, have to deal with oxidizers of different nature in 
their process of infection, meaning that a proper oxidative stress response is crucial and 





elicit different response mechanisms in the fungus which are very dependent on the nature 
of the oxidant. Oxidative stress encompasses a broad range of cellular insults that have 
different and very specific physiological consequences for the cell, where certain pathways 
are uniquely triggered and required for resistance to only one kind of ROS. For instance, in 
Saccharomyces cerevisiae, different oxidative stress-inducing agents such as H2O2, 
diamide or menadione, which alter intracellular oxidant concentration specifically, 
influence segments of the genome differentially with almost no overlap (Thorpe et al., 
2004; Pócsi et al., 2005).  
Fungi have antioxidant systems that detoxify and prevent ROS-damaging effects by 
enzymatic mechanisms and redox complexes. They include catalases, superoxide 
dismutases (SOD) and peroxidases, and mechanisms that provide reducing power such as 
the pentose phosphate pathway and the thioredoxin and glutathione redox systems.  
SODs reduce superoxides to H2O2, as a first line of defence against ROS (Aguirre et 
al., 2005). In A. fumigatus, there are four SOD encoding genes, one of them is essential, 
and the other three were reported to play a role in the MSB-induced response to oxidative 
stress and high temperature (Lambou et al., 2010). 
In a second step, catalases transform H2O2 into water and oxygen. CatAp, Cat1p and 
Cat2p are the only catalases that have been described in A. fumigatus so far. While CatA is 
conidia-specific, the other two have hyphal localisation (Paris et al., 2003).  
Also, the thioredoxin and glutathione systems are key mechanisms which act as a 
scavenger for oxidants by supplying electrons for reactive oxygen intermediates (ROI) 
(Carmel-Harel et al., 2000; Sato et al., 2009; Breitenbach et al., 2015; Bakti et al., 2017; 
Matsuzawa, 2017). 
These interconnected networks, that are mainly controlled by the transcription 
factors, AtfA, Yap1 and Skn7, seem to have overlapping functions to ensure that mutations 
in single OSR scavenging enzymes do not compromise the whole system (Chauhan et al., 
2006; Abad et al., 2010; Emri et al., 2015). 
Additional mechanisms that mitigate the deleterious effects of oxidizing agents have 
been reported in A. fumigatus. Some LaeA-regulated gene clusters have been described to 





oxidative stress (Owens et al., 2014). This mechanism establishes an association between 
the secondary metabolism and the oxidative stress response (OSR), which is critical to 
maintain fungal fitness and to control the cell fate, such as cell survival and apoptosis 
(Aguirre et al., 2005; Matsuzawa, 2017)  
 
1.2.2 Weak-acidic stress response 
Carboxylic acids are widely used in medicine (e.g., antimalarial, anticancer, 
immunosuppressive), in agriculture (e.g., herbicides, pesticides), in food and chemical 
industries (e.g., food preservatives, or as raw materials for the synthesis of plastic, 
cosmetics, etc.), among other possible applications (Mira et al., 2010 a). 
A link between the OSR and the weak acidic stress response has been established due 
to the capacity of some organic acids to influence oxidative stress. Accumulation of the 
anion fraction of dissociated preservatives, such as sorbic acid, is reported to cause 
oxidative stress within the cell. However, in contrast to menadione, which alters the redox 
balance of the cell, sorbic acid promotes a pro-oxidant effect through its capacity to 
potentiate the damages caused by ROS production by the respiratory chain  (Piper, 1999). 
The cellular responses to weak acidic compounds are highly dynamic and diverse as 
it is also the wide variety of different weak organic acids that triggers these pathways. 
Activation of H+-ATPases and vacuolar compartmentalization for the recovery of 
intracellular pH to more physiological values. The involvement of the HOG1-signalling 
pathway, and the reconfiguration of cell wall structure and plasma membrane to decrease 
the diffusion rate of undissociated weak acids and reduce the damage in the plasma 
membrane. Reduction of the intracellular concentration of the organic acid counterion 
through multidrug resistance (MDR) transporters of the ATP- binding cassette (ABC) and 
Major Facilitator Superfamily (MFS) (Mira et al., 2010 a, 2013). Inactivation of the weak-
acid by decarboxylation achieved by the decarboxylases PadA1 and OhbA1 (Plumridge et 
al., 2008, 2010). These are some examples of fungal described mechanisms that conforms 
the adaptive response to weak acidic stress. Transcriptomic profiling characterized several 
transcriptional regulatory networks of the weak acidic response in yeast that defines how 
these systems crosstalk in response to organic acids (Schüller et al., 2004; Mira et al., 2009, 
2010 b). Many of these mechanisms are unknown or poorly understood in Aspergillus 





et al., 2010). In addition, identification of several transcription factors as determinants of 
resistance to particular groups of carboxylic acids, revealed a much more complex 
regulatory network than the simple model that can be accepted so far (Mira et al., 2010 a). 
1.2.3 Light response 
Although fungi are not photosynthetic organisms, they interpret the light as a source 
of information. They respond to light qualities that range from blue (450 nm) to red light 
(750 nm), as the span of the visible spectrum for humans. Their ability to react to the light 
is mediated by photoresponsive proteins and receptors that are highly conserved in the 
fungal kingdom (Fuller et al., 2015). Light controls several important processes in fungi, 
from the stress response and secondary metabolism until the circadian clock and 
development. It has always been associated mainly with asexual development and 
sporulation, thus, in Neurospora crassa and A. nidulans, for instance, light is widely known 
to promote asexual development (Lee et al., 2003; Bayram et al., 2008 b). 
In contrast, A. fumigatus favours asexual development almost under any circumstance 
where the light seems to have a trivial effect, it is indeed a light-responsive organism. In 
the genome of A. fumigatus, a whole set of photoresponsive elements is represented, 
including all the genes necessary for a fully functional light-sensing machinery. These 
elements are blue light receptors, the lreA and lreB orthologous of A. nidulans, 
AFUA_3G05780 and AFUA_4G12690 in A. fumigatus, respectively. It also includes the 
red light receptor, the phytochrome FphA from A. nidulans that has two putative 
orthologous genes in A. fumigatus, fphA (AFUA_4G02900) and fphB (AFUA_6G09260) 
(Fuller et al., 2013). It also possesses opsin encoding genes as the nop1 orthologue from 
Neurospora crassa, the nopA gene in A. fumigatus (AFUA_1G14220), which is claimed to 
be a green light receptor (Fuller et al., 2016 a; Wang et al., 2018) and an opsin-related gene 
(AFUA_7G01430).  
Genome-wide transcriptional analyses revealed changes in the gene expression of 
250 genes upon light induction in A. fumigatus, representing more than 2% of the whole 
genome of this fungus (Fuller et al., 2013). Many of these characterized genes were 
proposed to play roles in regulation of metabolism and oxidative stress response. There 
were also two transcriptions factors encoding genes identified, nf-x1 (AFUA_7G04710) 
and cp2 (AFUA_3G11170), that demonstrated very early light inductions and which might 





member of the TspO/MBR (tryptophan-rich sensory protein/mammalian peripheral-type 
benzodiazepine receptor) family (AFUA_3G01430), which may belong to a conserved 
photoresponsive gene family was also identified. Orthologues of AFUA_3G01430 may 
have important roles in the fungal photoresponse. Furthermore, this gene was described to 
show the greatest expression fold-increase after light exposure in A. fumigatus (Fuller et 
al., 2013). Also the second most highly light-induced, a photolyase encoding gene called 
phr1 (AFUA_1G01600) was found. This gene is, in fact, the cryA orthologue from A. 
nidulans, where it is considered a cryptochrome, a nuclearly-localized protein that senses 
UVA and blue light. This protein represses sexual development by regulating other 
regulators such as VeA, NsdD, and RosA; and it is a member of the class I cyclobutane 
pyrimidine dimer (CPD) photolyase family (Bayram et al., 2008 a). 
Another important aspect of the physiology of A. fumigatus that is regulated by light 
is the secondary metabolism and the production of pigments. The protective role of 
melanins against UV light and how the production of this conidia-associated compounds is 
enhanced by light, is widely known (Calvo et al., 2002). Several studies reported that 
colonies grown under constant illumination or blue light are more pigmented than those 
that were kept in the darkness. By contrast, colonies grown under red light conditions 
presented features that resembles the darkness phenotype. (Fuller et al., 2013) 
Although light is one of the major inducer of pigmentation in the mycelium, there 
exist a huge variability in the behaviour of different A. fumigatus isolates (Fuller et al., 2016 
b). 
Altogether, these findings reflect the size and the complexity of the photobiology of 
A. fumigatus and the importance of the intraspecific heterogeneity and the genomic 
environment, which has a broader impact in our understanding of the biology of 
A.  fumigatus and other fungi. 
1.3 Secondary metabolism and anti-fungal drug response 
1.3.1 Secondary metabolism 
Aspergilli as well as filamentous fungi in general, are massive producers of secondary 
metabolites. These are often bioactive molecules, usually of low molecular weight, and are 
produced as families of related compounds at restricted parts of the cell cycle (Keller et al., 
2005). In contrast to primary metabolites, these compounds are not essential for viability 





serve as competitive weapons against other organisms, as metal transporting agents, as 
sexual hormones, differentiation effectors, etc., and the production of many of them is 
restricted to certain taxonomic groups (Vining, 1990; Keller et al., 2005). Many secondary 
metabolites provide medical benefits, such as lovastatin, which is an A. terreus-derived 
statin drug used for lowering cholesterol. But also there is a great number of these fungal 
molecules with an important negative impact for humankind, for example aflatoxins, which 
are poisonous carcinogenic compounds produced by certain Aspergilli that can contaminate 
corn and other foods (Cole et al., 2003; García-Estrada et al., 2011).  
Secondary metabolites are classified into different groups: polyketides, non-
ribosomal peptides, terpenes, indole alkaloids, etc. As a feature of the fungal genome, genes 
encoding for the enzymes necessary for most of the secondary metabolites are grouped 
together forming discrete clusters around the synthase genes (Keller et al., 2005; Andersen 
et al., 2013). The genome of A. fumigatus encodes approximately 317 genes organized in 
37 gene clusters with a proposed function in secondary metabolism (Lind et al., 2015). 
Nevertheless, the direct correlation of specific compounds with their corresponding 
biosynthetic gene cluster remains, in most of the cases, unknown. Quite often, gene clusters 
that encode for the synthesis of natural products are co-regulated by a coordinated 
expression control of biosynthetic genes mediated by transcription factors (Keller et al., 
2005). Therefore, there are pathway-specific regulators that can be found in the clusters and 
positively regulate gene expression. These proteins are commonly Zn(II)2Cys6 zinc 
binuclear cluster proteins (Woloshuk et al., 1994; Proctor et al., 1995; Fernandes et al., 
1998), and other kind of transcription factors such as Cys2His2 zinc-finger proteins (Keller 
et al., 2005).  
One key factor in the control and coordination of secondary metabolism in 
Aspergillus is the methyltransferase LaeA. While deletion of this global regulator leads to 
the silencing of many biosynthetic gene clusters (BGC), its overexpression triggers the 
transcription of several BGCs and the subsequent production of secondary metabolites (Bok 
et al., 2004). Secondary metabolism usually commences late in the fungal growth, and its 
control is often coordinated with differentiation and development. A link between sexual 
development and secondary metabolism has been reported, where its master regulator, 
LaeA, as a part of the velvet complex, has a crucial function (Bayram et al., 2008 b, 2012 





probably via activation of mycotoxins production, has been demonstrated (Estiarte et al., 
2016; Kumar et al., 2017; López-Díaz et al., 2018). 
Some of these secondary metabolites associated with developmental structures are 
the fungal pigments, such as melanins. Melanins are generally dark brown pigments that 
are synthesized during spore formation for deposition in the cell wall. These natural 
products have been well studied in pathogenic fungi, where they not only contribute to the 
integrity of the fungal spore but are also an important virulence factor (Calvo et al., 2002). 
Although SM gene clusters are often silent during laboratory growth (Gerke et al., 
2012), there are several reported mutations that can alter these cellular networks leading to 
biosynthesis of specific compounds. These approaches can be conducted with 
biotechnological purposes, for instance, for the industrial production and isolation of 
bioactive molecules that can be of interest for the humankind (Bok et al., 2004; Gerke et 
al., 2014; Guerriero et al., 2017). 
One group of secondary metabolites analysed in this study are the fumiquinazolines 
(FQ), which are a family of cytotoxic peptidyl alkaloids that are signature metabolites 
produced by A. fumigatus (Ames et al., 2010 a). They are reported to have significant 
antibacterial (Garcia Silva et al., 2004), antifungal (Belofsky et al., 2000), and antitumor 
activity against several cancer cell lines (Han et al., 2007). 
An association of this family of compounds with developmental structures and 
asexual sporulation has been shown, because some of its metabolic intermediates, such as 
FqC, are specific for the conidial cell wall (Lim et al., 2014). In fact, previous studies have 
demonstrated that the expression of the master regulator of asexual development, brlA, is 
both sufficient and necessary for Fq biosynthesis (Molloy, 2014; Lind et al., 2018). 
Fumiquinazolines biosynthesis involve, as most of the secondary metabolites, the 
coordinated participation of an enzymatic machinery encoded by a set of genes that are 
clustering together. This FQ cluster comprises two non-ribosomal peptide synthases 
(NRPS), two flavoproteins and one transporter gene. FQ biosynthesis consists of a four-
enzymatic reaction process that constructs increasingly complex Fq structures, starting with 
the condensation of L-Ala, L-Trp and L-anthranilate as building blocks. The process begins 
with the trimodular NRPS FmqA (AFUA_6G12080), which is required for the production 
of all Fq (Lim et al., 2014), and ends up with the FAD-dependent oxidoreductase, FmqD 





encoding genes termed from fmqA to fmqD and one transporter gene termed fmqE 
(AFUA_6G12040) (Figure 4A). FmqB (AFUA_6G12060) corresponds to a FAD-
dependent monooxygenase responsible for oxidization of FqF, which then is acted upon by 
the monomodular NRPS, FmqC (AFUA_6G12050), to form FqA. Then, FqA will be finally 
transformed by the oxidoreductase FmqD, into the final products FqC and FqD  (Lim et al., 
2014; Magotra et al., 2017) (Figure 4B). 
 
 
Figure 4: The fumiquinazolines (FQ) gene cluster and biosynthetic pathway 
(A) FQ gene cluster indicating orientation and predicted functions of gene products. (B) FQ 
biosynthetic pathway showing the different FQ intermediates and participating enzymes. Modified 






1.3.2 Antifungal drug resistance  
Fungal infections affect billions of people per year all around the world, and although 
most of them are relatively minor infections, others kill as many people as malaria or 
tuberculosis. Epidemiological data is very poor, so that the incidence and mortality rates of 
fungal infections remain underestimated (Brown et al., 2012). 
The development of drug resistance mechanisms has negatively contributed to the 
success in reducing the high mortality rates of fungal invasive infections such as 
aspergillosis or candidiasis. There are three major classes of antifungal drugs for the 
treatments of fungal infections. Echinocandins, as caspofungin, promote the formation of a 
defective cell wall leading to cell lysis or aberrant hyphal growth. Polyenes, as amphotericin 
B, promote cell death by the formation of pores in the plasma membrane. Azoles, as 
voriconazole, interfere with the ergosterol synthesis causing perturbations of the fungal 
membrane (Pearson et al., 2003). The mechanisms by which the fungus can get resistance 
to these antifungal drugs are quite diverse and specific to certain groups. Echinocandins 
resistance, for instance, is achieved by point mutations in the gene encoding for the target 
enzyme of this drug, Fksp (that is part of the β-glucan synthase complex). Resistance 
against amphotericin B can be obtained by altering the membrane ergosterol content (which 
is the target of this drug) or by increasing the catalase activity to reduce the oxidative-
induced damage (Pemán et al., 2009). The main focus of this chapter will be the anti-azole 
mechanism of resistance, especially in Aspergillus fungal pathogens. 
Four main mechanisms of resistance against azoles in Candida spp and other yeasts 
have been described. These mechanisms are 1) modification of the cellular target 2) 
upregulation of the target-encoding gene 3) reduction of the intracellular concentration of 
the drug by the action of efflux systems or decreasing the membrane permeability to the 
drug, and 4) the development of bypass or alternative pathways (Sanglard et al., 1998; 
Lamb et al., 1999) 
In Aspergillus spp., despite some common features, the anti-azole mechanisms of 
resistance seem to be different. Over the last decades, the increasing number of azole-
resistant A. fumigatus (ARAF) isolates, partially due to the use of pesticides in the 
agricultural industry, is becoming an important problem (Mosquera et al., 2002; Snelders 





A. fumigatus follows two major strategies to gain resistance against anti-azole agents 
and they can be classified as cyp51A mutations, which is the main mechanism, and non-
cyp51A mutations.  
 
Figure 5: Schematic representation of the main anti-azole resistance mechanisms in 
A. fumigatus 
Antidrug resistance mechanisms categorized in five classes. a. Changes in the amino acid sequence 
of Cyp51A which change the protein affinity to the drug. b. Overexpression of this modified version 
of the target protein. c. mutations in transcription factors that regulates cyp51A expression, such as 
hapE mutations. d. increased expression of multidrug resistance channels and drug efflux 
transporters. e. external cholesterol import to the fungal membrane compensating for depleted 






Most of the ARAF isolates harbour mutations in the cyp51A gene. Several kind of 
mutations have been described affecting either the amino acid composition of the Cyp51A 
protein, or the expression levels of the target-encoding gene. Also, mutations affecting 
transcription factors that controls the expression of the cyp51A gene, as the CCAAT-
binding transcription factor complex subunit HapE have been described (Camps et al., 
2012). Also, an increasing number of non-cyp51A alterations that leads to azole-gain of 
resistance phenotypes have been reported (Chowdhary et al., 2014). Some of these non-
cyp51A related mechanisms that contribute to such phenotypes involve modifications in the 
expression levels of multidrug resistance channels (MDR). These proteins sit in the fungal 
membrane and reduce the intracellular concentration of the drug by actively pumping it out 
of the cell (Fraczek et al., 2013; Meneau et al., 2016). An additional non-cyp51A 
mechanism is the import of external cholesterol to the plasma membrane (Xiong et al., 
2005).  
Whole-genome sequencing and transcriptomic techniques provide more knowledge 
of resistant isolates. The appearance of alternative pathways and its implications suggest a 
more complex scenario concerning drug resistance and adaptation in A. fumigatus 
1.4 The epigenetic Vap-Vip methyltransferase complex  
Epigenetics (epi-: “over, outside of”), is a concept that reflects that not everything 
that is ‘written’ in the genes determines the cell fate. The genome is much more than just 
the physical sum of genes, and gene expression is the consequence of gene presence but 
also the possibility of being expressed. There are countless examples of protein-gene 
interactions, gene-gene interactions or even interaction within one gene that, ultimately, 
modulate and determine gene expression. Epistatic interactions, chromatin remodelling, 
enzymatic activity, etc., epigenetic events contribute to a fine tune and to a more precise 
control of genomic regulation that governs gene expression throughout multiple 
generations (Berger et al., 2009; Gilbert et al., 2009).  
Key players in these epigenetic networks are methyltransferases. These enzymes can 
modify histones and thus remodel the chromatin to regulate expression. 
 Recently, the VapA-VapB-VipC complex, a methyltransferase system that controls 
and coordinates development through epigenetic modifications, was characterized in 





VipC was first discovered to be an interaction partner of the velvet protein VeA, and 
therefore, named VeA interacting protein C, VipC. Interaction studies with VipC as the bait 
protein led to the identification of the two other members of the complex: VapA and VapB, 
which received their names from VipC associated protein A and B. 
 
VapA-VapB-VipC represents a trimeric methyltransferase signalling cascade that is 
part of an epigenetic developmental control pathway of A. nidulans. It mediates the 
reception and integration of environmental signals from the membrane to the nucleus and 
controls developmental transcription factors and histone modification during development 
of A. nidulans. VapA is a FYVE-like Zinc finger membrane protein, which is able to attach 
the methyltransferases VipC and VapB to the plasma membrane in the darkness, when the 
fungus favours sexual development (Figure 5).  
Figure 6: Membrane-bound VapA-VapB-VipC trimeric complex predominates when sexual 
development is favoured. 
In the absence of light, VapA maintains the VapB-VipC heterodimer attached to the inner face of 
the plasma membrane, avoiding its internalization into the nucleus. Modified from Sarikaya-
Bayram et al., 2014. 
 
A yet unknown molecular mechanism results in the release of the VapB-VipC 
heterodimer from VapA and the membrane upon the right stimulus, and leads to the 





interferes with the function of the velvet protein VeA by avoiding its internalization into 
the nucleus, but also increasing its proteasomal degradation, preventing, sexual 
development (Figure 6).  
 
Figure 7: Release of VapB-VipC heterodimer from VapA interferes with the function of VeA 
A yet unknown signal promotes the release from VapA of the methyltransferases VapB and VipC. 
This heterodimer avoids the internalization of VeA into the nucleus and induces its proteasomal 
degradation in the cytoplasm. Modified from Sarikaya-Bayram et al., 2014. 
 
In the nucleus, VapB and VipC support the reduction of negative tri-methyl tags in 
the lysine 9 of the histone-3 (H3K9) posttranslational modifications and, therefore, 
promoting asexual development by enabling the expression of asexual related genes, such 
as brlA and abaA. Besides, this heterodimer can diminish the velvet complex formation in 
the nucleus by recruiting the VeA protein (Figure 7). Finally, the release of the VapB-VipC 
heterodimer from VapA leads to the activation of asexual development at the same time as 















Figure 8: VapB-VipC heterodimer avoids the formation of the velvet complex and promotes 
asexual development through histone modifications 
Inside the nucleus, VapB-VipC heterodimer impedes the formation of the velvet complex by 
recruiting VeA, therefore, inhibiting sexual development. Furthermore, due to its methyltransferase 
activity, it removes tri-methyl tags of the H3K9, enabling the expression of genes that controls 
asexual development. Modified from Sarikaya-Bayram et al., 2014. 
 
 
1.5 Aims of this work 
During the course of this study, homologous proteins of the VapA-VapB-VipC 
complex have been found in a set of Aspergillus species but the presence of some of its 
components is not always conserved. Analysis of several strains of A. fumigatus revealed 
the coexistence of two different Vap-Vip variants where the most abundant one has lost the 
vapB gene. The role and function of these proteins in this fungal pathogen are not yet 
known. The aim of this project was to characterize these proteins, to place the Vap-Vip 
system in the molecular context, and to analyse the cellular processes and the regulatory 
pathways where this system might be involved in A. fumigatus. Why did this system evolve 
to have two different variants and what is the relevance of both genomic configurations for 





This work gives insights about the importance and impact that these genes exert over 
key fungal processes. This study provides experimental evidences about the role of this 
system on the oxidative stress and the weak acidic response. It reveals the implications of 
these proteins in the biosynthesis control of fumiquinazolines and other secondary 
metabolites. It exposes a novel non-cyp51A mutation that regulates the expression of drug 
efflux transporter genes to increase the tolerance against certain azoles. In summary, the 
aims of this work is to characterize further the significance and the magnitude of this system 
over the fungal adaptive response in the biology of the human opportunistic pathogen 
Aspergillus fumigatus. For that purpose, a combination of phenotypic, genetic and 
proteomic approaches were conducted, revealing that this system may be part of a complex 
adaptive machinery in response to the changing environment. 
 




2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals, reagents and materials 
Chemicals used to make solutions, buffers and media were purchased from 
AppliChem GmbH (Darmstadt, Germany), Carl Roth GmbH & Co. KG (Karlsruhe, 
Germany), Fluka (now Sigma-Aldrich Chemie GmbH, Neu-Ulm, Germany), Merck KGaA 
(Darmstadt, Germany), Invitrogen (Carlsbad, CA, USA) Sigma-Aldrich Chemie GmbH 
(Taufkirchen, Germany), SERVA Electrophoresis GmbH (Heidelberg, Germany), 
Biozyme Scientific GmbH (Hessisch Oldendorf, Germany), Oxoid Limited (Basingstocke, 
United Kingdom), Oxoid Deutschland GmbH (Wesel, Germany). USB Corporation 
(Cleveland, United States of America), VWR International GmbH (Darmstadt, Germany), 
Novozymes (Bagsvaerd, Denmark), Roche Diagnostics GmbH (Mannheim, Germany), BD 
Becton Dickinson GmbH (Heidelberg, Germany) 
Also, deoxynucleotide mix, restriction enzymes, Phusion High fidelity DNA 
polymerase, DNA 1Kb Ladder, PageRulerTM Prestained Protein Ladder, Trypsin, RNaseA 
were purchased from: Thermo Fisher Scientific (Waltham, MA, United States of America), 
Roche Diagnostics GmbH (Mannheim, Germany), New England Biolabs (MA, United 
States of America), SERVA Electrophoresis GmbH (Heidelberg, Germany). 
Antibiotics for the selection of microorganism such as Ampicilin, Pyrithiamine 
hydrobromide, clonNAT nourseothricin dihydrgen sulfate and Phleomycin were obtained 
from Roth, Sigma-Aldrich, Werner-BioAgents (Jena, Germany) and Invivogen (CA, 
United States of America) 
Expendables such as plastic tubes, petri dishes, pipette tips, inoculation loops, etc., 
were purchased from Sarstedt Ag & Co. (Nümbrecht, Germany), StarLab GmbH 
(Hamburg, Germany), Nerbe Plus GmbH (Hamburg, Germany). Also, sterilization of 
solutions (small volumes) were carried out using Filtropur filters with a pore size of 0.2 and 
0.45 μm from Sarstedt. Mycelium was separated from liquid media by using Miracloth 
filters from Merck KGaA (Darmstadt, Germany). 




DNA purification from E. coli, gel extraction and cleaning, RNA isolation and 
cDNA-synthesis kits were purchased from Qiagen GmbH (Hilden, Germany) and 
Macherey-Nagel GmbH & Co. KG (Düren, Germany). 
DNA and protein concentrations were measured using a NanoDrop ND-1000 
photospectrometer from Peqlab Biotechnologie GmbH (Erlangen, Germany). 
Agarose gel electrophoresis was performed with Mini-Sub® Cell GT chambers and 
the PowerPacTM 300 power supply, and SDS-polyacrylamide gel electrophoresis and 
subsequent blotting with the Mini-Protean® Tetra Cell, Mini Trans-Blot® Electrophoretic 
Cell and powered with the PowerPacTM 3000 from Bio-Rad Laboratories (Hercules, CA, 
USA). 
DNA was transferred to AmershamTM Hybond-NTM ECL nylon membranes and 
proteins were transferred to AmershamTM ProtranTM 0.45 μm NC nitrocellulose blotting 
membranes from GE Healthcare Life Sciences (Buckinghamshire, United Kingdom) during 
Southern and Western hybridization, respectively, and, from the same company, 
AmershamTM HyperfilmTM-ECL was used for chemiluminescence detection.  
Primers were ordered from Eurofins Genomics GmbH (Ebersberg, Germany) 
Further materials and suppliers are indicated in the following sections. 
2.1.2 Strains, media and growth conditions 
2.1.2.1 Bacterial strain and culture conditions 
The Escherichia coli strain DH5α [F-, Δ(argF-lacZYA) U169, φ80dlacZΔM15-1, 
ΔphoA8, λ-, gyrA96, recA1, endA1, supE44, thi1, hsdR17 (rK-, mK+), relA1] (Woodcock 
et al., 1989) was used for general cloning procedures and expression of recombinant 
plasmids. E. coli cultures were grown in Lysogeny Broth medium (LB) (1% bactotryptone, 
0.5% yeast extract, 1% NaCl, pH 7.5) (Bertani, 1951) at 37°C on a shaker, for liquid LB 
medium. Solid medium was prepared by addition of 2% agar. The antibiotic Ampicillin 
was used as selective agent, when needed, at a concentration of 100 µg/ml. 
2.1.2.2 Fungal strains and culture conditions  
A. nidulans and A. fumigatus strains were cultivated in sterile Glucose Minimal 
Medium (GMM) [1% Glucose, 1X AspA (3.5 M NaNO3, 350 mM KCl, 560 mM KH2PO4, 
pH 5.5 with KOH), 2 mM MgSO4, 1X trace elements (5 g/L FeSO4 x 7H2O, 50 g/L EDTA, 




22 g/L ZnSO4 x 7H2O, 11g/L H3BO3, 5 g/L MnCl2 x 4H2O, 1.6 g/L CoCl2 x 6H2O, 1.6 g/L 
CuSO4 x 5H2O, 1.1 g/L (NH4)6Mo7O24 x 4 H2O; pH 6.5 with KOH)](Käfer, 1977)) or 
London Medium (LM) [1% glucose, 20 mL/L salt solution (26 g/L KCl, 26 g/L 
MgSO4x7H2O, 76 g/L KH2PO4 and 50 mL/L 1000X trace element solution, 10 mM NaNO3, 
pH 6.5 with NaOH] (Käfer, 1977). For solid medium plates, 2% agar was added. Standard 
growth of Aspergillus strains was performed at 37°C under white light or dark conditions. 
According to the experimental conditions, different antibiotics and supplements were added 
to the medium. For A. fumigatus pyrithiamine (final concentration 100-150 ng/mL (Takara 
Bio Europe, Saint-Germain-en-Laye, France)), and different concentrations of 
VFend/voriconazole (Pfizer, New York City, NY, United States of America), itraconazole 
(Sigma-Aldrich Chemie GmbH), and amphotericin B (Sigma-Aldrich Chemie GmbH) were 
used. Despite the use of these antifungal agents, in the case of strains with the A1160 
background, it was also necessary the addition to the medium of uracil and uridine, due to 
the pyrG1 genotype of this strain (final concentration 1gr/L and 0.025%, respectively). For 
A. nidulans, either phleomycin (final concentration 80 μg/mL; Cayla-InvivoGen, Tolouse, 
France) or clonNAT nourseothricin dihydrogen sulfate (final concentration 120 μg/mL 
(Werner BioAgents, Jena, Germany)) were added. Apart from antibiotics, cultivation of 
strains with AGB552 background also required the addition of 4-aminobenzoic acid 
(PABA, final concentration 0.0001%) and strains with the AGB551 background needed the 
supplementation of uracil (final concentration 1gr/L), uridine (final concentration 0.025%) 
and pyridoxin (final concentration 0.0001%) in the medium.  
For vegetative growth, Aspergilli were cultivated in liquid medium at 37°C in baffled 
flasks under shaking conditions for 16-24 h. To induce asexual development in 
A. fumigatus, spores were plated in solid MM or LM and incubated without illumination at 
37°C for three days. Then, conidiospores were harvested in 0.96% NaCl with 0.02% 
Tween-80 (Sigma-Aldrich) and stored at 4°C. The concentration of these spore solutions 
was determined using a counting chamber and used for the subsequent experiments. Note 
that, due to the experimental requirements, these culture conditions can be modified and 
they will be properly detailed when it corresponds. 
In the case of A. nidulans, to induce asexual development and obtain the 
conidiospores, the procedure is the same but keeping the plates under constant illumination. 
However, sexual development in this fungus was induced by cultivation of the solid 




medium plates at 37°C in the darkness and sealing the plates with Parafilm® M (Merck) to 
restrict the aeration.  
To obtain synchronized cultures of Aspergilli as a starting point for some of the 
experiments that will be further described in the ‘Methods’ part, strains were grown for 16-
24 h in submerged cultures. After this, mycelia were harvested and washed through sterile 
Calbiochem Miracloth filters (MERCK) and subsequently shifted onto solid MM or LM 
plates (Osiewacz, 2002). Fungal strains used in this study are listed in table 1 
 
Table 1: Fungal strains used in this study 
P = promoter, phleoR = phleomycin resistance cassette (non-recyclable), phleoRM = 
recyclable phleomycin resistance cassette, ptrAR = pyrithiamine resistance cassette (non-
recyclable). AGB corresponds to A. nidulans strains and AfGB or AfS corresponds to 
A. fumigatus strains. FGSC = Fungal Genetics Stock Center. Med. Microb. = Medical 
Microbiology. p. c. = personal communication  
Strain name Genotype/Information Reference 
FGSC #A4  veA+ FGSC, McCluskey, 
Wiest, & Plamann, 2010 
AGB551 ΔnkuA::argB, pyrG89, pyroA4, veA+ Bayram et al., 2012 
AGB552 ΔnkuA::argB, pabaA1, yA2, veA+  Bayram et al., 2012 
AGB741 ΔvipC::ptrA, ΔnkuA::argB, pyrG89, 
pyroA4, veA+ 
Sarikaya-Bayram et al., 
2014 
AGB743 ΔvapA::ptrA, ΔnkuA::argB, pyrG89, 
pyroA4, veA+ 
Sarikaya-Bayram et al., 
2014 
AGB745 ΔvapB::ptrA, ΔnkuA::argB, pyrG89, 
pyroA4, veA+ 
Sarikaya-Bayram et al., 
2014 
AGB1188 AnPvapA::AfvapA::phleoRM, ΔvapA::ptrA, 
ΔnkuA::argB, pabaA1, yA2, veA+ 
This study 
Af293, FGSC #A1100 A. fumigatus Wild-type, MAT1-2 Nierman et al., 2005 
AfGB147 (FGSC 
#A1160) 
A. fumigatus ΔakuB (ΔKU80), pyrG-, 
MAT1-1 (A1163 background) 
FGSC, McCluskey, 
Wiest, & Plamann, 2010 
AfGB148 (AfS77, 
FGSC #A1280) 
ΔakuA::loxP, MAT1-1 (ATCC46645 
background) 
Krappmann, S., 
Hartmann et al., 2010 
AfS35, FGSC #A1159 ΔakuA::loxP, MAT 1-2 Krappmann, Sasse, & 
Braus, 2006 




E1 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E4 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E18 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E58 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E66 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E70 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E73 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E86 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E97 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E123 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E162 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E168 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E171 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E227 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E235 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E255 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E259 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E280 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 




E320 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E329 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E362 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E391 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
E397 A. fumigatus WT. Environmental (E) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
CI541 A. fumigatus WT. Clinical isolated (CI) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
CI542 A. fumigatus WT. Clinical isolated (CI) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
CI543 A. fumigatus WT. Clinical isolated (CI) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
CI544 A. fumigatus WT. Clinical isolated (CI) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
CI545 A. fumigatus WT. Clinical isolated (CI) 
strain. Origin: Germany 
O. Bader (Med. Microb. 
Göttingen), p. c. 
AfGB149 ΔvapA::six, ΔakuA::loxP (AfS35 
background) 
This study 
AfGB150 ΔvipC1::ptrAR, ΔakuA::loxP (AfS35 
background) 
This study 
AfGB151 ΔvipC2::six, ΔakuA::loxP (AfS35 
background) 
This study 
AfGB152 ΔvapA::six, ΔvipC1::ptrAR, ΔakuA::loxP 
(AfS35 background) 
This study 
AfGB153 ΔvapA::six, ΔvipC2::six, ΔakuA::loxP 
(AfS35 background) 
This study 
AfGB154 ΔvipC1::ptrAR, ΔvipC2::six, ΔakuA::loxP 
(AfS35 background) 
This study 
AfGB155 ΔvapA::six, ΔvipC1::ptrAR, ΔvipC2::six, 
ΔakuA::loxP (AfS35 background) 
This study 
AfGB156 PvapA::vapA::sgfp::six, ΔvapA::six, 
ΔakuA::loxP (AfS35 background) 
This study 




AfGB157 PvipC2::vipC2::sgfp::six, ΔvipC2::six 
ΔakuA::loxP (AfS35 background) 
This study 
AfGB158 ΔvipC2::six, ΔakuA::loxP (AfS77 
background) 
This study 
AfGB159 ΔvapB::six, ΔakuB (ΔKU80), pyrG- 
(A1160 background) 
This study 




2.2 Nucleic acid methods 
2.2.1 Plasmid-DNA isolation and linearized DNA fragments purification 
Plasmid DNA was extracted from o/n cultures of E. coli by utilization of the 
QIAprep® Spin Miniprep Kit (Qiagen) or the NucleoSpin® Plasmid Kit (Macherey-Nagel) 
according to manufacturer’s specifications. Plasmid DNA was eluted from spin columns 
with 30-50 μl dH2O and stored at -20°C. 
2.2.2 Polymerase chain reaction (PCR) (Saiki et al., 1988) 
This technique was used to amplify DNA fragments from different sources such as 
plasmid-DNA, gDNA or cDNA for plasmid construction and to check if those generated 
plasmids were correct after seamless cloning and E. coli transformation (colony PCR) 
(Hofmann et al., 1991; Bergkessel et al., 2013). PCRs were performed in T Professional 
Standard 96, T Professional Trio 48 and T Professional Standard 96 Gradient thermocyclers 
from Biometra GmbH (Göttingen, Germany) and in Primus 96 Thermal Cyclers from 
MWG Biotech AG (Ebersberg, Germany). Phusion® High-Fidelity DNA Polymerase 
(Thermo Scientific) was used for DNA amplification and PCR programs were designed 
after manufacturer’s instructions and according to calculated melting temperatures (Tm) of 
utilized primers. The online ‘Tm calculator’ tool from New England Biolabs was used to 
determine the Tm of the primers and to estimate the annealing temperature of the reaction. 
2.2.3 Genomic DNA (gDNA) isolation and purification from fungal tissue 
Strains were inoculated in liquid medium and grown overnight (o/n) for the extraction 
of genomic DNA. Mycelia were harvested through Miracloth filters (Merck), frozen in 
liquid nitrogen and ground with a MM400 table mill from Retsch Technology GmbH 




(Haan, Germany). The resulting powder was mixed with 500 μl genomic DNA lysis buffer 
(Lee et al., 1990) (50 mM Tris-HCl pH 7.2, 50 mM EDTA, 3% SDS, 1% β-
mercaptoethanol), incubated, first, 15 min at 65°C, and cooled down 5 min on ice. Then, 
these solutions were mixed with 200 μl 8 M potassium acetate and centrifuged for 15 min 
at 13000 rpm at room temperature (rt). Supernatant was transferred into new tubes, mixed 
with 300 μl isopropanol and centrifuged 15 min at 13000 rpm at rt. DNA pellets were 
washed once with one ml 70% ethanol, centrifuged again 5 min and dried at 65°C prior 
their complete dissolution in H2O at 65°C. 
2.2.4 Agarose gel electrophoresis 
By the use of this technique, DNA fragments were separated according to size (Lee 
et al., 2012). 1% agarose gels in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) 
were used. For the detection of the DNA fragments, 0.001 mg/ml ethidium bromide was 
added to the mixture. DNA was applied in 10x DNA loading dye and visualized in-gel by 
exposure to UV light (λ = 254 nm). The visualization took place in a Gel iX20 Imager 
Windows Version and the Intas GDS gel documentation software from Intas Science 
Imaging Instruments GmbH (Göttingen, Germany) or on a TFX-20 MX Vilber Lourmat 
Super Bright transilluminator (Sigma-Aldrich). 
2.2.5 Purification of DNA-fragments from agarose gels 
Linearized DNA fragments from PCR amplification, enzymatic digests for plasmid 
linearization or construct excision were mixed with 10x DNA loading dye (10% Ficoll 400, 
200 mM EDTA pH 8.0, 0.2% bromophenol blue, 0.2% xylene cyanol FF), separated by 
agarose gel electrophoresis and gel pieces with respective DNA bands were cut out of the 
gel. DNA from these gel pieces were purified by employing the QIAquick® Gel Extraction 
Kit (Qiagen) or the NucleoSpin® Gel and PCR Clean-up Kit from Macherey-Nagel GmbH 
& Co. KG (Düren, Germany). Please note that after linearization of a circular plasmid 
digested with an enzyme that possess a unique restriction site, there is no need of loading it 
into a gel. The yield of the process can be increased by purifying directly the DNA from 
the digestion solution. 
 
2.2.6 Isolation and purification of fungal RNA and cDNA synthesis 
Similarly, strains were inoculated in liquid medium and grown o/n for vegetative 




tissue or, these mycelia from o/n cultures were shifted to solid medium plates under light 
or darkness conditions to induce asexual development during 12, 24 or 48 hours prior 
sample preparation for RNA extraction. Mycelia were harvested through sterile Miracloth 
filters and immediately frozen in liquid nitrogen. For asexual mycelia, an extra step to 
remove the spores as much as possible before freezing them was included. Frozen mycelia 
were ground with a table mill and approximately 200 μl of the resulting powder was 
processed for RNA isolation using the RNeasy® Plant Miniprep Kit from Qiagen (Hilden, 
Germany) according to manufacturer’s instructions without addition of β-mercaptoethanol. 
Concentrations of RNA were measured with a Nanodrop ND-1000 (PeqLab). cDNA was 
transcribed from approximately 0.8 μg RNA with the QuantiTect® Reverse Transcription 
Kit (Qiagen) according to manufacturer’s conditions. 
2.3 Genetic manipulation of microorganisms 
2.3.1 Transformation of bacteria 
Transformation of Escherichia coli was performed using the heat-shock method as 
described by Hanahan, Jessee, & Bloom, 1991; Inoue, Nojima, & Okayama, 1990. Shortly, 
the procedure is as follows, chemo-competent E. coli cells were incubated with plasmid 
DNA for 30 min on ice and subsequently heat shocked at 42°C during 30-60 seconds to 
allow plasmid uptake, and immediately cells were cooled down on ice for one to two 
minutes. Then, 800 μl of LB was added and cultures were incubated for 30 to 60 min at 
37°C on a rotary shaker. After this, E. coli cells were harvested by centrifugation and 
inoculated on solid LB plates supplemented with 1:1000 ampicillin (final concentration: 
100 µg/ml) to prevent plasmid loss and allow for selection of the clones, which successfully 
incorporated the plasmid. Plates were grown o/n at 37°C. Next day, E. coli colonies were 
screened for positive clones that successfully incorporated the right plasmid via PCR 
amplification of specific fragments present in the respective constructs (colony PCR). 
2.3.2 Transformation of fungi 
A. fumigatus and A. nidulans were transformed by polyethylene glycol-mediated 
protoplast fusion as described by (Punt et al., 1992). For all genetic modifications in 
A. fumigatus, AfS35, AfS77, and A1160 (FGSC A1160 (CEA17), derived from the A1163 
(CEA10)) were used as WT and transformation host of the different deletion constructs. 
Single vapA, vipC1 and vipC2 knockouts in the AfS35 background were also used as hosts 




for the generation of all the double and triple deletion mutants, as described above. In the 
case of A. nidulans, AGB551, AGB552 and their derived strains were used as hosts for the 
subsequent transformations. All the host strains used in this study harbour the ΔakuA (or 
ΔakuB) and ΔnkuA mutation for A. fumigatus and A. nidulans, respectively (see genotypes 
in the strains table). Loss of these orthologous genes remarkably increases homologous 
recombination during transformation and results in on-locus integration of linearized 
genetic constructs (Krappmann et al., 2006; Nayak et al., 2006). 
Fresh spores of the host strains were inoculated in liquid medium and grown o/n on 
a rotary shaker at 37°C. Next day, mycelia were harvested through sterile Miracloth filters 
(Merck) and washed with sterile citrate buffer (150 mM KCl, 580 mM NaCl, 50 mM Na-
citrate pH 5.5). These mycelia were transferred into new autoclaved flasks and mixed with 
protoplastation solution (30mg/ml Vinoflow® Max or Vinotaste® Pro from Novozymes 
(Bagsvaerd, Denmark) (for A. nidulans protoplastation, 15 mg/ml of lysozyme (Serva) was 
also needed), dissolved in citrate buffer and sterile filtered through 0.45 μm filters (Sarstedt) 
and incubated for 60-90 min at 30°C under constant gentle agitation to allow the 
protoplastation. Formation of protoplasts and its efficiency was monitored by microscopy. 
Protoplasts were filtered through sterile Miracloth filters and collected in pre-cooled sterile 
50 ml centrifuge tubes (Sarstedt). Then, samples were filled up to 50 ml with ice cold STC 
1700 buffer (1.2 M sorbitol, 10 mM Tris pH 5.5, 50 mM CaCl2, 35 mM NaCl) and incubated 
on ice for 10 min. Subsequently, protoplasts were centrifuged at 2500 rpm at 4°C for 12 
min and washed with ice cold STC1700. This step was repeated once more. Protoplasts 
were incubated in 15 ml tubes with approximately 2 to10 μg of respective DNA linear 
constructs (after excision from respective plasmids) for 30 min on ice. 1.35 ml sterile PEG 
solution (10 mM Tris pH 7.5, 50 mM CaCl2, 60% (v/v) PEG4000) was added sequentially 
in three steps, two times 250 μl and one time 850 μl, to increase DNA uptake of protoplasts 
and they were incubated for another 20-30 min over the ice, to avoid crystals formation. 
After that, tubes were filled up to 15 ml with ice cold STC 1700 buffer again and centrifuged 
at 2500 rpm for 15 min. Supernatants were discarded and protoplasts distributed on freshly 
prepared solid MM or LM plates, supplemented with 1.2 M sorbitol and respective selecting 
agents (pyrithiamine 1:1000, nourseothricin 0.7:1000 or phleomycin 1:1000). After three 
to seven days, individual positive clones were picked and they were singularized twice on 
selective MM or LM plates. Successful transformation of constructs into A. fumigatus and 
A. nidulans hosts was verified by Southern hybridization. Recyclable marker cassettes were 




eliminated from the genome of respective mutants by growing the fungus in the presence 
of xylose (0.5% glucose, 0.5% xylose MM or LM plates) and isolating single colonies two 
times (Hartmann et al., 2010). Successful marker recycling was monitored by Southern 
hybridization again. 
2.4 Plasmid construction, cloning and ligation for the genetic manipulation of 
fungi 
Fungal strains carrying NHEJ-deficient (Non-Homologous End Joining repair) 
mutations were used as transformation hosts in this study. They have an increased 
frequency of Homologous Recombination (HR) that allows transformation on-locus with 
higher efficiency and yield. Based on this, and for the knockout mutant strains generation, 
1.2-2 kilobases fragments of the flanking UTR regions (FR) of the gene of interest were 
amplified and inserted into a cloning vector. In between these two FR, instead of the target 
gene, it’s placed a recyclable marker that consist in: a resistance cassette against an 
antibiotic as selective agent, a prokaryotic small β-serine recombinase (β-rec) under the 
control of a xylose-inducible promotor (xylP) followed by a fungal terminator region (trpCt), 
and its six recognition sequences flanking this whole recyclable marker (Rojo et al., 1993, 
1994; Canosa et al., 1996; Hartmann et al., 2010) (Figure 9).  
This system allows the removal of the marker cassette from the fungal genome once 
the transformation succeed by growing the fungus in the presence of xylose. Therefore, 
having a marker-free deletion mutant and the possibility to use the same antibiotic as a 
selective agent for a next round of transformation over the same host. This system also 
prevents the accumulation of large resistance cassettes integrated in the genome of the 
fungus, which can lead to undesired side effects. 
Two different recyclable marker cassettes were used in this study: pSK485 harbours 
the A. oryzae ptrA gene, which confers resistance against pyrithiamine (Hartmann et al., 
2010), and pME4305 (J. Gerke) harbours the ble gene from Streptoalloteichus hindustanus, 
which confers resistance to phleomycin (Drocourt et al., 1990). 





Figure 9: Schematic representation of a resistance recyclable marker in a KO construct 
5’ and 3’ UTRs are amplified with overhang regions complementary to the cloning vector (pink) 
and to the recyclable marker. Also, two unique restriction sites are generated at both sides of the 
deletion construct to allow scission from the plasmid (procedure of plasmid design and construction 
is detailed in the text and also in section 1.3.1.). xylP = xylose-inducible promotor, β-rec = 
prokaryotic small β-serine recombinase, trpCt = fungal terminator region, six = β-rec recognition 
sequences. Modified according to Hartmann et al., 2010. 
 
Primer design and cloning strategy for the generation of the different individual 
constructs will be detailed in the corresponding sections but, in general, there are some 
aspects that need to be considered: 1) For ‘on-locus’ transformation of fungi, a linear 
fragment is needed. 2) This linear fragment will consist in two regions where the 
recombination will occur (5’ and 3’ UTRs in Figure 1) flanking the recyclable marker. 3) 
This fragment will be excised from the plasmid, prior transformation, by the use of specific 
endonucleases. 4) This DNA fragment will be integrated in the fungal genome due to two 
events of HR that will take place in the flanking homologous regions. 
The restriction sites that will be recognised by the specific nuclease need to be 
generated at both sides of the linear fragment that will be used to transform in the 
subsequent steps. These endonucleases recognise long and rare restriction sites in the DNA. 




One of the most commonly used is MssI (also called PmeI), whose target sequence is 
GTTT/AAAC, and it cuts directly in the middle.  
The vector used as a backbone for the construction of all the deletion and 
complementation strains of this study was the pBluescript SK+. All constructs harbouring 
a recyclable marker cassette and not recyclable were cloned into the EcoRV multi-cloning 
site (MCS) of the same vector. The plasmids constructed and used in this study are listed 
in the table 4. The primers used to amplify DNA fragments to produce all the different 
plasmids of this study are listed in the table 5. The software used for designing the maps of 
the constructs and the primers was Lasergene from DNA Star Inc. (Madison, WI, USA). 
Genetic sequences and information were obtained from Ensembl Fungi (Kersey et al., 
2018), AspGD (Cerqueira et al., 2014) and CADRE (Mabey et al., 2004) 
Table 2: Plasmids used and generated in this study 
Genes and/or flanking UTRs coming from A. nidulans are denoted as AN. The rest of DNA sequences 
and fragments, from A. fumigatus, are denoted as Afu. All plasmids constructed in this study use 
pBluescript SK+ as backbone, if not stated otherwise. P = promoter, t = terminator, R = resistance. 
prtARM = recyclable ptrA resistance cassette from pSK485, phleoRM = recyclable phleo resistance 
cassette from pME4305 
Plasmid Description Reference 
pBluescript SK+ Cloning vector, ampR  Fermentas GmbH 
pME4305 six-PxylP::β-rec::trpCt-phleoR-six J. Gerke 
pSK485 six-PxylP::β-rec::trpCt-ptrAR-six Hartmann et al., 2010 
pME4292 Plasmid containing sgfp B. Jöhnk 
pME4741 P-ANvapA::AfuvapA::t-AfuvapA::phleoRM This study 
pME4742 Afu∆vapA::ptrARM This study 
pME4743 Afu∆vipC1::ptrAR This study 
pME4744 Afu∆vipC2::ptrARM This study 
pME4745 P-AfuvapA::AfuvapA::sgfp::ptrARM This study 
pME4746 P-AfuvipC2::AfuvipC2::sgfp::ptrARM This study 
pME4747 Afu∆vapB::ptrARM This study 
 




For the integration of all the fragments into de backbone vector, the GeneArt® 
Seamless Cloning and Assembly Kit (Invitrogen) or the GeneArt® Seamless Cloning and 
Assembly Enzyme Mix (Invitrogen) was used. Primers used for seamless cloning reactions 
were designed to introduce 15 base pairs (bp) complementary to adjacent sequences in the 
way that two adjacent sequences share a 15 bp homology region. 
As templates for DNA amplification in A. fumigatus, genomic DNA from the AfS35, 
AfS77 (ATCC 46645 background) and A1160 (A1163 background) strains were used. For 
A. nidulans, gDNA from the FGSC A4, AGB551 and AGB552 WT strains were used 
Generated plasmids were sequenced, when necessary, by Seqlab Sequence 
Laboratories GmbH (Göttingen, Germany) and the obtained sequences were analysed with 
the Lasergene software package (DNA Star Inc.) 
Table 3: Oligonucleotides used in this study for DNA sequence amplification and plasmid 
construction 
Designation 5’ – sequence – 3’ Size 
CS998 GCG CGT AAT ACG ACT CAC 18mer 
CS999 TAA CCC TCA CTA AAG GGA AC 20mer 
CS1062 AAC AAT TCG ACT TAC AAG CC 20mer 
sGFP Fw GGT GGT AGC GGT GGT GTG AGC AAG GGC GAG GAG 33mer 
sGFP Rv CCT ATA GGC CTA TTT AAA GAA GGA TTA CCT CTA 
AAC AA  
38mer 
HA01 ATC GAT AAG CTT GAT GTT TAA ACG GCG CAC GCG 
GGA A 
37mer 
HA04 CTG CAG GAA TTC GAT GTT TAA ACC ACC CAC TTG 
GTT TAG GAT CTC 
45mer 
HA05 ATC GAT AAG CTT GAT GTT TAA ACG CAG CTA GGA 
TAG ATC 
39mer 
HA07 ATA ATA TGG CCA TCT AAG ACT GTT GTT TCA AAG 
AGC 
36mer 
HA08 CTG CAG GAA TTC GAT GTT TAA ACT AGG ATC CCT 
TGC G 
37mer 
HA09 ATC GAT AAG CTT GAT GTT TAA ACA TTT CCT TCG 
AAC TG 
38mer 
HA10 TTG ACC TAT AGG CCT ATT TAA ATC TTC GCT GTA TCC 
TCT TAT G 
43mer 
HA11 ATA ATA TGG CCA TCT CGA AAA TCG CTT TGC ATT 
TTC C 
37mer 
HA12 CTG CAG GAA TTC GAT GTT TAA ACT CCG GCC ATT 
CCC G 
37mer 
HA13 ATA CAG CGA AGA TTT ATG TCC AGT CAG AAC GAC 
CC  
35mer 
HA14 ACC ACC GCT ACC ACC CGT GGT AGC GCT CAT GTT TG  35mer 




HA15 TCA CCG CTA TCA TTT ATG GCC AGT CCA AGA CCA 
CAA TC  
38mer 
HA16 ACC ACC GCT ACC ACC ATC CGT CTC GGG CCG CTG  33mer 
HA17 AAG TGA GCA GAA TTT ATG GCG GGG GAA AAG CAC  33mer 
HA18 ACC ACC GCT ACC ACC ATC CTG TGG CTT CTG ACC 
GTA AAC  
39mer 
HA19 TTG ACC TAT AGG CCT CAC GTG TCT GCT CAC TTG 
AAC TGT TC 
41mer 
HA20 CAA GTG AGC AGA CAC ATG GCG GGG GAA AAG CAC  
HA21 ACC TAT AGG CCT CAC AAA GAA GGA TTA CCT CTA 
AAC AA 
38mer 
HA22 GGT GGT AGC GGT GGT GTG AGC AAG GGC GAG GAG 33mer 
HA45 TCT TGC ATC TTT GTT TGT ATT A 22mer 
HA46 AGA TCT GAC AGA CGG GCA 18mer 
HA47 AAC AAA GAT GCA AGA GAT AGC GGT GAT GTG ATT 
GAT GAT GGA G 
43mer 
HA48 CCG TCT GTC AGA TCT TCC CGT GCG GGC ATA ACA 33mer 
HA51 ACG GTA TCG ATA AGC TTG ATA TTT AAA TGA ACG 
CTT GAC GTG 
42mer 
HA52 GGG TCG TTC TGA CTG GAC ATG GTT AAG GAC GGT 
GGG TC 
38mer 
HA53 ATG TCC AGT CAG AAC GAC CC 20mer 
HA54 TAT TGA CCT ATA GGC CTG AGA CAG TCG GCA CAG 
ATC AAT C 
40mer 
HA57 TGA GCA TAA TAT GGC CAT CTT GAA GGG AGC GAG 
ACT CC 
38mer 
HA58 CCG GGC TGC AGG AAT TCG ATA TTT AAA TCG GGT 
CCT TAC TAT TCG AG 
47mer 
HA174 AGG AAT TCG ATA TTT GTT TAA ACC TCT TGT AGG 
TCA ACC 
39mer 
HA175 ATA GGC CTG AGA TTT AAA TGG TTG CTA GTC GCT 
ATA TTT G 
40mer 
HA176 ATA TGG CCA TCT CAC GGA ATA GTC GCA AAC ACT CC 35mer 
HA177 GAT AAG CTT GAT CAC GTT TAA ACT CGA CGT TTC 
GAG C 
37mer 
HA180 ATG TCG ACA TCC CAG TCC 18mer 
HA181 TCA GGA CTT TGG AGT CTC G 19mer 
HA182 ATG CTT ACC GCG CTG GAT C 19mer 
HA183 CTA TGG CTT CCA GCC GGC 18mer 
HA184 ATG GCG GAC ACG GAG CAC 18mer 
HA185 CTA CTC CGG CTT CTG CCC ATA AAC 24mer 
 
2.4.1 Plasmid and strain construction of A. fumigatus and A. nidulans mutants 
Genomic DNA of AfS35 (A. fumigatus WT, ΔakuA) was used as template, if not 
stated otherwise. Note that all DNA fragment sizes given in the upcoming sections as a 
result of the cloning procedure are rounded. Only those that comes from PCR amplification 




products for plasmid construction or as a result of plasmid digestion for fragment excision 
for transformation refers to linear fragments.  
2.4.1.1 Generation of the ΔvapA deletion construct and ΔvapA knockout strain in 
A. fumigatus AfS35 
For the generation of the vapA deletion strain in A. fumigatus, 1.6 kb long fragment 
of the 5’ UTR immediately adjacent to the vapA gene (AFUA_5G11190) was amplified 
from A. fumigatus AfS35 WT genomic DNA with the primer pair HA09/HA10 introducing 
15 nts overlapping with the pBluescript SK+ (in the tail of the HA09 primer) and an 
overhang of 15 nts homolog to the six site of the recyclable marker cassette, respectively. 
In the tail of the HA10 primer, between the gDNA annealing region and the six site 
overlapping region, it was included the 8 nts that are recognised by SwaI as restriction 
cutting site. This will allow the generation of the VapA-GFP complementation strain faster 
and easier as it will be explained later in the coming section. The respective 1.6 kb long 
fragment of the 3’ UTR right after the gene was amplified with the primer pair HA11/HA12 
and, as for the 5’ UTR, it also contains overhangs of 15 bp homolog to the six site of the 
recyclable marker cassette (in the tail of the HA11 primer) and pBluescript SK+ (in the tail 
of the HA12 primer). Both sequences and the PtrA-recyclable marker cassette were cloned 
into the EcoRV multi-cloning site of the pBluescript SK+ in a seamless cloning reaction 
according to manufacturer’s instructions, resulting in the generation of the pME4742 
plasmid. The linear deletion cassette was subsequently excised with PmeI (MssI), purified, 
and transformed into AfS35 WT, resulting in the generation of the strain AfGB149. The 
correct replacement of the original gene with the deletion construct was verified by 
Southern hybridization before and after the marker recycling. 
2.4.1.2 Generation of the ΔvipC1 deletion construct and ΔvipC1 knockout strain in 
A. fumigatus AfS35 
For the ΔvipC1 strain generation in A. fumigatus, a different approach was conducted. 
It involves the use of a regular PtrA resistance cassette and not a recyclable marker. The 
procedure is similar, though, and it was performed as it follows. 
1.8 kb long fragment of the 5’ UTR immediately adjacent to the vipC1 gene 
(AFUA_8G01930) was amplified with the primer pair HA01/HA47 introducing 15 nts 
overlapping with the pBluescript SK+ and an overhang of 15 nts homolog to the PtrA 




resistance cassette, respectively. The respective 1.6 kb long fragment of the 3’ UTR right 
after the gene was amplified with the primer pair HA48/HA04 and, as for the 5’ UTR, it 
also contains overhangs of 15 bp homolog to the PtrA resistance cassette and 
pBluescript SK+, respectively. The 2 kb of the ptrA resistance cassette was amplified from 
the pSK485 plasmid with the HA45/HA46 primer pair (no overlapping regions). Both 
UTRs and the PtrA-resistance cassette were cloned into the EcoRV multi-cloning site of 
the pBluescript SK+ in a seamless cloning reaction according to manufacturer’s 
instructions, resulting in the generation of the pME4743 plasmid. The linear deletion 
cassette was subsequently excised with PmeI (MssI), purified, and transformed into AfS35 
WT, resulting in the generation of the strain AfGB150. The correct replacement of the 
original gene with the deletion construct was verified by Southern hybridization. 
2.4.1.3 Generation of the ΔvipC2 deletion construct and ΔvipC2 knockout strain in 
A. fumigatus AfS35 
The procedure and the strategy are identical as for the generation of the ΔvapA strain 
with some differences that will be mentioned below. 
For the generation of the vipC2 deletion strain in A. fumigatus, 2 kb long fragment of 
the 5’ UTR immediately adjacent to the vipC2 gene (AFUA_3G14920) was amplified from 
A. fumigatus AfS35 WT genomic DNA with the primer pair HA05/HA19 introducing 15 
nts overlapping with the pBluescript SK+ and an overhang of 15 nts homolog to the six site 
of the recyclable marker cassette, respectively. In the tail of the HA19 primer, between the 
gDNA annealing region and the six site overlapping region, it was included the 6 nts that 
are recognised by PmlI as restriction cutting site. This will allow the generation of the 
VipC2-GFP complementation strain faster and easier as it will be explained later in the 
coming section. The respective 1.5 kb long fragment of the 3’ UTR right after the gene was 
amplified with the primer pair HA07/HA08 and, as for the 5’ UTR, it also contains 
overhangs of 15 bp homolog to the six site of the recyclable marker cassette and pBluescript 
SK+, respectively. Both sequences and the PtrA-recyclable marker cassette were cloned 
into the EcoRV multi-cloning site of the pBluescript SK+ in a seamless cloning reaction 
according to manufacturer’s instructions, resulting in the generation of the pME4744 
plasmid. The linear deletion cassette was subsequently excised with PmeI (MssI), purified, 
and transformed into AfS35 WT, resulting in the generation of the strain AfGB151. The 




correct replacement of the original gene with the deletion construct was verified by 
Southern hybridization before and after the marker recycling. 
2.4.1.4 Generation of the ΔvapA/ΔvipC1 double knockout strain in A. fumigatus 
AfS35 
The ΔvapA strain was used as host for the transformation with the vipC1 deletion 
construct (5’UTR-PtrA-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4743 with PmeI (MssI), purified, 
and transformed into AfS35 ΔvapA, resulting in the generation of the double deletion strain 
AfGB152. The correct replacement of the vipC1 gene with the deletion construct was 
verified by Southern hybridization. 
2.4.1.5 Generation of the ΔvapA/ΔvipC2 double knockout strain in A. fumigatus 
AfS35 
The ΔvipC2 strain was used as host for the transformation with the vapA deletion 
construct (5’UTR-PtrA_Rec.Mark-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4742 with PmeI (MssI), purified, 
and transformed into AfS35 ΔvipC2, resulting in the generation of the double deletion strain 
AfGB153. The correct replacement of the vapA gene with the deletion construct was 
verified by Southern hybridization. 
2.4.1.6 Generation of the ΔvipC1/ΔvipC2 double knockout strain in A. fumigatus 
AfS35 
The ΔvipC2 strain was used as host for the transformation with the vipC1 deletion 
construct (5’UTR-PtrA-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4743 with PmeI (MssI), purified, 
and transformed into AfS35 ΔvipC2, resulting in the generation of the double deletion strain 
AfGB154. The correct replacement of the vipC1 gene with the deletion construct was 
verified by Southern hybridization. 




2.4.1.7 Generation of the ΔvapA/ΔvipC1/ΔvipC2 triple knockout strain in 
A. fumigatus AfS35 
The ΔvapA/ΔvipC2 strain was used as host for the transformation with the vipC1 
deletion construct (5’UTR-PtrA-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4743 with PmeI (MssI), purified, 
and transformed into AfS35 ΔvapA/ΔvipC2, resulting in the generation of the triple deletion 
strain AfGB155. The correct replacement of the vipC1 gene with the deletion construct was 
verified by Southern hybridization. 
2.4.1.8 Generation of the VapA-GFP tagged complementation strain in A. fumigatus 
AfS35 
The vapA knockout strain was used as host for the generation of the GFP-tagged 
VapA complementation strain. For the production of the VapA-GFP complementation 
construct, the pME4742 plasmid was opened with SwaI between the 5’UTR and the PtrA 
recyclable marker, where its restriction site was included. The 1.2 kb long vapA gene was 
amplified from the AfS35 WT strain of A. fumigatus using the HA13/HA14 primer pair. 
Again, as it is required for the seamless cloning ligation procedure, overhang regions were 
included in the primer tails: in the HA13, 15 bp overlapping with 5’ UTR; and 15 bp 
overlapping with the linker that connects the vapA gene with the GFP in the HA14. 
Importantly, in the HA14 primer, the vapA stop codon needs to be removed for the correct 
translation of the GFP if you want the tag in the Ct of your gene of interest. The sGFP 
together with a termination region known as trpCt (700 bp each, approximately) were 
amplified as a unique DNA fragment (from now on called just as ‘GFP’) using the 
HA22/sGFP Rv primer pair from the pME4292 plasmid. Finally, vapA gene and GFP were 
cloned into the SwaI site of the linearized pME4742 plasmid in a seamless cloning reaction 
according to manufacturer’s instructions, resulting in the generation of the pME4745 
plasmid. The linear complementation construct (5’UTR-vapA-GFP-PtrA_Rec.Mark-
3’UTR) was subsequently excised with PmeI (MssI), purified, and transformed into AfS35 
ΔvapA strain, resulting in the generation of the complementation strain AfGB156. The 
correct reinsertion of the original vapA gene tagged with GFP was confirmed by Southern 
hybridization before and after the marker recycling. 




2.4.1.9 Generation of the VipC2-GFP tagged complementation strain in A. fumigatus 
AfS35 
The procedure is identical as for the generation of the VapA-GFP complementation 
strain with some differences that will be described below. 
The vipC2 knockout strain was used as host for the generation of the GFP-tagged 
VipC2 complementation strain. For the production of the VipC2-GFP complementation 
construct, the pME4744 plasmid was opened with PmlI between the 5’UTR and the PtrA 
recyclable marker, where its restriction site was included. The 1.5 kb long vipC2 gene was 
amplified from the AfS35 WT strain of A. fumigatus using the HA20/HA18 primer pair. 
Again, as it is required for the seamless cloning ligation procedure, overhang regions were 
included in the primer tails: in the HA20, 15 bp overlapping with 5’ UTR; and 15 bp 
overlapping with the linker that connects the vipC2 gene with the GFP in the HA18. 
Importantly, in the HA18 primer, the vipC2 stop codon needs to be removed for the correct 
translation of the GFP if you want the tag in the Ct of your gene of interest. The sGFP 
together with a termination region known as trpCt (700 bp each, approximately) were 
amplified as a unique DNA fragment (from now on called just as ‘GFP’) using the 
HA22/HA21 primer pair from the pME4292 plasmid. Finally, vipC2 gene and GFP were 
cloned into the PmlI site of the linearized pME4744 plasmid in a seamless cloning reaction 
according to manufacturer’s instructions, resulting in the generation of the pME4746 
plasmid. The linear complementation construct (5’UTR-vipC2-GFP-PtrA_Rec.Mark-
3’UTR) was subsequently excised with PmeI (MssI), purified, and transformed into AfS35 
ΔvipC2 strain, resulting in the generation of the complementation strain AfGB157. The 
correct reinsertion of the original vipC2 gene tagged with GFP was confirmed by Southern 
hybridization before and after the marker recycling. 
2.4.1.10 Generation of the ΔvipC2 knockout strain in A. fumigatus AfS77 
The AfS77 WT (AfGB148) strain was used as host for the transformation with the 
vipC2 deletion construct (5’UTR-PtrA_Rec.Mark-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4744 with PmeI (MssI), purified, 
and transformed into AfS77 WT (AfGB148), resulting in the generation of the strain 
AfGB158. The correct replacement of the vipC2 gene with the deletion construct was 
verified by Southern hybridization. 




2.4.1.11 Generation of the ΔvipC2 knockout strain in A. fumigatus A1160 
The A1160 WT (AfGB147) strain was used as host for the transformation with the 
vipC2 deletion construct (5’UTR-PtrA-Rec.Mark-3’UTR) generated as described before.  
The linear deletion cassette was excised from pME4744 with PmeI (MssI), purified, 
and transformed into A1160 WT (AfGB147), resulting in the generation of the strain 
AfGB160. The correct replacement of the vipC2 gene with the deletion construct was 
verified by Southern hybridization. 
2.4.1.12 Generation of the ΔvapB deletion construct and ΔvapB knockout strain in 
A. fumigatus A1160 
For the construction of the vapB deletion plasmid, a different version of the 
pBluescript SK+ was used (Gerke J.). It already includes the recyclable marker cassette 
within its sequence flanking by SwaI and PmlI cutting sites. 
In order to generate the vapB deletion strain in A. fumigatus A1160 (and also for the 
AfS77), 1.4 kb long fragment of the 5’ UTR immediately adjacent to the vapB gene 
(AFUB_080160) was amplified from A. fumigatus A1160 WT genomic DNA with the 
primer pair HA174/HA175 introducing 15 nts overlapping with the pBluescript SK+ (in 
the tail of the HA174 primer) and an overhang of 15 nts homolog to the six site of the 
recyclable marker cassette, respectively. In the tail of the HA175 primer, between the 
gDNA annealing region and the six site overlapping region, it was also included 4 nts to re-
generate the SwaI restriction cutting site. This will make the generation of the VapB-GFP 
complementation strain faster and easier as for the other GFP complementation strains 
explained above. The respective 1.9 kb long fragment of the 3’ UTR right after the gene 
was amplified with the primer pair HA176/HA177 and, as for the 5’ UTR, it also contains 
overhangs of 15 bp homolog to the six site of the recyclable marker cassette (in the tail of 
the HA176 primer) and pBluescript SK+ (in the tail of the HA177 primer). Both UTRs were 
cloned sequentially in a two-step approach. First, the 5’ UTR in the SwaI site and then, after 
confirmation by colony PCR and control digestions, the 3’ UTR was inserted into the PmlI 
restriction site of this pBluescript SK+ in a seamless cloning reaction according to 
manufacturer’s instructions. As a result, the pME4747 plasmid was generated. The linear 
deletion cassette was subsequently excised with PmeI (MssI), purified, and transformed 
into A1160 WT (AfGB147), resulting in the generation of the strain AfGB159. The correct 




replacement of the original gene with the deletion construct was verified by Southern 
hybridization before and after the marker recycling. 
2.4.1.13 Generation of the AfvapA complementation construct to transform over the 
ΔvapA knockout strain of A. nidulans  
For the generation of the VapA complementation strain using the gene from 
A. fumigatus over the vapA deletion strain of A. nidulans, 1.4 kb long fragment of the 5’ 
UTR immediately adjacent to the vapA gene (AN0186) was amplified from A. nidulans 
AGB552 WT genomic DNA with the primer pair HA51/HA52 introducing 20 nts 
overlapping with the pBluescript SK+ (in the tail of the HA51 primer) and an overhang of 
20 nts homolog to the 5’ end of the vapA gene from A. fumigatus AfS35, respectively. The 
1.3 kb long fragment of the 3’ UTR after the vapA gene was amplified from A. nidulans 
AGB552 WT with the primer pair HA57/HA58 and, as for the 5’ UTR, it also contains 
overhangs of 20 bp homolog to the six site of the recyclable marker cassette (in the tail of 
the HA57 primer) and pBluescript SK+ (in the tail of the HA58 primer). The vapA gene 
(1.2 kb) including 500 bp of the 3’ UTR as a terminator region (1.7 kb long in total) was 
amplified from A. fumigatus AfS35 using the primer pair HA53/HA54. The HA53 has no 
tail but the HA54 has an overhang of 20 bp overlapping with the six site of the recyclable 
marker cassette. Both UTRs, the ‘vapA gene + terminator’ fragment and the phleo-
recyclable marker cassette were cloned into the EcoRV multi-cloning site of the pBluescript 
SK+ in a seamless cloning reaction according to manufacturer’s instructions, resulting in 
the generation of the pME4741 plasmid. The linear deletion cassette was subsequently 
excised with SwaI, purified, and transformed into A. nidulans AGB552 ΔvapA strain, 
resulting in the generation of the strain AGB1188. The correct replacement of the original 
gene with the deletion construct was verified by Southern hybridization before and after the 
marker recycling. 
2.5 Southern hybridization  
Southern hybridization is a technique that was used to check and confirm successful 
mutagenesis of genetic loci (Southern, 1975). This method is based on the use of restriction 
enzymes (Thermo Fisher Scientific) to digest genomic DNA of the generated mutant clones 
in a way that allow us to see a difference with respect to the WT strain regarding one 
specific locus. There are few considerations that need to be taken into account: 1) at least 
one of the restriction sites should be outside the construct that has been integrated into the 




genome of the fungus to confirm on-locus integration 2) as stated before, after digestion, 
generated DNA fragments of the WT and mutant strains should have different sizes in order 
to be able to differentiate them when separated by agarose gel electrophoresis. The 
procedure is as follows: it starts by digesting o/n the gDNA of the respective mutant strains 
and the WT with the selected enzymes according to manufacturer’s instruction. Next day, 
samples were loaded into an agarose gel and DNA fragments were separated according to 
size. After separation, gels were washed for 10 min in wash buffer 1 (0.25 M HCl) 
(depurination), followed by washing with buffer 2 for denaturation (0.5 M NaOH, 1.5 M 
NaCl) for 25 min and finally, 30 min in buffer 3 (0.5 M Tris, 1.5 M NaCl, pH 7.4) for 
neutralization. All washing steps were performed under constant gentle agitation at room 
temperature (rt). Subsequently, DNA was transferred onto AmershamTM HybondTM-N 
nylon membranes (GE Healthcare) by dry blotting for 90 min till o/n at rt. Membranes were 
subsequently dried at 75°C for 10 min, if needed and DNA was cross-linked to the 
membrane by UV light exposure (λ = 254 nm) for 3 min per side. After that, membranes 
were pre-hybridized in hybridization solution from the AmershamTM Gene Images AlkPhos 
Direct Labelling and Detection System (GE Healthcare, prepared after manufacturer’s 
instructions) for at least 45 min at 55°C in a HERA hybrid R hybridization oven (Heraeus 
Instruments) prior to application of the DNA probe. DNA probes were prepared with the 
aforementioned kit according to manufacturer’s instructions (GE Healthcare). 
Hybridization of the membranes with the respective DNA probes was performed o/n at 
55°C in the same rotor. Next day, membranes were washed twice in post-hybridization 
buffer I (1 mM MgCl2, 3.5 mM SDS, 50 mM sodium phosphate buffer, 150 mM NaCl, 2 
M Urea, 0.2% blocking reagents) for at least 10 min each washing step at 55°C, and twice 
in post-hybridization buffer II (2 mM MgCl2, 50 mM Tris, 100 mM NaCl, pH 10) for at 
least 5 min at rt under constant agitation (these steps can be also performed at 55°C in the 
same rotor). For detection of DNA bands, the detection solution CDP-Star (GE Healthcare) 
was applied during 5 min directly to the membranes and protected from the light and then, 
they were exposed to AmershamTM HyperfilmTM ECL (GE Healthcare). 
2.6 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
By the use of a fluorophore that is intercalated into the double-stranded DNA, this 
technique allows us to measure gene expression levels and to see the amplification in real 
time. Gene expression was measured by the use of MESA GREEN qPCR MasterMix Plus 
for SYBR® Assay purchased from Eurogentec (Lüttich, Belgium) in a CFX ConnectTM 




Real-Time System (BioRad). The used qRT-PCR protocol is given in table 2. Primers for 
qRT-PCR were designed using the online tool ‘Primer3 software’ (Koressaar et al., 2007; 
Untergasser et al., 2012) and they are listed in the table 3. Gene expression was measured 
from 1:5 dilutions of respective cDNA. Obtained qRT-PCR data was analysed with the 
CFX ManagerTM 3.1 software package (BioRad) using the 2-ΔΔCT method for relative 
quantification of gene expression (Schmittgen et al., 2008). Expression of h2A (AN3468) 
and Afh2A (Afu3g05360) were used for A. nidulans and A. fumigatus qRT-PCR, 
respectively, as references for relative quantification. 
For measurement of the expression of antifungal-drug resistance related genes, strains 
were inoculated and grown in submerged cultures at 37°C on a rotary shaker for 16-24 h. 
Then, mycelia were filtrated and transferred to new sterile flask containing 0.5 μg/ml of 
Voriconazole and incubated for four more hours before collecting the samples (vor 
induction). Control strains were also filtrated and changed to new sterile flask with fresh 
medium without Voriconazole. After this 4h incubation on a shaker under the same 
conditions, mycelia were harvested as described above. 
qRT-PCR measurements were conducted in at least two independent biological 
replicates as indicated. Each biological replicate was measured in three technical replicates. 
 
Table 4: qRT-PCR program used in this study 
Steps 2 to 4 were repeated 39 times (although for the gene expression analysis, only 32 cycles 
were considered) 
Step Temperature (°C) Duration (min)  
1 95 05:00  
2 95 00:15  
3 60 00:22 Repeated 39 times 
4 72 00:40  
5 95 00:10  
6 72 05:00  
 
  




Table 5: qRT-PCR primers used in this study 
Primers for qRT-PCR with A. nidulans cDNA are marked with an. All the other primers are for 
A. fumigatus cDNA  
Designation Gene 5’ – sequence – 3’ Size 
KT312  h2Aan-1 TCT CGA GCT TGC TGG AAA CG  20mer  
KT313 h2Aan-2 CAC CCT GGG CAA TAG TGA CG  20mer  
KT274 brlAan-1 CAG GAT CAC TCC CCA ACA ACA C 22mer 
KT275 brlAan-2 GTA AGC GAG TCC TTG AGC GAC A  22mer 
HA145 h2A-1 GCC GCT GTT TTG GAG TAT CT 20mer 
HA146 h2A-2 TAC GAG TCT TCT TGT TGT CAC G 22mer 
HA111 lreA-1 GAT AAG TCG GCA AGG GGT TC 20mer 
HA112 lreA-2 GCG GTT CTG TTT CTC CAG TTC 21mer 
HA113 lreB-1 GAT TGA CCG AAG GAA AAG ATT G 22mer 
HA114 lreB-2 ATT ACA ACC GCA GGC ATT ACA C 22mer 
HA115 phr1-1 GAA TGG GAG TAT GAG GAG GAC A 22mer 
HA116 phr1-2 GAC AGA AAA GAC GCA ACA ATC A 22mer 
HA117 fphA-1 GTT TTG ACG GGT GGA TTA TGA A 22mer 
HA118 fphA-2 AGT AGC CAG GTC GGT AAA TGG T 22mer 
HA119 fphB-1 CCA CAT CTT AGT AGC CGA GGA C 22mer 
HA120 fphB-2 GCG AAA TAC AGA AGC ACA TTC C 22mer 
HA121 nopA-1 GTG TCA TTG TCT CCG TCA AGG 21mer 
HA122 nopA-2 TCT TCT CCT CTC TCA TCT TCT GC 23mer 
HA123 nf-x1-1 CTG AGG TTG CGG ATA ACT GG 20mer 
HA124 nf-x1-2 TCC ATT CTG TGC TGT TCT TCT C 22mer 
HA125 cp2-1 TCT CAA GCA CCC AGT CAA AGT 21mer 
HA126 cp2-2 GTG GAA AGC GAA TGT AGA AAC A 22mer 
HA127 putative opsin-1 CAC CGT CTC ATT CAT CGT CTA C 22mer 
HA128 putative opsin-2 GGA AGT AAT CCT GCG TGG TAT C 22mer 
HA129 TspO/MBR, putative-1 AGA GTT TTT CAC CTC CCC AGT C 22mer 
HA130 TspO/MBR, putative-2 GAG TTC TTT TGT GTG GCT GTT G 22mer 
HA133 fmqA-1 CAG TGG GAT GGG GTA TCT ATT C 22mer 
HA134 fmqA-2 TCC AGA AAT CAA AGG CAG GT 20mer 
HA135 fmqB-1 CTA ATG GAG GCG GGA AAC TCT A 22mer 
HA136 fmqB-2 ATT GGG AAA CGC AAA GAC ACT 21mer 
HA137 fmqC-1 GTC TTT GGC GAG TTT GTT GAG 21mer 
HA138 fmqC-2 CTG GGA ATG CTT GAG GAG GT 20mer 
HA139 fmqD-1 CGA CTT CTC CTC CAA AAA CC 20mer 
HA140 fmqD-2 CCT ACT CCC CTC TCG CTA AGA 21mer 
HA141 fmqE-1 CGT TAT CTC TTG GTT CCT CGT T 22mer 
HA142 fmqE-2 ACT GTC GCT TTG GCA GAC TT 20mer 
HA143 fmqF-1 CCA CCT TGG CTG ATA GTG CT 20mer 
HA144 fmqF-2 GTT TGT GAA GAA CAG GGA ACC T 22mer 
KT332 brlA-1 TCA TCA AGC AGG TGC AGT TC 20mer 
KT333 brlA-2 TTG GAG TGG CTC TTC ATG TG 20mer 
CS1316 abcA-1 ACG ATG TTC CTG TTG ATT CTC A 22mer 
CS1317 abcA-2 GAA GAG CAG TTG TGC GAT GTT 21mer 
CS1229 abcB-1 CGA CTT TCC TCA AGA CCA TCT C 22mer 
CS1230 abcB-2 ACA TCC GTT TCA GCA GTG TAG A 22mer 
CS1227 cyp51A-1 ACT AAG GAG CAG GAG AAC GAC A 22mer 
CS1228 cyp51A-2 ACC AAA CGG AAG ATA GGG ACT T 22mer 




CS1314 mdr1-1 CAC TAC GAT TGC TCT GCT TGA G 22mer 
CS1315 mdr1-2 GCG GTA TGA GTT GAC ATT GAG T 22mer 
 
2.7 Protein methods 
2.7.1 Protein extraction and isolation 
As for the genomic DNA isolation, it starts with the inoculation of fresh spores in 
liquid medium. Strains were grown o/n under vegetative conditions on a rotary shaker at 
37°C. For protein isolation from vegetative tissue, samples can be directly processed after 
16 to 24 hours of incubation. For asexually developed mycelia, cultures were grown 
vegetatively for 16-24 h as before, and subsequently shifted onto solid MM or LM plates 
and let them grow asexually. Samples can be harvested at different time points; 12, 24, 48 
and 72 hours after asexual development induction. Mycelia were harvested through sterile 
filter (Miracloth), washed with 0.96% sterile NaCl and immediately frozen in liquid 
nitrogen. Frozen mycelia were ground in a MM400 table mill (Retsch) and approximately 
200 mg of the resulting powder was mixed with 300 μl of B+ buffer (300 mM NaCl, 100 
mM Tris pH 7.5, 10% glycerol, 1 mM EDTA, 0.1% NP-40) supplemented with 1.5 mM 
DTT, 1 tablet/50 ml Complete EDTA-free protease inhibitor cocktail (Roche), 1 mM 
PMSF, phosphatase inhibitor mix (1 mM NaF, 0.5 mM sodium-orthovanadate, 8 mM ß-
glycerolphosphate disodium pentahydrate and 1.5 mM benzamidine) and centrifuged for 
15-30 min at 13000 rpm at 4°C. Supernatant was transferred into fresh new tubes and 
protein concentration was measured with a NanoDrop ND-1000 spectrophotometer 
(Peqlab). Samples were mixed with 3x SDS sample buffer (250 mM Tris-HCl pH 6.8, 15% 
β-mercaptoethanol, 30% glycerol, 7% SDS, 0.3% bromophenol blue) and boiled at 95°C 
for 5 min followed by 5 min incubation on ice. At this point, samples can be directly used 
for further experiments or stored at -20°C. 
2.7.2 SDS-PAGE and Western hybridization 
This is one of the ways to further proceed with the analysis of a protein sample 
generated, for example, as in the previous section. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) was used to separate proteins according to size for western hybridization 
(Laemmli, 1970; Schinke et al., 2016). Equal amounts of protein, which were determined 
with the NanoDrop, were loaded on 12% SDS gels (separation gel: 2.8 ml H2O, 3.75 ml 1 
M Tris pH 8.8, 100 μl 10% SDS, 3.3 ml 30% acrylamide, 10 μl TEMED, 50 μl 10% APS; 




stacking gel: 3.67 ml H2O, 625 μl 1 M Tris pH 6.8, 30 μl 10% SDS, 650 μl 30% acrylamide, 
5 μl TEMED, 25 μl 10% APS) and separated according to size first at 100 V during 10 min 
and then at 200 V in running buffer (25 mM Tris, 0.25 M glycine, 0.1% SDS). Proteins 
from SDS gels were blotted for 1 h at 100 V on AmershamTM ProtranTM 0.45 μm NC 
nitrocellulose membranes (GE Healthcare) in ice cooled transfer buffer (25 mM Tris, 192 
mM glycine, 0.02% SDS) (Towbin et al., 1979). After the transference, membranes were 
blocked with 5% skim milk powder dissolved in TBS-T buffer (10 mM Tris-HCl pH 8.0, 
150 mM NaCl, 0.05% Tween 20) for 1 h at rt and subsequently probed with 1:1000 mouse 
α-GFP antibody (sc-9996, Santa Cruz Biotechnology, Dallas, TX, USA) in TBST-M 
(blocking solution) (TBST buffer, supplemented with 5% skim milk powder) and incubated 
o/n at 4°C (incubation with the primary antibody can be also performed 1 h at rt). After this, 
antibody solution(s) where collected and membranes were washed three times in TBS-T 
for at least 10 min each step under constant agitation at rt. After the last washing step, 
membranes were directly incubated for 1 h at rt with 1:1000 horseradish peroxidase coupled 
goat α-mouse antibody (115-035-003, Jackson Immuno Research, West Grove, CA, USA) 
as secondary antibody in TBST-M. Again, antibody solution(s) can be collected and further 
reused. Next, membranes were washed for three times 10 min with TBS-T under constant 
agitation at rt. That followed, membranes were covered with a 1:1 mixture of solution A 
(2.5 μM luminol, 400 μM paracoumarat, 100 mM Tris-HCl pH 8.5) and solution B (5.4 
mM H2O2, 100 mM Tris-HCl pH 8.5) and incubated for 2-5 min under constant agitation 
at rt in the dark (Suck et al., 1996). As for the Southern hybridization, chemiluminescent 
signals were detected by exposing the membranes to AmershamTM HyperfilmTM ECL (GE 
Healthcare). As loading control membranes were stained with Ponceau staining before the 
blocking step (Romero-Calvo et al., 2010). 
2.7.3 GFP-Trap pull-downs 
From a purified protein sample, and using specific antibodies, pull-downs can be 
performed to enrich your samples in the protein of interest. For the GFP-trap, you obviously 
need a strain that expresses a GFP-tagged protein that will be recognised by the antibody, 
and also this method requires bigger amounts than for a regular protein extraction. Protein 
pull-downs employing GFP-Trap®_A beads from ChromoTek (Planegg-Martinsried, 
Germany) were conducted as described earlier (Jöhnk et al., 2016). A. fumigatus strains 
were inoculated in liquid medium in a concentration of 2x106 spores/ml in 500 ml MM and 
grown vegetatively on a rotary shaker at 37°C for 16-24 h (vegetative samples), or shifted 




to solid agar plates after that time and let them develop asexually according to the 
experimental conditions (asexual mycelia samples). Mycelia were harvested, washed and 
immediately frozen in liquid nitrogen (Recommendation: for the asexual samples, before 
the harvesting it is convenient to remove the spores from the mycelia and wash them as 
much as possible). Frozen mycelia were ground with a table mill in liquid nitrogen and 5 
ml of the resulting powder were mixed in a 15 ml tube with ice-cold supplemented B+ buffer 
in a relation of 1:1 (5 ml) and centrifuged during 30 min at 4500 rpm at 4°C. Supernatant 
was taken to a fresh new 15 ml tube and mixed with 20-40 μl of GFP-Trap®_A beads 
(ChromoTek) and incubated from few hours to o/n at 4°C. Subsequently, GFP-Trap®_A 
beads were washed once with 5 ml of B+ buffer, transferred into 1.5 ml reaction tubes and 
washed once more with 1 ml of B+ buffer. GFP-Trap®_A beads were centrifuged at 3000 
rpm at rt for 2 min and subsequently boiled in 40-80 μl 3x SDS sample buffer at 95°C for 
10 min. At this point, protein extracts can be directly used or stored at -20°C until further 
processing. 
2.7.4 Protein identification by mass spectrometry from a complex protein sample 
Protein samples can be digested by the use of specific proteases (trypsin is one of the 
most common enzymes, but others can be used depending on the experimental conditions) 
and the resulting peptides can be analysed by HPLC coupled with MS.  
After separating your protein sample by SDS-PAGE, and staining with Coomassie to 
visualize the proteins, you can cut the desired band(s) and proceed with the tryptic digestion 
and sample preparation for LCMS. But also, you can analyse the whole content of a 
complex protein mixture, for example after GFP-trap pull-downs, as it was performed in 
this study. This approach is commonly used to seek for specific proteins that might be 
interacting or forming a complex with your pulled-down protein, and/or to search all the 
hypothetical interactor partners of the protein used as bait (in this case, your GFP-tagged 
protein). 
After the GFP-Trap was carried out, as much volume of the samples (around 30 μl) 
were loaded in a SDS-PAGE a let them run for 10 to 15 min or until the samples has entered 
into the separation gel for approximately 2 cm (at this point, all the proteins of your samples 
are condensed in this part of the gel). Next, the complete lane (just these two cms where the 
proteins are) was cut out and placed it in new fresh tubes to proceed with the tryptic 




digestion and sample preparation. The tubes used for the whole procedure are Protein 
LoBind Tubes PCR Clean from Eppendorf AG (Hamburg, Germany). 
2.7.4.1 Trypsin protein digestion 
Tryptic digestion of proteins was performed as published by Shevchenko and 
collaborators using Sequencing Grade Modified Trypsin (Promega) (Shevchenko et al., 
1996).  
After the whole lane was excised and before place it the new Protein LoBind tubes, 
it was cut into small pieces of approximately 2 mm. Gel pieces were shaken in acetonitrile 
for 10 min at rt and dried in a SpeedVac Concentrator (Thermo Fisher Scientific). Then, 
proteins were reduced in-gel to separate disulfide bonds by incubating the gel pieces in 10 
mM DTT in 100 mM NH4HCO3 at 56°C for 1 h. Subsequently, the DTT solution was 
exchanged with 55 mM iodoacetamide in 100 mM NH4HCO3 to allow alkylation of reduced 
cysteine residues to prevent refolding, and the samples were incubated for 45 min in the 
dark. Afterwards, the gel pieces were washed in 100 mM NH4HCO3 for 10 min and 
dehydrated in acetonitrile for 10 min. These hydration/dehydration steps were repeated 
once more and the gel pieces were completely dried in the SpeedVac Concentrator at 50°C. 
After this, gel pieces were covered with trypsin-digestion buffer (Promega; prepared 
according to manufacturer’s specifications) and incubated on ice for 45 min. The excess of 
this buffer was removed and gel pieces were covered with 25 mM NH4HCO3 and incubated 
o/n at 37°C. Next day and from this moment on, supernatants will always be collected in 
fresh new reaction tubes after each step and not discarded (all the supernatants 
corresponding to the same sample will be combined). For the extraction of the acidic 
peptides, gel pieces will be covered with 20 mM NH4HCO3 and incubated for 10 min at rt. 
Supernatants were collected and the gel pieces were incubated in 50% acetonitrile and 5% 
formic acid and incubated for 20 min at rt. This procedure was repeated three times to 
extract remaining peptides. The combined supernatants were dried completely in the 
SpeedVac Concentrator. Finally, peptides were resuspended in 20 μl of LCMS-sample 
buffer (98% H2O, 2% acetonitrile, 0.1% formic acid) and incubated in an ultrasonic bath at 
35°C for 3 min at maximum power. 
2.7.4.2 Purification of tryptic-digested peptides by C18 StageTipping 
Before measurement with LC-MS/MS, peptides were purified from salts and other 




contaminations, using the StageTip purification method (Rappsilber et al., 2003, 2007). For 
this, C18 (reversed-phase material) stage tips were first prepared by introducing C18 plugs 
into 200 μl pipet tips. StageTips were equilibrated in three sequential steps, first with 100 
μl of 0.1% formic acid in HPLC grade methanol, then with 100 μl of 0.1% formic acid in 
70% acetonitrile and finally with 100 μl of 0.1% formic acid in dH2O. This last step was 
repeated once more. Peptides resuspended in LCMS-sample buffer were loaded onto the 
StageTips, incubated during 3-5 min, making sure that they are in contact with the C18 
material, and centrifuged 5 min at 4000 rpm. After this, samples were reloaded and this step 
was repeated to increase the yield. Subsequently, the StageTips were washed twice with 
100 μl of 0.1% formic acid in dH2O and, at the end, peptides were eluted by adding 60 μl 
(two times 30 μl) of 70% acetonitrile containing 0.1% formic acid after an incubation of 5 
min. Peptides were dried completely in the SpeedVac Concentrator at 50°C. 
Prior to mass spectrometry analysis, peptides need to be resuspended in 20 μl of 
LCMS-sample buffer (98% H2O, 2% (v/v) acetonitrile, 0.1% formic acid) and incubated in 
an ultrasonic bath at 35°C for 3 min at maximum power. 
2.7.4.3 Protein identification by LC-MS/MS 
Liquid chromatography-coupled mass spectrometry was done using the Orbitrap 
Velos Pro mass spectrometer and the RSLCnano Ultimate 3000 chromatography system 
(Thermo Fisher Scientific). Peptides of proteins hydrolysed by trypsin and purified with 
C18 stage tips were separated at nano-flow with Acclaim PepMap RSLC columns (Thermo 
Fisher Scientific) through a water-acetonitrile gradient. Online ionization of eluting 
peptides through nano-electrospray was achieved by the use of the Nanospray Flex Ion 
Source (Thermo Fisher Scientific). Full scans within the mass range of 300-1850 m/z were 
recorded with the Orbitrap-FT analyser at a resolution of 30.000. In parallel data-dependent 
top ten collision-induced dissociation (CID) in the LTQ Velos Pro linear ion trap took place. 
The XCaliburTM 2.2 software (Thermo Fisher Scientific) was used for LC-MS method 
programming and the mass spectra acquisition. MS/MS2 data processing for peptide 
analysis and protein identification was performed either with the MaxQuant 1.5.1.0 and 
Perseus 1.5.3 or the Proteome Discoverer 1.4 software (Thermo Scientific) using the 
SequestHT and the Mascot search engines. As protein database, an A. fumigatus specific 
database with common contaminants was used.  




2.7.5 Bioinformatic analyses of protein features and genomic sequences 
The presence of putative orthologues and paralogues of the members of the vapA, 
vapB and vipC from A. nidulans in other fungi was analysed in silico with the Basic Local 
Alignment Search Tool (Altschul et al., 1990). Orthologues were investigated in pairwise 
sequence alignments using EMBOSS Needle (Rice et al., 2000; McWilliam et al., 2013; Li 
et al., 2015). NCBI (Agarwala et al., 2016), Ensembl fungi (Kersey et al., 2018) and AspGD 
(Cerqueira et al., 2014) databases were used. For the search and identification of functional 
protein domains and motifs, InterPro database and InterProScan (Jones et al., 2014; Finn et 
al., 2017), Pfam (Finn et al., 2016) and Prosite (Sigrist et al., 2002, 2013) were used. These 
places are meta-sites that provide functional analysis of protein sequences by classifying 
them into families and predicting the presence of domains and important sites. Putative 
nuclear localization sequences were searched with cNLS Mapper (Kosugi et al., 2009) and 
NucPred (Brameier et al., 2007). LocNES (Xu et al., 2015) and NetNES 1.1 (La Cour et 
al., 2004) were employed to identify nuclear export signals in silico.  
2.8 Analysis and extraction of secondary metabolites in A. fumigatus 
2.8.1 Secondary metabolites isolation for HPLC measurements 
This method can be performed either from liquid cultures or, as for the purpose of 
this study, from solid agar plates as a starting point. The procedure was conducted as 
described by Gerke and collaborators for the extraction of SMs (Gerke et al., 2012). 
For the secondary metabolites extraction from asexually developed cultures 2x106 of 
fresh spores were plated on big petri dishes (15 cm diameter) containing 100 ml of LM and 
let them grow asexually for three days under light or dark conditions. Subsequently, fungal 
cells and spores were washed off with cotton swabs and 0.96% NaCl solution, containing 
0.02% Tween. The agar was cut into small pieces (1 cm2, approximately), transferred into 
500 ml flasks and covered with 300 ml ethyl acetate. Samples were shaken at 160 rpm at 
30°C for 30 min followed by 15 min ultra-sonication in a Bandelin SonorexTM Digital 10P 
ultrasonic bath from Bandelin Electronic GmbH & Co. KG (Berlin, Germany) at highest 
level. Ethyl acetate was transferred to round bottom flasks and evaporated in a Hei-VAP-
Advantage rotary evaporator from Heidolph Instruments GmbH & Co. KG (Schwabach, 
Germany) with a MWG Lauda RM6 from Lauda-Brinkmann LP (Delran, NJ, USA) and a 
Laboxact KNF vacuum system (Sigma-Aldrich) at 37°C under constant gyration (120 rpm). 




Secondary metabolites were resolved in 3 ml methanol by swirling and transferred 
into small glass tubes. Methanol was evaporated in the same rotary evaporator at 37°C 
under constant gyration (200 rpm) and samples were stored at -20°C. Samples were 
resolved in 250-500 μl methanol depending on the concentration and colour intensity. If at 
this point, the presence of solid particles in suspension is evident, an extra centrifugation 
step can be performed and carefully transfer the supernatant to fresh new tubes for 
measurements with high-performance liquid chromatography (HPLC). 
2.8.2 Analysis of secondary metabolites by high-performance liquid 
chromatography (HPLC) coupled with a UV diode array detector (UV-DAD) 
HPLC measurements were carried out by Dra Jennifer Gerke (Department of 
Molecular Microbiology and Genetics, Georg-August University Göttingen, Germany). 
Analytical HPLC/UV-DAD measurements were performed using the following system: 
HPLC pump 420, SA 360 autosampler, Celeno UV-DAD HPLC detector, ELSD-Sedex 85 
evaporative light-scattering detector (ERC)) with a Nucleodur 100-5 C18 end-capped (ec) 
column (250 mm x 3 mm) and the solvent system: A = H2O + 0.1% trifluoroacetic acid 
(TFA), B = acetonitrile + 0.1% TFA (from Goebel Instrumentelle Analytik GmbH, 
Au/Hallertau, Germany). Secondary metabolite extracts were dissolved in 250-500 μl 
methanol and an injection volume of 20 μl was analysed under gradient conditions (20% B 
to 100% B in 20 minutes) with a flow rate of 0.5 ml/min. 
HPLC data was analysed with the Geminyx III software from Goebel Instrumentelle 
Analytik GmbH (Au/Hallertau, Germany). 
2.8.3 Analysis of secondary metabolites by HPLC coupled with MS/MS 
The extraction of the secondary metabolites of asexually induced mycelia from agar 
solid plates was performed as described in the section 2.8.1 following the procedure of 
Gerke and collaborators (Gerke et al., 2012).  
In the last step, secondary metabolites were resolved in 3 ml methanol, evaporated at 
37°C under constant gyration (200 rpm) and then, stored at -20°C until further processing.  
Preparation of the samples and LCMS analyses were conducted by Dr. Antje K. 
Heinrich from the group of Prof. Dr. Helge B. Bode (Goethe-University, Frankfurt am 
Main, Germany). The extracts were resuspended again in 1 ml methanol and centrifuged 
15 min at 17000g at room temperature (table top centrifuge). 100 μl of the supernatant were 
transferred to HPLC-vials and 5 μl of the samples were injected for LCMS analysis. Liquid 




chromatography-coupled mass spectrometry was done using an Impact II mass 
spectrometer (Bruker) and the Dionex Ultimate 3000 HPLC (Thermo Fisher). The column 
that was used was a reversed phase UHPLC column: C18-UHPLC column (Acquity UPLC 
BEH C18 1.7 lmRP 2.1 × 50 mm (Waters)) with a C18-pre-column (Acquity UPLC BEH 
C18 1.7 lmRP 2.1 × 5 mm (Waters)). A linear gradient from 5-95% B in 12 min, at 30°C, 
with a flow rate of 0.6 ml/min was used. Solvent A: water supplemented with 0.1% formic 
acid. Solvent B: acetonitrile supplemented with 0.1% formic acid. For internal mass 
calibration, an injection of a 10 mM sodium formate solution was used. Positive and 
negative mode: m/z: 100-1200. DataAnalysis 4.3 software from Bruker was used for data 
analysis and sum formula prediction. 
2.9 Spotting tests on plate 
2.9.1 Stress response and growth tests 
Fresh spores of the different strains were harvested in 0.96 % NaCl-Tween 80 
solution, counted, and diluted to a concentration of 2x106 spores per ml. 2 μl per spot of 
these spore solutions (approximately 4000 spores/spot) were plated on solid LM or MM 
plates containing the different stressing agents (they were mixed with the liquid agar plates 
in the moment of preparation). All the mutant strains were always spotted inside the same 
plate to keep the conditions as much homogeneous as possible and to avoid variations due 
to micro differences from plate to plate. Assays were performed under light or darkness 
conditions to assess the effect of illumination over the conditions tested and at least by 
duplicate to discard possible pipetting mistakes or random effects. The impact of the 
different treatments over the deletion mutants generated in this study was always compared 
with the parental strain present inside each plate as well as with the control condition plate 
(only LM or MM grown under light or darkness conditions). Plates were cultured during 3 
days at 37°C if not stated otherwise. Further information about the use of the different 
compounds and their concentrations as well as incubation periods will be detailed in the 
corresponding Results section. 
2.9.2 Drug resistance tests 
Similarly to the stress test, the effect and impact of different antifungal agents over 
the deletion mutants were assessed. The drugs tested were voriconazole, itraconazole and 
amphotericin B, also under light and darkness conditions. Drugs were added to the liquid 
agar medium before solidification but avoiding extreme temperatures during the plates 




preparation. Plates were incubated at 37°C under light or darkness conditions during 3 days. 
Further information about concentrations will be detailed in the corresponding Results 
section of this study. 
2.9.2.1 Dilution spot tests 
This approach was performed to better visualize the impact and the resistance 
capacity of the different deletion strains against the antifungal agents tested. It was 
performed in square plates with 50 ml of LM containing the drug at the indicated 
concentrations where it corresponds. 10-fold serial dilutions of the spore solutions were 
spotted in the subsequent rows starting from a 5x107 spores/ml solution if not stated 
otherwise. 2 μl of each solution were plated, which means approximately 1x105 spores per 
spot in the first row and 10 times less from one row to the next. Plates were incubated at 
37°C under light or darkness conditions during 3 days (the negative control plate was taken 
out of the incubator at the day two to avoid colony mergers) 
2.10 Minimum inhibitory concentration determination (MIC test) 
This method was carried out aiming to determine the minimum concentration of the 
drug that totally inhibits the fungal growth (Andrews, 2002). It was performed in 96-well 
plates. Each well was loaded with 200 μl of liquid LM containing the spores (1000 spores 
per well) plus the corresponding amount of the drug. The first row is the negative control 
condition (no drug) and from the second on, the drug concentrations were doubled from 
one well to the next. Plates were incubated at 37°C during at least 48 h to clearly see 
differences. More information about concentrations, drugs and the strains tested will be 
shown in the Results section. 
2.11 Virulence assay in the wax moth infection model Galleria mellonella 
This technique was performed to assess the virulence capacity of the different vapA 
vipC1 and vipC2 mutants generated in A. fumigatus AfS35. 
G. mellonella larvae were infected as previously described (Reeves et al., 2004; 
Renwick et al., 2006). Larvae were purchased from Fauna Topics GmbH (Marbach am 
Neckar, Germany) and directly infected the day of arrival or the day after to ensure and 
maximize the initial viability. Worms were injected in the leg of the last body segment in 
groups of 20 individuals per strain approximately, with 5x105 spores per worm in 50 μl (50 
μl from a 1x107 spores/ml solution). Control group was injected with sterile 0.96% NaCl 




solution, supplemented with 0.02% Tween-80 without spores, to measure the quality of the 
infection process. Also a mock treated group was included (untreated control group, not 
injected) to monitor the general health of the worms and to ensure that neither the infection 
procedure nor the storage conditions were responsible for the observed mortality. In all the 
injected conditions, 10 μg/ml of the antibiotic rifampicin was added to the solutions to 
prevent infection with other microorganisms. Micro-FineTM+ 0.3 ml insulin syringes (BD 
Biosciences) were used for injection and discarded after infection of six individuals to 
decrease contamination risk. Larvae were kept at 37°C in petri dishes, separated according 
to the fungal strain. Survival was monitored every 24 hours. Dead larvae were count and 
removed from the petri dishes when no evident movement was observable upon contact 
and dark discoloration was observable. Suspended larvae were sacrificed at -20°C prior to 







3.1 VapA and VipC without VapB is the most common system in Aspergilli  
3.1.1 All analysed Aspergilli contain a vapA and at least one vipC gene 
In A. nidulans, the VapA-VapB-VipC represents a trimeric complex with two 
methyltransferases that integrates environmental signals for the control and coordination of 
development through epigenetic modification (Sarikaya-Bayram et al., 2014). In silico 
BLAST (Basic Local Alignment Search Tool (Altschul et al., 1990)) analyses, using the 
online databases NCBI (Agarwala et al., 2016), Ensembl Fungi (Kersey et al., 2018), and 
AspGD (Cerqueira et al., 2014), were performed to search for orthologous candidates 
among Aspergilli. VapA, VapB and VipC peptide sequences from A. nidulans were used 
as query to ‘BLAST’ them against a set of 19 species of Aspergilli. The phylogeny of these 
19 species is published and it has been inferred from 149 conserved protein sequences (de 
Vries et al., 2017). Homologues of these proteins were found but their presence was not 
always conserved among all of them. Only in the case of VapA, a clear unique candidate 
gene was detected in every species (Table 6). It can be concluded that the presence of this 
gene is widely conserved among all the Aspergillus species tested. 
For VapB and VipC proteins, the situation was more variable and diverse among all 
the Aspergilli that were inspected. Many of them appeared to have several possible 
candidates which shared high similarities. In order to select the best candidate(s) for each 
protein in each specie, all these protein-BLASTs (P-BLAST) were validated performing 
also nucleotide-BLASTs (N-BLAST) using the genomic sequences of vapA, vapB and vipC 
from A. nidulans. The top hits (according to identity (%), coverage (%), e-value and BLAST 
score) that came out in both approaches were selected for the analysis. If there were more 
than one, other parameters such as protein size or the presence of similar functional domains 
(methyltransferase domains, SAM-binding motifs), were also inspected. Protein sequences 
were aligned using MUSCLE algorithm (which stands for MUltiple Sequence Comparison 
by Log- Expectation) (Edgar, 2004). After this, alignments were visually inspected together 
with a phenetic method, neighbor-joining (Saitou et al., 1987), for drastic incongruences 
among all the candidates to check which of them were falling out of a reasonable model. 
These outliers were filtrated and eliminated for the next round of analysis and Multiple 





Table 6: Different Aspergillus species possess different Vap-Vip systems in which VapA and 
VipC are always present 
In silico BLAST analysis of the VapA, VapB and VipC proteins among a set of 19 Aspergillus 
species. P-BLAST and N-BLAST were performed using the sequences from A. nidulans as query 
and best hits were considered. While vapA and vipC are always present, only five out of 19 tested 
species possess the vapB gene. The BLAST engine tool from Ensembl Fungi was used (Kersey et 
al., 2018). Also, gene names corresponding to these proteins can be found in the Table 11 (Annex). 
Aspergillus species VapA VapB VipC 
A. niger CBS 513.88 1 0 1 
A. niger ATCC 1015 1 0 1 
A. luchuensis CBS 106.47 1 0 1 
A. kawachii IFO 4308 1 0 1 
A. tubingensis CBS134.48 1 0 1 
A. brasiliensis CBS101740 1 0 1 
A. carbonarius CBS141172 1 0 1 
A. aculeatus CBS172.66 1 0 1 
A. clavatus NRRL1 1 0 1 
A. wentii CBS141173 1 0 1 
A. ruber CBS135680 (E. rubrum) 1 0 1 
A. glaucus CBS516.65 1 0 1 
A. versicolor CBS795.97 1 1 1 
A. sydowii CBS593.65 1 1 1 
A. nidulans FGSC A4 1 1 1 
A. fumigatus Af293 1 0 2 
N. fischeri 1 0 2 
A. terreus NIH 2624 1 0 2 
A. flavus NRRL3357 1 1 2 
A. oryzae RIB40 1 1 2 
 
In 14 out of 19 species, the search did not succeed to find an appropriate candidate to 
be considered as vapB orthologue. Only five were proposed to have one homologue of 
VapB. In the case of VipC, each Aspergilli tested presented at least one homologous 
candidate, and even five out of 19 presented a second copy of this gene (Table 6). This 
result revealed a more diverse scenario regarding the presence of homologues of VapB and 
VipC proteins among Aspergilli. While VipC homologues can be found in all the tested 
species, the vapB gene does not seem to be conserved.  
 
3.1.2 Gain of vapB and vipC has occurred at different time points during evolution 
of Aspergilli 
In an effort to get more insight about the course of these genes during evolution of 
Aspergilli, the recently published phylogenetic tree of these species was explored. This 





likelihood method (de Vries et al., 2017). When the different detected Vap-Vip systems 
were incorporated into the phylogeny of these Aspergillus species, a tendency was 
observed. The different proposed models tend to group together forming clusters in which 
the species harbouring no vapB homologue (green and blue) are more abundant (Figure 
10A). The species that possess the vapB gene fall into very restricted areas of this tree, 
indicating that the gain of this gene is an unstable event. According to an evolutionary 
model where the least number of changes have occurred, the gain of vipC2 (purple 
diamonds) and vapB (yellow triangles) are shown (Figure 10B). This indicates that the gain 
of these genes did not happen linearly, but as single events at different moments during the 
course of evolution in Aspergilli. 
 
Aspergillus species VapA VapB VipC 
A. niger CBS 513.88 1 0 1 
A. niger ATCC 1015 1 0 1 
A. luchuensis CBS 106.47 1 0 1 
A. kawachii IFO 4308 1 0 1 
A. tubingensis CBS134.48 1 0 1 
A. brasiliensis CBS101740 1 0 1 
A. carbonarius CBS141172 1 0 1 
A. aculeatus CBS172.66 1 0 1 
A. clavatus NRRL1 1 0 1 
A. wentii CBS141173 1 0 1 
A. ruber CBS135680 (E. rubrum) 1 0 1 
A. glaucus CBS516.65 1 0 1 
A. versicolor CBS795.97 1 1 1 
A. sydowii CBS593.65 1 1 1 
A. nidulans FGSC A4 1 1 1 
A. fumigatus Af293 1 0 2 
N. fischeri 1 0 2 
A. terreus NIH 2624 1 0 2 
A. flavus NRRL3357 1 1 2 





Figure 10: VapA and VipC are key elements of the VapA/methyltransferase system whereas the 
presence of VapB is variable 
(A) In silico BLAST analysis of the VapA, VapB and VipC proteins among a set of 19 Aspergillus 
species. P-BLAST and N-BLAST were performed and best hits were considered. The different colours 
indicate the different kind of systems that were identified based on the presence of these genes. (B) 
Maximum likelihood phylogeny adapted from de Vries et al., 2017, inferred from 149 conserved 
protein sequences in which the colour code represents the different Vap-Vip systems. Purple diamond 





3.1.3 The strains of A. fumigatus contain always two vipC but only sometimes a 
vapB 
The previous results show that different VapA/methyltransferases systems within the 
group of Aspergilli exist. Using the information from the aforementioned databases, NCBI 
and Ensembl Fungi, in silico BLAST analysis of other sequenced A. fumigatus strains were 
performed, revealing differences even within one specie. While the Af293 and the var. RP-
2014 strains presented the same system without vapB and a second copy of vipC, the A1163 
and Z5 strain possess the vapB gene and both copies of vipC. In order to check whether this 
intraspecific variability is equally distributed, a set of unsequenced A. fumigatus strains 
have been investigated during this study.  
The presence of the genes encoding the different components of the Vap-Vip system 
(vapA, vapB, vipC1 and vipC2) was assessed in several environmental and clinical isolate 
strains kindly provided by Dr. Oliver Bader (Institute for Medical Microbiology, Georg-
August University, Göttingen). Primer pairs targeting these genes were used for their 
amplification from gDNA. Out of 32 different tested A. fumigatus strains (23 environmental 
derived strains (E) and 9 clinical isolates (CI)) 24 possess only the three genes vapA, vipC1 
and vipC2, of which 19 were environmental isolates and five were clinical isolates. The 
remaining eight strains possess all four genes, four strains coming from natural 
environments and four clinical isolates (Figure 11A-C). It is a common feature of this 
fungus that either if it is a clinical derived strain or an environmental isolate, two different 
systems coexist: one composed by all the four genes vapA, vapB, vipC1 and vipC2, and 
another predominant one in which the vapB gene has been lost.  
Since vapA, vipC1, and vipC2 are always existing in both ‘models’ in A. fumigatus 
and vapB can be present or not, this circumstance was also explored in different strains of 
A. nidulans. For that purpose, primers targeting the vapA, vapB and vipC genes were used 
for PCR amplification from gDNA of the A. nidulans laboratory strains AGB551 and 
AGB552, and the WT strain FGSC A4 (Figure 11D). All these three strains possess a copy 






Figure 11: A. fumigatus possesses two different systems: one composed by all four genes vapA, 
vapB, vipC1 and vipC2, and second in which vapB is absent 
Genomic DNA of the indicated strains was used to amplify the corresponding genes by PCR.  
1: vapA (1241 bp); 2: vipC1 (1577 bp); 3: vipC2 (1510 bp); 4: vapB (1526 bp). (A) A variety of 
environmental isolated strains (E) coming from all over Germany. (B) Five clinical isolated strains 
(CI) coming from patients with Aspergillosis. (C) Four different strains also derived from clinical 
isolates. AfS35, AfS77 and A1160 carry NHEJ-deficient mutations whereas Af293 is a WT strain. 
Primers used for gene amplification were HA13/HA14 (vapA), HA15/HA16 (vipC1), HA17/HA18 
(vipC2), and HA178/HA179 (vapB) (D) 1: ANvapA (1154 bp); 2: ANvapB (1281 bp); 3: ANvipC 
(1493 bp). Primers used for genomic PCR amplification were HA180/HA181 (ANvapA), 
HA182/183 (ANvapB), and HA184/185 (ANvipC). All the ‘E’ and ‘CI’ strains were provided by 







Based on the new evidences, these five A. fumigatus strains were included into the 
Aspergilli phylogeny adapted from de Vries et al., 2017. Three out of these five are 
sequenced strains that were available on the databases, A1163, Z5 and var. RP-2014. The 
other two, AfS35 and AfS77, are strains whose vap-vip components were sequenced and 
incorporated during the course of this study. In addition, the analysed 23 environmental (E) 
strains and five more clinical isolates (CI) were also included in this phylogeny. The 
resulting tree with the hypothetical events where the gains of genes have occurred, 
according to the reasonable evolution within these species and clades are displayed (Figure 
12). It can be noticed that although most of the different proposed systems tend to cluster 
together, they are also represented in more distant species. This implies that genomic 
rearrangement, gene duplications or gene generation, have taken place at different points 
during the evolution of these species. 
This new scenario raises the questions, what are the advantages for this fungus of 
having two different systems and why there are strains in which the vapB gene has been 
lost. To address these questions, this study continued with a clinical isolate derived from 
the D141 strain, the AfS35, considering that A. fumigatus is a human opportunistic 
pathogen. This strain and the Af293, possess the most abundant Vap-Vip variant within 
A. fumigatus, the ‘three components system’ AfVapA, VipC1, and VipC2’. Deletion 
mutants of this complex have been generated and their behaviour under different kind of 
conditions have been assessed. The clinical isolates A1160 (A1163) and AfS77 (ATCC 
46645) of A. fumigatus, which have the ‘four components system’ are under research in 









Figure 12: Gain of vapB and vipC genes are events that happened at different points 
during evolution of Aspergilli 
Modified maximum likelihood phylogeny from de Vries et al., 2017, inferred from 149 
conserved protein sequences in which all the unsequenced environmental and clinical 
isolated A. fumigatus strains were included. The colour code represents the presence of the 






3.2 VapA-VipC homologues of A. fumigatus AfS35 are presumably interaction 
partners 
3.2.1 VapA, VipC1 and VipC2 share similar features with their homologues of 
A. nidulans 
In A. nidulans, VapA, VapB and VipC proteins are forming a complex when the 
sexual development is favoured (Sarikaya-Bayram et al., 2014, 2015). The vapA gene 
encodes a FYVE-like zinc finger membrane protein, and vapB and vipC encode two 
methyltransferases. Homologues of VapA and VipC proteins were found in A. fumigatus 
AfS35. They were first inspected in silico for similar features and functional domains 
compared to the A. nidulans proteins. Thus, AfVapA was also identified to have a zinc 
finger domain (FYVE/PHD-type), and both, AfVipC1 and AfVipC2, present 
methyltransferase domains and SAM-binding motifs (Figure 13). 
 
 
3.2.2 VipC2 is expressed under asexual and vegetative growth 
Previous findings showed that VapA, VipC1 and VipC2 share similar functional 
domains with their homologues in A. nidulans. Next, expression levels of these proteins 
were assessed in A. fumigatus strain AfS35. For this purpose, strains expressing GFP-



















Figure 13: VapA and VipC homologues present similar domains and motifs 
Schematic representation of VapA, VipC1 and VipC2 proteins in the AfS35 strain indicating 
the positions of the functional domains. For the protein sequence analysis, Prosite (Sigrist et al., 
2002, 2013), Pfam (Finn et al., 2016), and InterPro (Jones et al., 2014; Finn et al., 2017) 





by western hybridization. Genes were expressed under native promoter (a functional 
version of VipC1-GFP could not be generated). The VipC2-GFP protein was detected in 
mycelia grown under vegetative and asexual conditions (Figure 14A and 14B, respectively, 




In order to check whether VapA is not being expressed or if it could not be detected 
under these experimental conditions, GFP pull-downs were performed. Following the GFP-
trap protocol, protein samples deriving from vegetative mycelia, and asexual mycelia 
grown under dark or light conditions were analysed. VipC2-GFP was again detectable 
under all the conditions (Figure 15A and 15B, also before the pull-downs (Figure 14)) but 
A B
Figure 14: VipC2-GFP, but not VapA-GFP, is detectable under vegetative and asexual 
conditions 
Same protein amounts of the corresponding samples were analysed by western hybridization 
using anti-GFP antibodies. (A) Vegetative conditions. (B) Asexual conditions. Ponceau staining 
of the gels are shown as loading control (lower panels). Red arrows point the VipC2-GFP fusion 





VapA-GFP could only be detected in the vegetative conditions after pull-down experiments 
(Figure 15B). Whole cell extract (input) and unbound fractions are also shown to check the 
quality of the enrichment (note that the volume of the pull-downs that were loaded was 10-
times less than inputs). This indicates that VapA is produced in vegetative conditions 
although its expression seems to be lower than for VipC2, but we cannot exclude that VapA 
is also being expressed in asexual conditions but its detection is being affected by the GFP-
tag (it has to be considered that VapA is a putative membrane protein which normally are 
difficult to extract). 
 
A B 
Figure 15: VipC2-GFP is expressed and detectable in vegetative and asexual conditions 
whereas VapA-GFP is only detectable after enrichment (pull-down experiments) in 
vegetative growth 
GFP-trap protocol was performed and protein samples were analysed by western hybridization 
and visualized using anti-GFP antibodies. (A) Asexual mycelia of the corresponding strains grown 
under light or darkness conditions for 3 days. Input, unbound and bound (GFP pull-down) fractions 
are shown to check the quality of the experimental procedure (the loaded amounts of the pull-
downs were 10-times less than inputs). VipC2-GFP could be effectively enriched whereas VapA-
GFP was not detectable under these circumstances. (+) indicates the sample that have been loaded 
in the corresponding lane (B) Vegetative mycelia of the corresponding samples. VapA and VipC2 
could be enriched and detected in vegetative conditions. Red arrows and blue arrow point the 
VipC2-GFP and VapA-GFP fusion proteins, respectively (approximate sizes: GFP = 26-30 kDa, 





3.2.3 VapA, VipC1 and VipC2 interact under vegetative and asexual conditions 
The ability of the proteins VapA, VipC1 and VipC2 to interact and to form a complex 
in A. fumigatus AfS35 was assessed by High-Performance Liquid Chromatography (HPLC) 
coupled with Mass Spectrometry (MS). For this purpose, 2x106 spores/ml of the 
aforementioned strains expressing VapA or VipC2 GFP-fusion proteins were inoculated in 
liquid medium and GFP-Trap technique was performed in vegetative and asexual 
development grown under light or darkness conditions. VapA-GFP was not detectable in 
asexual conditions, not even after enrichment (Figure 15A). This means that, concerning 
VapA-GFP pull-downs, only the information coming from vegetative samples is displayed. 
GFP pull-downs were carried out using VapA or VipC2 as bait. In vegetative samples, 
VipC1 and VipC2 were pulled with VapA, and VapA and VipC1 were pulled with VipC2 
(Table 7 and 8, respectively). In asexual conditions, using VipC2-GFP as bait, VapA and 
VipC1 were also pulled under dark and light conditions (Table 9 and 10, respectively). The 
identification of these proteins in all the developmental stages tested is an indication that 
these proteins interact and might form a complex. The identification of VapA in asexual 
development, using VipC2 as bait, also confirms that VapA is expressed under those 
conditions. The C-terminally GFP tag of VapA might be interfering with the expression or 
the function of the protein and that could be an explanation of why it cannot be detected by 
Western hybridization under asexual conditions, even after enrichment.  
Note that all the proteins listed in the coming tables were filtered according to highly 
abundant protein presents in the controls. This means that all the proteins present in any of 
the controls with a LFQ intensity value higher or equal than 19 (for vegetative conditions) 
or 20 (for asexual conditions) were removed from the pull-downs. Also, proteins that were 
identified with more than two unique peptides in the controls were not further considered. 
Ultimately, all the proteins that were identified according to these criteria, only in the 






Table 7: Proteins identified in vegetative conditions using VapA as bait for GFP pull-downs 
All proteins identified in at least two out of three VapA-GFP pull-downs and not in the controls 
are listed. Table inferred from three independent biological replicates performed in A. fumigatus 
AfS35. Proteins were filtered for highly abundant proteins present in the GFP controls using a cut-
off for the log2 LFQ intensity ≥ 19 and a cut-off for unique peptides > 2. List was sorted 
according to the mean of the LFQ intensities. Analyses were performed using MaxQuant (Cox et 
al., 2008) and Perseus (Tyanova et al., 2016) software. Entries in bold represent AfVapA, 
AfVipC1 and AfVipC2 proteins. LFQ: Label-free quantification 
Mean log2  
LFQ intensity 
Protein name and description Gene name 
21.31 Uncharacterized protein (VapA) AFUA_5G11190 
20.81 TAM domain methyltransferase, putative (VipC2) AFUA_3G14920 
16.92 Methyltransferase LaeA-like, putative (VipC1) AFUA_8G01930 
15.60 Branched-chain-amino-acid aminotransferase AFUA_4G06160 
15.49 Proteasome regulatory particle subunit (RpnE), putative AFUA_3G06610 
15.06 Proteasome subunit alpha type  AFUA_6G04790 
15.06 ATP-dependent RNA helicase Dhh1 AFUA_3G05430 
14.39 ATP-dependent RNA helicase Dbp2  AFUA_2G10750 
13.45 KH domain RNA binding protein AFUA_2G04940 
 
Table 8: Proteins identified in vegetative conditions using VipC2 as bait for GFP pull-downs 
All proteins identified in at least two out of four VipC2-GFP pull-downs and not in the controls are 
listed. Table inferred from four independent biological replicates performed in A. fumigatus AfS35. 
Proteins were filtered for highly abundant proteins present in the GFP controls using a cut-off for 
the log2 LFQ intensity ≥ 19 and a cut-off for unique peptides > 2. List was sorted according to the 
mean of the LFQ intensities. Analysis were performed using MaxQuant (Cox et al., 2008) and 
Perseus (Tyanova et al., 2016) software. Entries in bold represent AfVapA, AfVipC1 and AfVipC2 
proteins. LFQ: Label-free quantification 
Mean log2 
LFQ intensity  
Protein name and description Gene name 
22.60 TAM domain methyltransferase, putative (VipC2) AFUA_3G14920 
20.65 Uncharacterized protein (VapA) AFUA_5G11190 
18.32 Branched-chain-amino-acid aminotransferase AFUA_4G06160 
17.76 Allergen, putative AFUA_5G01440 
17.64 Biotin synthase, putative  AFUA_6G03670 
17.30 FK506-binding protein 1A (FKBP) (Rapamycin-binding 
protein) Fpr1A  
AFUA_6G12170 
17.29 Glycogen synthase kinase (Skp1), putative  AFUA_6G05120 
17.02 Casein kinase I, putative AFUA_2G02530 
16.97 GMC oxidoreductase, putative AFUA_3G01580 
16.93 Electron transfer flavoprotein alpha subunit, putative AFUA_7G05470 
16.80 Protein transport protein Sec23 AFUA_1G03400 
16.74 RNP domain protein AFUA_6G12300 
16.59 KH domain RNA binding protein AFUA_2G04940 
16.42 Leucyl-tRNA synthetase AFUA_6G12630 
16.36 2-dehydropantoate 2-reductase  AFUA_3G00740 





16.23 Mitochondrial large ribosomal subunit YmL35, putative AFUA_5G12810 
16.08 Actin-bundling protein Sac6, putative AFUA_2G07420 
16.07 Methyltransferase LaeA-like, putative (VipC1) AFUA_8G01930 
16.05 Hexokinase Kxk, putative  AFUA_2G05910 
16.03 Proteasome regulatory particle subunit (RpnG), putative AFUA_6G07760 
15.97 NADPH--cytochrome P450 reductase (P450R) CprA  AFUA_6G10990 
15.92 Adenine phosphoribosyltransferase 1  AFUA_7G02310 
15.89 Adenylosuccinate synthetase (AMPSase) (AdSS) (IMP--
aspartate ligase) 
AFUA_1G15450 
15.82 NADH-ubiquinone oxidoreductase 213 kDa subunit AFUA_6G12280 
15.82 Hsp90 binding co-chaperone (Sba1), putative AFUA_5G13920 
15.80 Methylenetetrahydrofolate reductase  AFUA_2G11300 
15.79 NIMA-interacting protein TinC AFUA_7G02570 
15.76 AhpC/TSA family thioredoxin peroxidase, putative AFUA_8G07130 
15.76 6,7-dimethyl-8-ribityllumazine synthase  AFUA_6G06345 
15.68 GMP synthase [glutamine-hydrolyzing] (Glutamine 
amidotransferase) Gua1 
AFUA_3G01110 
15.67 Proteasome component Pre6, putative AFUA_5G02150 
15.66 T-complex protein 1, beta subunit, putative AFUA_1G01740 
15.65 Glycine dehydrogenase AFUA_4G03760 
15.57 Transcription factor RfeF, putative AFUA_4G10200 
15.56 Glutaredoxin Grx5, putative AFUA_4G05950 
15.54 Eukaryotic translation initiation factor 3 subunit G (eIF-
3 RNA-binding subunit) (p33 subunit homolog) Tif35  
AFUA_2G09870 
15.43 Proteasome subunit alpha type 3, putative AFUA_6G06350 
15.41 Calcium-transporting ATPase AFUA_6G06740 
15.39 Cytochrome c oxidase subunit 2 AFUA_m0490 
15.35 NTF2 and RRM domain protein AFUA_5G04160 
15.32 Microtubule associated protein EB1, putative AFUA_3G11860 
15.29 Glycerol-3-phosphate dehydrogenase [NAD(+)]  AFUA_1G02150 
15.20 Uncharacterized protein AFUA_3G00730 
15.17 Proliferating cell nuclear antigen AFUA_1G04900 
15.15 Orotidine 5'-phosphate decarboxylase  (Uridine 5'-
monophosphate synthase) (UMP synthase) PyrG  
AFUA_2G08360 
15.11 C1 tetrahydrofolate synthase, putative AFUA_3G08650 
15.07 Nitrate reductase AFUA_1G12830 
15.01 Proteasome component Prs3, putative  AFUA_6G06440 
14.99 Proteasome regulatory particle subunit (RpnE), putative AFUA_3G06610 
14.90 Transcription factor (Snd1/p100), putative AFUA_5G09250 
14.88 Fatty acid activator Faa4, putative  AFUA_2G09910 
14.86 Homoserine dehydrogenase (HDH)  AFUA_3G11640 
14.67 Mitochondrial ribosomal protein, putative AFUA_5G09490 
14.60 ATP phosphoribosyltransferase His1, putative  AFUA_7G04500 
14.59 Importin beta-3 subunit, putative AFUA_1G06790 
14.22 Nuclear pore complex protein (SonA), putative AFUA_1G09020 





Table 9: Proteins identified in asexual tissue grown under darkness conditions using VipC2 
as bait for GFP pull-down 
All proteins identified in the VipC2-GFP pull-down and not in the controls are listed. Table inferred 
from two independent biological replicates performed in A. fumigatus AfS35. Proteins were filtered 
for highly abundant proteins present in the GFP controls using a cut-off for the log2 LFQ intensity 
≥ 20 and a cut-off for unique peptides > 2. List was sorted according to the mean of the LFQ 
intensities. Analysis were performed using MaxQuant (Cox et al., 2008) and Perseus (Tyanova et 




Protein names Gene names 
26.72 TAM domain methyltransferase, putative (VipC2) AFUA_3G14920 
23.93 Uncharacterized protein (VapA) AFUA_5G11190 
21.60 Methyltransferase LaeA-like, putative (VipC1) AFUA_8G01930 
18.91 Alcohol dehydrogenase, putative AFUA_2G10960 
18.82 60S ribosomal protein L35 AFUA_1G10510 
18.65 Uncharacterized protein AFUA_4G04190 
18.30 Sterol carrier protein, putative AFUA_4G06380 
18.11 FK506-binding protein 1A (FKBP) (Peptidyl-prolyl 
cis-trans isomerase) (Rapamycin-binding prot) Fpr1A 
AFUA_6G12170 
17.86 T-complex protein 1, theta subunit, putative AFUA_4G09740 
17.77 Acetyl-CoA-acetyltransferase, putative AFUA_6G14200 
17.75 Uncharacterized protein AFUA_3G00940 
17.72 Acetyltransferase, GNAT family AFUA_3G07750 
17.69 O-acetyltransferase, putative AFUA_3G11510 
17.67 Actin cytoskeleton protein (VIP1), putative AFUA_2G10030 
17.66 Phytanoyl-CoA dioxygenase family protein AFUA_8G00480 
17.65 SIR2 family histone deacetylase, putative AFUA_6G09210 
17.63 Dihydrodipicolinate synthetase family protein AFUA_2G01230 
17.56 Glutamine dependent NAD+ synthetase, putative AFUA_5G03350 
17.56 ATP-dependent Clp protease proteolytic subunit AFUA_3G08330 
17.41 Uncharacterized protein AFUA_4G00520 
17.39 Uncharacterized protein AFUA_2G14620 
17.30 Beta-alanine synthase, putative AFUA_6G12670 
17.17 Proteasome regulatory particle subunit (RpnK), 
putative 
AFUA_2G03400 
17.17 Uncharacterized protein AFUA_4G03722 
17.15 Casein kinase I homolog, putative AFUA_6G06870 
17.03 Clathrin light chain AFUA_4G10020 
17.00 Extracellular lipase, putative AFUA_5G02040 
16.97 AhpC/TSA family thioredoxin peroxidase, putative AFUA_8G07130 
16.89 C2H2 transcription factor, putative AFUA_1G13050 
16.81 Glycogen synthase Gsy1, putative AFUA_5G02480 
16.74 40S ribosomal protein S27 AFUA_3G06640 
16.73 Cytochrome c subunit Vb, putative AFUA_2G03010 
16.66 Vacuolar protein 8, Vac8 AFUA_5G13540 





16.54 Nonribosomal peptide synthetase 14, NRPS14, PsoA, 
PesO 
AFUA_8G00540 
16.43 Thioredoxin AFUA_6G10300 
16.29 3-oxoacyl-(Acyl-carrier-protein) reductase, putative AFUA_3G10540 
16.29 Uncharacterized protein AFUA_6G03025 
16.24 Uncharacterized protein AFUA_2G09140 
16.15 Probable glycosidase Crf2 (Crh-like protein 2) Crf1 
Utr2 
AFUA_2G03120 
15.94 Elongation factor G1, mitochondrial (EF-Gmt) Mef1 AFUA_4G08110 
15.91 TPR domain protein AFUA_2G15490 
15.87 Prenylcysteine lyase, putative AFUA_3G09330 
15.86 Steroid monooxygenase, putative AFUA_8G00440 
15.57 60S acidic ribosomal protein P1 (AfP1) AFUA_1G06830 
15.56 Catalase  AFUA_2G18030 
15.39 Fe-containing alcohol dehydrogenase, putative AFUA_2G04520 
15.19 Uncharacterized protein AFUA_6G06970 
15.05 Sarcosine oxidase, putative AFUA_3G01180 
14.92 Fructosyl amino acid oxidase, putative AFUA_8G06440 
14.78 Lysophospholipase 3 (Phospholipase B 3) Plb3 AFUA_3G14680 
14.49 Ubiquitin carboxyl-terminal hydrolase  AFUA_2G06330 
14.38 3-isopropylmalate dehydrogenase AFUA_1G15780 
14.20 Ubiquitin-protein ligase Ufd4, putative AFUA_6G08880 
14.01 Uncharacterized protein AFUA_3G00960 
13.77 Alpha-amylase, putative AFUA_2G00710 
 
Table 10: Proteins identified in asexual tissue grown under light conditions using VipC2 as 
bait for GFP pull-down 
All proteins identified in the VipC2-GFP pull-down and not in the controls are listed. Table inferred 
from two independent biological replicates. Proteins were filtered for highly abundant proteins 
present in the GFP controls using a cut-off for the log2 LFQ intensity ≥ 20 and a cut-off for unique 
peptides > 2. List was sorted according to the mean of the LFQ intensities. Analysis were performed 
using MaxQuant (Cox et al., 2008) and Perseus (Tyanova et al., 2016) software. Entries in bold 
represent AfVapA, AfVipC1 and AfVipC2 proteins. LFQ: Label-free quantification 
Mean log2 
LFQ intensity 
Protein names Gene names 
26.46 TAM domain methyltransferase, putative (VipC2) AFUA_3G14920 
24.36 Uncharacterized protein (VapA) AFUA_5G11190 
21.27 Methyltransferase LaeA-like, putative (VipC1) AFUA_8G01930 
20.99 UPF0619 GPI-anchored membrane protein AFUA_3G00880 
20.82 Actin-bundling protein Sac6, putative AFUA_2G07420 
20.43 Anthranilate synthase component I, putative AFUA_6G12580 
20.38 Orotidine 5'-phosphate decarboxylase (Uridine 5'-
monophosphate synthase) PyrG 
AFUA_2G08360 
19.79 Single-stranded DNA-binding protein AFUA_5G07890 
19.66 26S proteasome regulatory subunit Mts4, putative AFUA_5G11720 
19.66 Hsp90 binding co-chaperone (Sba1), putative AFUA_5G13920 





19.54 Transcription factor RfeF, putative AFUA_4G10200 
19.46 Calcium/calmodulin-dependent protein kinase, 
putative 
AFUA_2G13680 
19.40 Membrane bound C2 domain protein (Vp115), 
putative 
AFUA_7G01840 
19.31 Diphosphomevalonate decarboxylase  AFUA_4G07130 
19.21 Carbamoyl-phosphate synthase, large subunit  AFUA_2G10070 
19.14 NADH-ubiquinone dehydrogenase 24 kDa subunit, 
putative 
AFUA_2G09130 
18.99 Proteasome component Pup3, putative AFUA_4G07420 
18.88 Exportin KapK AFUA_1G08790 
18.81 Mannose-1-phosphate guanyltransferase (Mpg1) AFUA_4G11510 
18.78 DUF323 domain protein AFUA_2G15650 
18.73 Aldehyde reductase (AKR1), putative  AFUA_6G10260 
18.06 Ran GTPase activating protein 1 (RNA1 protein) AFUA_3G07680 
17.88 Glycerol-3-phosphate dehydrogenase  AFUA_1G08810 
Other proteins that could be potential interaction partners of VipC2 or VapA were 
also identified. Although these tables represent the proteins that were identified only in the 
VapA-GFP (Table 7) or in the VipC2-GFP pull-downs (Tables 8-10) and not in the GFP 
controls, it could be possible that some proteins were unspecifically pulled-down. This can 
happen, for example, because of their relative abundance or stochastically, and it can 
include proteins like proteasome subunits, RNA-helicases, ribosomal-related proteins or 
chaperones. However, this is not known and should be carefully considered not to discard 
any potential interaction partner. In addition, there is a high representation of enzymes that 
participates in different metabolic and signalling pathways that might be interesting. 
Among of which we can find several proteins related with the energetic and amino acids 
metabolism as the aminotransferase encoded by the AFUA_4G06160 gene (pulled-down 
with VapA and VipC2 in vegetative conditions), glutamine synthetase, glycine 
dehydrogenase, PyrG, hexokinases, etc. There are proteins related with the oxidative stress 
response: catalases, thioredoxins, oxidoreductases, glutaredoxin Grx5, AhpC/TSA family 
thioredoxin peroxidase, CprA reductase, etc., and secondary metabolism-related proteins 
as the PsoA (NRPS14). There are membrane bound proteins like Vp115, GPI-anchored 
membrane proteins, and proteins from the nucleocytoplasmic transport like exportins 
(KapK), importins (β3 subunit) and proteins related with the nuclear pore complex (Son3). 
Several acetyltransferases such as Acetyl-CoA-acetyltransferase, O-acetyltransferase, 
GNAT family-acetyltransferase, SIR2 family histone deacetylase were identified. 
Signalling components as Ran GTPase or many kinases, and several transcription factors 





3.2.4 vapA from A. fumigatus AfS35 partially restores the effect of the vapA 
deletion in A. nidulans 
To get more insight about the functions of VapA, VipC1 and VipC2 proteins, the 
ability of AfVapA to complement the lack of its homologue in A. nidulans was tested by 
integrating on locus the vapA gene of A. fumigatus strain AfS35 into the vapA deletion 
background of A. nidulans. Deletion of vapA leads to an activation of asexual development 
through the increased expression of its master regulator brlA in A. nidulans (Sarikaya-
Bayram et al., 2014). Since the phenotypic complementation on plate was a subtle effect 
and the recovery was not that clear, brlA transcript levels were also used as readout. mRNA 
extracted from asexually-induced mycelia was analysed by qRT-PCR and brlA expression 
levels were measured. The introduction of the vapA gene from A. fumigatus in A. nidulans 
∆vapA strain can restore the brlA levels (Figure 16). This results suggest a related function 
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Figure 16: AfVapA can partially restore the phenotype of the ANvapA deletion mutant in 
A. nidulans 
Approximately 1x106 spores/ml of the indicated strains were inoculated in liquid London 
medium (LM) o/n at 37°C on a rotary shaker. Then, samples were allowed to develop asexually 
for 12h under light conditions and mRNA isolated from those mycelia were analysed by qRT-
PCR for brlA transcript levels. Relative expression was normalized with the histone H2A gene. 
WT corresponds to the parental A. nidulans AGB552 strain. WT expression levels was set to 
100%. This result shows upregulation of brlA upon ANvapA deletion and the recovery after 
integration of AfvapA into AN∆vapA (****P<0.001). Gene expression is given relative to WT 





3.3 VipC2 modulates the response against oxidative stress and weak-acidic stress 
3.3.1 VipC2 affects differently the menadione-induced response to oxidative 
stress depending on the genomic environment 
Under basal conditions, deletion of any of the methyltransferases alone or combined 
with any other member of the VapA/methyltransferase system results in several 
phenotypical differences. The colonies tend to be larger with a more remarkable white halo 
surrounding the colony. The deletion of vipC1 together with vapA, in addition, displays 
irregular radial growth. Interestingly, the triple deletion of vapA, vipC1 and vipC2 recovers 
the WT phenotype (Figure 17A, control).  
Intracellular ROS (reactive oxygen species) accumulate mostly as a result of cellular 
respiration and can damage all kind of biomolecules. A proper oxidative stress response is 
crucial and determinant, for instance, for the infection capacity of pathogenic fungi (Brown 
et al., 2009). Tests using the oxidizers menadione (MSB: menadione sodium bisulfite), 
H2O2 and diamide as stressing agents were carried out to analyse a possible effect of the 
VapA, VipC1 and VipC2 proteins upon the cellular response to oxidative stress. The loss 
of vipC1, and specially vipC2, but not vapA, results in an increased resistance to MSB-
induced oxidative stress in A. fumigatus AfS35 (Figure 8A). All the double deletions and 
even the triple deletion mutant exhibit a phenotype of resistance against menadione. This 
effect of resistance was specific for MSB since H2O2 and diamide showed no significant 
differences compared to WT (Figure 17B and 17C).  This phenotype could be restored by 
the reintroduction of the vipC2 gene (Figure 17D). This supports a repressive role of VipC1 
and VipC2 in the control of the MSB-mediated oxidative stress response in this strain. 
The ∆vipC2 strain produces a dark coloured pigmentation at the bottom of the colony, 
especially when the fungus was grown under light conditions (Figure 17D, bottom views 
















Figure 17:  Deletion of vipC1 or vipC2 confers resistance against MSB in A  fumigatus AfS35 
Approximately 4000 spores of the indicated mutant strains were spot inoculated on agar LM plates 
and incubated for three days in light or darkness conditions at 37°C. (A) 0.015 mM MSB was added 
(MSB: menadione sodium bisulfite). (B) and (C) 1.5 mM H2O2 or 1mM diamide were added, 
respectively. (D) Bottom view of the WT, ∆vipC2 and vipC2-GFP strains showing the pigmentation 
of ∆vipC2 at the bottom of the colony 
The effect on MSB was explored in other A. fumigatus strains to check the impact of 
the vipC2 deletion towards the MSB-induced oxidative stress response under different 
backgrounds. vipC2 deletion strains were constructed in the A1160 and AfS77 
backgrounds. Also, vapB deletion mutant in the A1160 strain was generated. While the 
vipC2 deletion has no effect in AfS77, loss of vapB or vipC2 leads to a higher sensitivity 




Figure 18: ∆vapB and ∆vipC2 strains are more sensitive against MSB in A. fumigatus A1160 
Approximately 4000 spores of the corresponding strains were spot inoculated on agar LM plates 
and incubated for three days in light or darkness conditions at 37°C. (A) 0.015 mM MSB was 
added. 1.5 mM H2O2 or 1 mM Diamide were added in (B) and (C), respectively. vapB and vipC2 





MSB since H2O2 and diamide showed no significant differences compared to WT (Figure 
18B and 18C).    
Altogether, these results indicate a differential role of VipC2 towards the MSB-
induced oxidative stress response depending on the genetic background. There is an effect 
of resistance in the strain AfS35 (Figure 17A), or increased sensitivity in the strain A1160 
(Figure 18A) or no effect in AfS77 (Figure 18A). There is also a light-dependent effect 
upon the MSB-induced OSR where this fungus can grow better under darkness conditions 
than in light (Figures 17 and 18). This differential stress response depending on the light 
correlates with the data published by Fuller et al., 2013. 
There exist differences in the MSB-induced OSR within strains of A. fumigatus. In 
line with these observations, to check whether this effect can be extended to other species, 
vapA, vapB and vipC deletion mutant in A. nidulans were challenged with MSB. Deletion 
of any of these genes have no significant effect upon treatment with this oxidizing agent 
(Figure 19). 
 
This result indicates that the regulation by these methyltransferases of the MSB-
induced response against oxidative stress is modulated by the genetic environment. It 
responds not only to interspecific variations but also to intraspecific genomic arrangements. 
Figure 19: VapA, VapB and VipC are dispensable in the stress response against MSB in 
A. nidulans 
Approximately 4000 spores of the WT or the vapA, vapB and vipC single deletion mutants were 
spot inoculated on agar MM plates and incubated for three days at 37°C. 0.03 mM MSB was 
added. Regarding resistance, no further differences were observed under any of the conditions and 
concentrations tested. WT refers to the A. nidulans AGB551 strain used as parental strain to 





3.3.2 Responses to weak acid and MSB-induced stresses are affected by the Vap-
Vip system and display an opposite correlation  
The accumulation of the anion fraction of dissociated carboxylic acids such as sorbic 
acid can lead to oxidative stress (Piper, 1999). Weak-acid stress response mediated by 
potassium sorbate was tested in vapA, vipC1 and vipC2 deletion mutants in A. fumigatus 
AfS35 strain. Loss of vipC2 alone, or combined with vapA, results in an increased 
sensitivity towards weak-acidic conditions (Figure 20A). The weak effect was reproducible 
and could be complemented by the reintroduction of the vipC2 gene (Figure 20B). This 
indicates a positive role of VipC2 in the control of the weak-acidic response mediated by 
sorbic acid in this strain. 
It has been observed how distinct A. fumigatus strains respond differently to the MSB-
induced oxidative stress. The presence of organic acids was reported to have a pro-oxidant 
effect where in the AfS35 strain, the deletion of vipC2, display an opposite correlation 
compared to MSB. In order to check the influence of the vipC2 deletion over the weak-
acidic response in a different genomic environment, other A. fumigatus strains were tested. 
The tolerance against sorbic acid was investigated in A. fumigatus A1160, AfS77 and Af293 
backgrounds. vipC2 deletion mutants were generated in A1169 and AfS77. Besides, vapB 
deletion was also constructed in the A1160 strain. While deletion of vipC2 shows no 
difference in AfS77, loss of vapB or vipC2 has a protective effect over the weak-acidic 
stress promoted by sorbic acid in A. fumigatus A1160 (Figure 21). As for the MSB-induced 
stress, the tolerance of A. fumigatus against sorbic acid also tend to be higher in darkness 







Figure 20: vipC2 mutants display increased sensitivity against sorbic acid 
Approximately 4000 spores of the corresponding strains were spot inoculated on agar LM plates in 
the presence of sorbate at the indicated concentrations and incubated for 3 days at 37°C. (A) Only 
light conditions are shown, where the production of the pigment can be also appreciated. (B) VipC2-










This result together with the MSB-induced OSR effect in both A. fumigatus strains, 
AfS35 and A1160, exhibit a negative and opposite correlation. While the vipC2 deletion in 
the AfS35 strain results in an increased resistance to MSB and a higher sensitivity against 
Figure 21: In A. fumigatus A1160, deletion of vapB or vipC2 results in an increased 
resistance against sorbic acid 
Approximately 4000 spores of the indicated strains were spot inoculated on agar LM 
plates and incubated under light or darkness conditions for 3 days at 37°C. 5 mM 
sorbate was added. A. fumigatus A1160 ∆vapB and ∆vipC2 strains display resistance 
against weak acidic stress. Top and bottom views of the colonies are shown. Please 
note, there is no dark light-dependent pigmentation upon deletion of vipC2 in these 





sorbic acid, in the A1160 strain, the effect is exactly the opposite. The deletion of vipC2 in 
the AfS77 background did not show any effect upon MSB or sorbic acid treatment. 
Altogether, these results point out the importance of the genomic environment in the control 
and modulation of the stress response by the Vap-Vip system in A. fumigatus. 
 
3.3.3 VipC1 and VipC2 affects the fitness of the fungus under stress conditions 
In an effort to further characterise the role of VapA, VipC1 and VipC2 over the fungal 
stress response, deletion mutants of their encoding genes were challenged with compounds 
that exert different kind of stresses in the cell. Thus, congo red was used to induce the cell 
wall stress response. High temperature (42°C) and different pH conditions (4.5 and 8.5) 
were also tested. The ATM and ATR-mediated DNA damage response was triggered by 
methyl methanesulfonate (MMS) or UV light, respectively. Ataxia-telangiectasia mutated 
(ATM) and ataxia telangiectasia and Rad3-related protein (ATR) are two key kinases in the 
main DNA damage repair pathways. Nocodazole, which interferes with the microtubules 
polymerization promoting M-phase arrest of the cell cycle, or benomyl, a tubulin-targeted 
antimitotic antifungal agent (Clément et al., 2010) were used to promote microtubule stress. 
Amino acid starvation conditions by the use of MSX (L-methionine sulfoximine), a potent 
inhibitor of the glutamine synthetase activity, and different carbon sources (cellulose) were 
screened as well. It can be appreciated that morphological changes affect different aspects 
of the fungal physiology upon deletion of the methyltransferases. Loss of vipC1, vipC2, 
vapA/vipC2 or vipC1/vipC2 negatively affects conidiation under exposure to MSX, high 
temperature, UV-light or microtubule disrupters. Also, double deletion of vapA and vipC1 
results in an irregular radial growth even in control conditions, and it shows a ‘fluffy 
phenotype’ characterised by the production of whitish aerial hypha at the centre of the 
colony when grown at 42°C. 
In general, the deletion of vipC1, vipC2 or all their double combined mutants display 
phenotypes under stress conditions that are a magnification of the effects that these 
deletions induce in untreated conditions. Remarkably, the inactivation of the whole Vap-
Vip system, achieved by the simultaneous deletion of vapA, vipC1 and vipC2, recovers the 
WT phenotype (Figure 22). The deletion of vipC1, vipC2, vapA/vipC2 or vipC1/vipC2 leads 






Figure 22: VipC1 and VipC2 maintain the fitness of the fungus under different kind of stresses 
Approximately 4000 spores of the corresponding strains were spot inoculated on agar LM plates 
containing the indicated substances. The pH was taken to 4.5 and 8.5 values by the addition of HCl 
or NaOH, respectively. In the UV light condition, spores were allowed to germinate overnight on 
normal LM and plates were, then, irradiated (100 seconds dose). Plates were scanned after three 
days of incubation at 37°C except in the ‘high temperature’ condition which it was 42°C (and, as 







Altogether, these results indicate that the Vap-Vip system is involved in the 




Figure 23: Deletion of vipC2 increases the colony size 
Approximately 4000 spores of the indicated strains were spot inoculated on agar LM 
plates and grown under light or darkness conditions for 3 days at 37°C. Diameter of the 
corresponding colonies was measured after 3 days and surface was calculated. Colonies 
of the ∆vipC2, ∆vapA/vipC2 and ∆vipC1/vipC2 strains are 10-15% bigger. Error bars 
























3.4 VipC2 controls the biosynthesis of fumiquinazolines and other secondary 
metabolites 
It is widely known that VeA controls sexual development and secondary metabolism 
in Aspergillus nidulans (Kim et al., 2002; Kato et al., 2003). For instance, VeA is an 
inhibitor of the orsellinic acid gene cluster. Overexpression of VapB drastically reduces 
VeA levels, leading to an accumulation of orsellinic acid derivatives (Sarikaya-Bayram et 
al., 2014). This establishes a connection between the VapA-VapB-VipC complex and 
secondary metabolism in Aspergillus nidulans. Therefore, the role of VapA, VipC1 and 
VipC2 in secondary metabolism was explored in Aspergillus fumigatus 
3.4.1 Loss of vipC2 leads to the production of a blue light-dependent pigmentation 
It was shown that deletion of vipC2 in A. fumigatus AfS35 results in the production of a 
dark coloured pigmentation in the bottom of the colony. This pigmentation increases and 
focalizes to the centre when grown under constant illumination (Figure 17D, 20B and 24A). 
The production of pigment(s) by all the different vapA, vipC1 and vipC2 deletion mutants 
was also explored under red and blue light. Only the deprivation of vipC2 alone promotes 
the generation of dark compound(s) under blue light illumination but not red (Figure 24B). 
This result shows there is a blue light-dependent alteration of the secondary metabolism in 






Figure 24: ∆vipC2 strain produces an intense and focalized dark pigmentation upon blue light 
Approximately 4000 spores of the indicated strains were spot inoculated on agar LM plates and 
incubated under constant white illumination or darkness conditions for 3 days at 37°C in (A) or 
under blue light or red light illumination in (B). ∆vipC2 strain presents a dark coloured pigmentation 
at the bottom of the colony when grown under blue light conditions and this effect can be 









3.4.2 Light-dependent pigmentation in the absence of VipC2 is stress-dependent 
The deletion of vipC2 leads to the production of a dark coloured pigmentation in the 
bottom of the colony. When all the different stress conditions were screened, it could be 
noticed that some of them interfered with the production of these compounds, mainly in 
light. Out of all the stresses tested, there were just three conditions in which this more 
intense light-dependent pigmentation by the ∆vipC2 strain was highly reduced: high 
temperature, nocodazole and benomyl treatment (Figure 25). 
Figure 25: Light-dependent pigmentation of the ∆vipC2 strain is supressed upon benomyl, 
nocodazole or high temperature 
Approximately 4000 spores of the AfS35 WT, ∆vipC2 or VipC2-GFP complementation strains were 
spot inoculated on agar LM plates under the indicated conditions. Under these conditions, the dark 
light-dependent pigmentation was no longer visible. Plates were scanned after three days on 





3.4.3 Expression of the light-sensing machinery remains unaffected upon deletion 
of vipC2  
The production of dark compound(s) in the ∆vipC2 strain is a blue light-dependent 
effect. To get more insights into this phenomenon, gene expression studies were carried 
out. mRNA levels of the blue, red and putative green light receptors (lreA/B, fphA/B and 
nopA, respectively) were analysed. Also, a set of light-related genes, including the blue-UV 
light receptor orthologue of A. nidulans, cryA (named phr1 in A. fumigatus), were assessed 
by qRT-PCR in the vipC2 deletion strain. In vegetative conditions, no significant 
differences in the expression levels of the blue and red light receptors were observed upon 
deletion of vipC2 (Figure 26A). 
Since the production of dark pigment(s) was observed after growing the fungus in 
solid medium under light conditions, mRNA isolated from asexually-induced mycelia were 
subjected to analysis by qRT-PCR. Expression levels of these main light receptors and 
phytochromes in addition to the aforementioned sort of light-related genes were tested. 
Similarly than before, no significant differences were observed in the vipC2 deletion strain 
compared to the WT after 48 hours of asexual development inducement under light 
conditions (Figure 26B). This result suggests that the regulation is not on gene expression 
level of light receptor genes. It cannot be excluded that these methyltransferases are 
controlling light receptors at the protein level, through post-translational modifications, for 
instance. Also, it could be that there are other regulatory elements that are participating in 







Figure 26: Transcript levels of light receptors, phytochromes and a sort of light-related genes 
remain unaffected by the vipC2 deletion 
(A) Approximately 1x106 spores/ml of the AfS35 WT, ∆vipC2 and VipC2-GFP complementation 
strains were inoculated in 100ml of liquid LM and incubated overnight (16-20h) on a rotary shaker 
at 37°C. Samples were then processed and mRNA levels of the indicated genes were analysed by 
qRT-PCR (vegetative samples). (B) Approximately 1x106 spores per ml of the AfS35 WT, ∆vipC2 
and VipC2-GFP complementation strains were inoculated in 100ml of liquid LM and incubated 
overnight (16-20h) on a rotary shaker at 37°C. Mycelia were then shifted to solid medium plates 
and incubated under light conditions during 48h at 37°C to induce asexual development. Samples 
were then harvested, processed and mRNA levels of the indicated genes were analysed by qRT-
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3.4.4 ∆vipC2 strain presents alterations in the secondary metabolite profile when 
grown under constant illumination 
As it could be observed before, this blue light-dependent pigmentation that takes 
place in the vipC2 deletion mutant is specific for the A. fumigatus strain AfS35 (Figure 21, 
control light samples). Next step was to confirm further by HPLC whether there is a change 
in the secondary metabolite production pattern. For that purpose, 2x106 spores of the WT 
AfS35, vipC2 deletion strain, and VipC2-GFP complementation strain were plated on solid 
london medium under light or darkness conditions for 3 days at 37°C. HPLC analysis of 
the samples confirm differences in the secondary metabolite profile but only in those grown 
under constant illumination, and not in the dark, and this effect can be complemented by 
integration of the vipC2 gene in the vipC2 deletion strain (Figure 27). 
As a result of the vipC2 deletion, there is a modification in the production of 
metabolites that can be detected by HPLC. There are peaks that are absent in the ∆vipC2 
strain (yellow star) and peaks that are only present or enhanced in this deletion mutant strain 
(green star). This result confirms that VipC2 exerts a light-dependent control of the 












































Figure 27: ∆vipC2 strain exhibits differences in the secondary metabolite profile in light 
Approximately 2x106 spores of the AfS35 WT, ∆vipC2, and VipC2-GFP complementation strains 
were plated on agar LM under light or darkness conditions at 37°C. HPLC analysis of the 
secondary metabolites extracted from the corresponding samples were carried out after three days 
of incubation. (A) Darkness conditions, panel on the left corresponds to the evaporative light 
scattering detector (ELSD), and right panel to the UV/VIS detector at 280 nm. (B) and (C) 
correspond to the light samples where the ELSD and the UV/VIS detector at 280 nm were used, 
respectively. No differences were observed under darkness conditions. Differentially detected 





3.4.5 VipC2 supresses the production of fumiquinazolines in light 
In an effort to associate these differential peaks that appear or disappear in the vipC2 
deletion strain to individual compounds, HPLC coupled with MS analysis of these samples 
were performed in collaboration with the group of Prof. Dr. Helge B. Bode from the 
Goethe-University, Frankfurt am Main, Germany. 2x106 spores of the WT AfS35 and the 
vipC2 deletion strain were plated on solid London Medium under constant illumination for 
3 days at 37°C. Metabolites extracted from the agar using the same procedure were analysed 
by LCMS confirming differences in the production of certain compounds. Thus, there are 
peaks only present or enhanced in the vipC2 deletion strain or peaks that were absent in this 
knockout strain (Figure 28A). Further analysis of the individual peaks revealed that some 
of them, enhanced in the vipC2 deletion strain, were identified to belong to the 
fumiquinazolines family of compounds. 
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Figure 28: LCMS analysis of the ∆vipC2 strain confirmed differences in the secondary metabolite 
production pattern in light 
HPLC-MS analysis of the secondary metabolites extracted from AfS35 WT and ∆vipC2 grown under light 
conditions for three days at 37°C using the same procedure as for the HPLC analysis (Figure 18). (A) BPC 
(Base Peak Chromatogram): negative mode representation of the assay (B) Structural formula of the 





An example of these peaks that are differentially present in the ∆vipC2 strain, can be 
found, depicted by the blue numbers 1, 2, and 3, in the Figure 19A. These higher abundant 
peaks correspond to different fumiquinazoline molecules. 1: Fumiquinazoline A (FQA), 2: 
Fumiquinazolines C and/or D (FQC/D), and 3: Fumiquinazoline F (FQF) (Figure 28B). 
FQC and FQD are isomers of the same molecule with the same molecular weight, therefore, 
they cannot be distinguished by mass. 
 
3.4.6 VipC2 inhibits the expression of fmqC in vegetative conditions 
As a feature of the fungal genome, genes encoding for the biosynthetic enzymes, 
regulatory or transport proteins necessary for most of the secondary metabolites produced 
by these organisms are grouped together forming discrete clusters around the synthase 
genes (Keller et al., 2005; Andersen et al., 2013). The fumiquinazolines gene cluster is 
formed by four enzyme-encoding genes, named fmqA-D, and one transporter gene, fmqE. 
Also, the vicinity of the genomic region corresponding to this Fq cluster was inspected 
aiming to find a hypothetical regulator of the cluster that might be controlling the synthesis 
of these metabolites. It was found, upstream of the fmqE transporter gene, a putative 
Cys2His2 zinc-finger transcription factor encoded by the gene AFUA_6G12020. Up to date, 
no role of this gene in the control of the fumiquinazoline gene cluster have been reported.  
Following up with the nomenclature of this cluster, this gene, in this study, was called 
‘fmqF’. 
The mRNA expression levels of fmqF gene, in addition to all the other components 
of the Fq gene cluster were subjected to analysis by qRT-PCR in A. fumigatus AfS35 WT, 
vipC2 deletion and VipC2-GFP complementation strains. Loss of vipC2 results in an 
upregulation of fmqC in vegetative conditions. In the case of the fmqA gene, it was also 
observed a two-fold increase in its expression levels upon deletion of vipC2 (Figure 29), 
however, this effect could not be complemented. One explanation might be that the C-
terminally GFP tag of VipC2 is affecting certain aspects of the protein function, disturbing, 
for instance, the 3D structure and domains or protein-protein interactions. This result 







Figure 29: VipC2 represses fmqC expression under vegetative conditions 
Approximately 1x106 spores/ml of the A. fumigatus AfS35 WT, ∆vipC2 and VipC2-GFP 
complementation strains were inoculated in 100ml of liquid LM and incubated overnight (16-20h) 
on a rotary shaker at 37°C. Samples were then processed and mRNA levels of the indicated genes 
were analysed by qRT-PCR. This result shows upregulation of fmqC upon vipC2 deletion. It also 
shows fmqA upregulation but this effect cannot be complemented (*P<0.05 ****P<0.001). Gene 
expression is given relative to WT from three independent biological replicates. 
 
3.4.7 VipC2 interferes with the brlA expression 
Previous results have reported a selective accumulation of FqC in asexual 
reproduction structures such as the conidia (Gauthier et al., 2012). A recent study shows 
the link between the master regulator of asexual development, brlA, and the 
fumiquinazolines production (Lind et al., 2018). Deletion mutants of brlA are still capable 
of producing FqF but they fail to produce all the other fumiquinazoline moieties. Besides, 
expression analysis of the fumiquinazolines’ BGC (biosynthetic gene cluster) showed that 
fmqA, fmqB, fmqC, fmqD and fmqE transcripts were undetectable upon brlA deletion (Lim 
et al., 2014). To further assess the regulatory impact of VipC2 on Fq production, expression 
analyses were performed and brlA mRNA levels were measured in the absence of vipC2. 
Deletion of vipC2 leads to an upregulation of brlA (Figure 30). This result supports the 
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Figure 30: VipC2 negatively regulates brlA expression 
Approximately 1x106 spores/ml of the A. fumigatus AfS35 WT, ∆vipC2 and VipC2-GFP 
complementation strains were inoculated in 100ml of liquid LM and incubated overnight (16-20h) 
on a rotary shaker at 37°C. Samples were then processed and brlA mRNA levels were analysed by 
qRT-PCR. This result shows upregulation of brlA upon vipC2 deletion (*P<0.05). Gene expression 
is given relative to WT from three independent biological replicates. 
 
3.5 VipC1 and VipC2 negatively affect the anti-azole drug resistance 
A. fumigatus is a human opportunistic pathogen in which the increasing antifungal 
drug resistance has become an important issue over the last decades (Mosquera et al., 2002; 
Snelders et al., 2008, 2009; Rivero-Menendez et al., 2016). A connection between 
secondary metabolism, fumiquinazolines synthesis and asexual development regulators 
have been shown (this study and Lind et al., 2018). There are studies that shows an 
association between secondary metabolism, toxins production and virulence (Jöhnk et al., 
2016), and others that links azole resistance with dysregulation of secondary metabolites 
gene clusters (Bromley et al., 2016). In the coming sections, clinical aspect of the biology 
of A. fumigatus such us the antifungal drug tolerance and the virulence will be investigated 




































3.5.1 Loss of vipC1 or vipC2 leads to an increased resistance against 
voriconazole 
The ability of vapA, vipC1 and vipC2 deletion strains to resist and survive to 
voriconazole was assessed. Deprivation of vipC1 or vipC2 results in an increased resistance 
against voriconazole. The double deletion strain vapA/vipC2 also shows an increased 
resistance, but the highest effect was observed for the vipC2 single mutant (Figure 31A). 
This phenotype seems to be a light-independent mechanism since the same effect of 
resistance was observed after growing the fungus under light or darkness conditions (Figure 
31B). The production of a reddish pigmentation in the bottom of the colony upon 
voriconazole treatment in the ∆vipC2 strain could be noticed as well, which correlates with 
the secondary metabolism effect (Figure 31). 
In an effort to characterise further the level of resistance of the ∆vipC2 strain against 
voriconazole, the minimum inhibitory concentration (MIC) was determined. The test 
revealed that the minimum concentration of the drug that completely suppresses the fungal 
growth is almost four times bigger in the vipC2 deletion than in the WT. Whereas in the 
AfS35 WT and vipC2-GFP complementation strain the concentration that totally inhibited 







Figure 31: vipC2 deletion positively affects anti-voriconazole resistance and influences secondary 
metabolism 
(A) Approximately 4000 spores of the indicated strains were spot inoculated on agar LM plates 
and incubated for three days at 37°C. 0.75 µg/ml voriconazole was added. Regarding the 
resistance, no light-dependent effect was observed, only dark conditions are shown. (B) 
Dilution spot test in which the indicated amounts of spores were spot inoculated on agar LM 
plates and incubated for three days under light or darkness conditions at 37°C. A. fumigatus 
AfS35 WT, ΔvipC2 and VipC2-GFP complementation strains are presented. Top and bottom 
views of the plates are shown (control plates were scanned after two days). ΔvipC2 strain is 









To further assess the regulatory impact of VipC2 on the voriconazole resistance in 
other A. fumigatus strains, the basal voriconazole sensitivity of four different WTs was 
tested. Different amounts of spores of AfS35, Af293, AfS77 and A1160 WT strains were 
spotted on LM containing different concentrations of voriconazole. AfS77 and A1160 
strains are proposed to have the ‘four components system’, harbouring the genes vapA, 
vapB, vipC1 and vipC2. In AfS35 and Af293, however, the vapB gene has been lost, leading 
to a ‘three components system’. While AfS77 and A1160 strains were almost unable to 
grow at a concentration of 0.5 µg/ml voriconazole, AfS35 and Af293 colonies were 
remarkably evident after the same incubation period (Figure 33, right panel). This result 
might suggest that the gain of resistance mechanism in different A. fumigatus strains could 
be related to the presence of the methyltransferases vapB, vipC1 and vipC2. 
Figure 32: ΔvipC2 strain is almost four times more resistant than WT against voriconazole 
MIC (minimum inhibitory concentration) measurements in which 1000 spores per well of 
A. fumigatus AfS35 WT, ∆vipC2 and VipC2-GFP complementation strains were inoculated in 
200 µl of liquid LM. Indicated amounts of voriconazole were added and fungal growth was 
measured after 48 hours of incubation at 37°C (panel of the left). The panel of the right 
correspond to a second independent biological replicate five days post-inoculation. While the 
WT and VipC2-GFP complementation strains cannot grow at concentrations higher than 0.5 






Figure 33: In A. fumigatus, AfS77 and A1160 strains exhibit higher sensitivity against 
voriconazole treatment 
The indicated amounts of spores of the corresponding A. fumigatus WT strains were spot inoculated 
on agar LM plates and incubated for three days at 37°C (control plate was scanned after two days). 
0.25 and 0.5 µg/ml voriconazole were added. The background strains AfS35 and Af293 exhibit 
increased resistance against this antifungal agent. 
 
To test this hypothesis, vapB and vipC2 deletion strains were generated in the A1160 
background. The vipC2 deletion mutant was also constructed in the AfS77 background. 
Equal amounts of spores of these strains were spotted on LM containing 0.25 or 0.5 µg/ml 
voriconazole and their resistance was assessed. Loss of vapB or vipC2 in the A1160 
background, or vipC2 deletion in the AfS77, did not alter the tolerance capacity against 
voriconazole (Figure 34). This result pointed out once more the differences that exist 
between strains, and how the same modulator(s), VipC2 in this case, under different 








Figure 34: VapB and VipC2 are inessential for the resistance against voriconazole in 
A. fumigatus A1160, and VipC2 in the AfS77 
Approximately 4000 spores of the indicated strains were spot inoculated on agar LM plates 
and incubated under light conditions for three days at 37°C. 0.25 and 0.5 µg/ml 
voriconazole was added. Top and bottom view of the plates are shown. WT, ∆vipC2 and 
VipC2-GFP complementation strains in the AfS35 background are also presented to 




In order to extend these findings beyond the intraspecific barrier, the anti-azole 
impact of the Vap/methyltransferase system was also tested in A. nidulans. For that purpose, 
different amounts of spores of the vapA, vapB and vipC deletion mutants were spotted in 
LM containing 0.1 µg/ml voriconazole and their tolerance was assessed. Loss of any of 
these genes did not have any effect compared to the WT (Figure 35), indicating a trivial 









3.5.2 Deprivation of VipC2 confers resistance against itraconazole  
To check whether there is a general anti-azole mechanism of resistance upon 
deletion of vipC2 in A. fumigatus AfS35 or if it is a voriconazole-specific effect, other 
antifungal agents from the same class were tested. Tolerance capacity of the vapA, vipC1 
and vipC2 deletion mutants were challenged with 6 µg/ml itraconazole. Loss of vipC2 leads 
to a higher resistance against itraconazole (Figure 36), suggesting that VipC2 might also 
act as a repressor in the cellular response to this drug. 
  
Figure 35: VapA, VapB and VipC are not required for the drug tolerance against 
voriconazole in A. nidulans 
Dilution spot test in which the indicated amounts of spores were spot inoculated on agar 
LM plates and incubated for three days at 37°C. 0.1 µg/ml voriconazole was added. No 
differences were observed. A. nidulans AGB 551 WT, ΔvapA, ΔvapB, and ΔvipC strains 







3.5.3 VipC2 acts as a repressor of abcA and abcB expression 
It has been shown that the deletion of vipC2 in A. fumigatus AfS35 leads to an 
increased resistance against voriconazole and itraconazole treatment. One of the 
mechanisms by which fungi can become resistant to azoles involve alterations in the 
expression levels of multidrug resistance channels (MDR) (Fraczek et al., 2013; Meneau et 
al., 2016). mRNA expression levels of four top candidate genes for azole resistance were 
assessed by qRT-PCR: the ATP-binding cassette (ABC) transporter encoding genes, abcA 
(AFUA_2G15130) and abcB “cdr1B” (AFUA_1G14330), cyp51A and the drug efflux 
transporter gene mdr1. Deletion of vipC2 results in a more than two-fold upregulation of 
abcA and abcB genes after voriconazole induction (Figure 37). A positive effect of AbcB 
over the resistance to voriconazole in A. fumigatus AfS35 and Af293 has been reported, 
and also against itraconazole in the Af293. AbcA, though, showed a minor effect in the 
same direction but only against voriconazole in the Af293 strain and not in the AfS35 (Paul 
et al., 2013). Altogether, these results could explain why an overexpression of abcA and 
abcB, in which VipC2 acts as an inhibitor, leads to a gain of resistance against voriconazole 
and, to a minor extent, against itraconazole in A. fumigatus AfS35.  
Figure 36: VipC2 negatively affects resistance against itraconazole 
Approximately 4000 spores of the indicated strains were spot inoculated on agar LM plates and 
incubated three days at 37°C. 6 µg/ml itraconazole was added. No light-depending effects were 






3.5.4 VapA, VipC1 and VipC2 are dispensable for the resistance against 
amphotericin B 
The loss of vipC2 confers the ability to tolerate higher concentrations of 
voriconazole to A. fumigatus AfS35 and, to a minor extent, also of itraconazole. To test 
whether this is a general antifungal mechanism of resistance or if it is an azole-specific 
effect, the polyene amphotericin B (Amp B) was tested. vapA, vipC1 and vipC2 mutant 
strains were exposed to 0.5 or 0.75 µg/ml of this drug and their resistance was tested. No 
effect was observed upon deletion of any of these genes, not under light nor darkness 
conditions (Figure 38). This result confirms that deletion of vipC2 does not lead to a general 
activation of the antifungal drug response. In contrast, it is a light-independent resistance 
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vipC2 KO +vor vipC2-GFP -vor vipC2-GFP +vor
Figure 37: VipC2 regulates abcA and abcB expression upon voriconazole treatment 
Approximately 1x106 spores per ml of the AfS35 WT, ∆vipC2 and VipC2-GFP 
complementation strains were inoculated in 100 ml (1x108 spores per flask) of liquid LM 
and incubated overnight (16-20h) on a rotary shaker at 37°C. Induction was, then, carried 
out by addition of 0.5 µg/ml voriconazole (+ vor) for four hours. Samples were processed 
and transcript levels of the indicated genes were analysed by qRT-PCR. In the absence of 
vipC2, abcA and abcB are upregulated upon voriconazole treatment (****P<0.001). Gene 
expression is given relative to WT +vor from two independent biological replicates. Error 







indirectly, as a repressor. The loss of vipC2 in A. fumigatus strain AfS35 results in an 





Figure 38: VapA, VipC1 and VipC2 are nonessential for the drug tolerance against 
amphotericin B in A. fumigatus AfS35 
(A) Approximately 4000 spores of the indicated strains were spot inoculated on agar LM plates and 
incubated for three days under darkness conditions at 37°C. 0.5 and 0.75 µg/ml amphotericin B was 
added. (B) Dilution spot test in which the indicated amounts of spores were spotted on agar LM plates 
containing 1 µg/ml amphotericin B and incubated for three days under light or darkness conditions at 
37°C. A. fumigatus AfS35 WT, ΔvipC2 and VipC2-GFP complementation strains are presented. Top 
and bottom views of the plates are shown. Please note the production of the dark pigmentation 
remains unaffected under these circumstances (for control conditions, refer to figure 31). No 





3.5.5 VapA, VipC1 and VipC2 are nonessential for the virulence 
It has been shown how this Vap-Vip system affects the MSB-induced oxidative stress 
response, secondary metabolism and anti-azole drug resistance in A. fumigatus AfS35. To 
test whether these proteins are also required for virulence, the wax moth infection model of 
Galleria mellonella was used. Larvae of G. mellonella were infected with 5x105 spores of 
the AfS35 WT and all the vapA, vipC1 and vipC2 deletion mutants. An avirulent strain, 
AfS12, was taken as a control to compare the ability to kill the larvae. Survival of injected 
individuals was monitored daily. None of the deletion mutants assessed have lost their 
virulence and infection capacity since all of them were able to kill the larvae with a tendency 
similar to the WT (Figure 39). This result indicates that VapA, VipC1 and VipC2 are 
dispensable for the virulence of A. fumigatus AfS35 in this invertebrate wax moth infection 
model under the conditions tested. 
 
 
Figure 39: vapA, vipC1 and vipC2 mutants are as virulent as the WT strain 
Virulence assay in the wax moth infection model Galleria mellonella. Approximately 5x105 spores 
of the corresponding deletion mutants were injected in each larva. Viability of the individuals was 
assessed every 24 hours. AfS12 represents an A. fumigatus strain that is totally avirulent. This result 
reveals that VapA, VipC1 and VipC2 are dispensable for the virulence of A. fumigatus AfS35. (days 


























4.1 Evolution of the Vap-Vip system among Aspergilli 
During the course of this study, the high variability regarding the presence of the 
components of the Vap-Vip system in Aspergilli has been shown. At least four different 
variants of this system have been detected, all of which always share the presence of vapA 
and vipC. These two genes, in the absence of vapB, seem to conform the minimum unit and 
the most abundant variant of the system (Figure 10). According to the species that were 
inspected and their phylogenetic relationship, this variant, only composed of vapA and 
vipC, would be also the origin of all the other versions of the system. Some species have 
generated a second copy of vipC, among of which we find several strains of A. fumigatus 
or A. terreus. Some others, as A. nidulans, possess a very rare variant which have included 
a new gene, vapB, in addition to vapA and vipC. Finally, a combination of these two 
variants, consisting in vapA, vapB, vipC1 and vipC2 genes, also exists. This is the case in 
some other A. fumigatus strains and A. flavus, for instance. However, we cannot exclude 
that more different variants of this system exist. It could be possible that vapA is the 
conserved component of this system and that depending on the organism and environmental 
conditions, different methyltransferases can interact and receive the information from 
VapA. 
Orthologues of vapA and vipC have been found in Penicillium and other genera of 
the family Aspergilaceae. The presence of orthologues of the components of this system in 
more distant filamentous fungi have also been reported (Sarikaya-Bayram et al., 2014). 
Interestingly, no vapA orthologues were found neither in the basidiomycete Ustilago ssp., 
nor in higher eukaryotes as the human, or in the yeast model organism Saccharomyces 
cerevisiae. Saccharomyces and Aspergillus genera are two members of the phylum 
Ascomycota but they belong to different subphylums, Saccharomycotina (true yeast) and 
Pezizomycotina, respectively. This observation suggests that the presence of this Vap-Vip 
system could be restricted to some taxonomic groups within the Ascomycota, and it 
appeared at some point during the evolution of certain filamentous fungi. 
This raises the question concerning the origin of these genes, whether vipC2 and vapB 
are the result of a gene duplication and subsequent paralogue evolution, if they appeared as 





In the context of gene duplication, paralogue generation and evolution there are 
several models suggested to describe the underlying mechanisms and to predict the fate of 
a duplicated gene. Essentially, a duplicated gene can have three different outcomes 
depending on the resulting functions. Neofunctionalisation is when the duplicated gene(s) 
gains a new function. By contrast, nonfunctionalisation is when the new gene accumulates 
mutations and is eventually lost over time. Finally, it could also happen that after the 
duplication event, both resulting genes might take over different functions of the ancestral 
gene (subfunctionalisation) (Kaltenegger et al., 2015). In the case of the Aspergillus species 
with only one copy of vipC, its gene product could also work as a homodimer or even 
forming homo-oligomeric complexes, which are functionally essential and highly abundant 
in living cells (Venkatakrishnan et al., 2010). In fact, most of the proteins exist as 
symmetrical complexes formed by subunits encoded by the same locus and only a minority 
of them work as single units. This might be the case even if the monomeric subunit has also 
catalytic activity on its own (facultative oligomers) (Lynch, 2013). Normally, in most of 
the gene duplication models, this tendency to form symmetrical homomer complexes is 
abandoned when a protein-encoding gene is duplicated (Kaltenegger et al., 2015). At first, 
both duplicates are identical and cross-interact to form paralogous heteromers when 
coexpressed. However, when both gene products dimerize or interact with other molecules 
on their own, they can evolve differently and both are subjected to distinct selective 
pressures where degenerative mutations can occur. As a result of this, mutations in one 
copy can generate repressor alleles that influence or inhibit the function of the other 
(Bridgham et al., 2008; Lynch, 2013). Something similar might have happened for the 
duplication of vipC to produce vipC2 in some Aspergilli, where a dual inhibition model 
between both gene products is proposed along the coming sections. There are several 
examples in nature of multimeric enzymes with a regulatory mechanism that resembles 
certain analogy with the Vap-Vip system, for instance, the widely known, protein kinase A 
(PKA). This prototypic protein kinase is a holoenzyme (it uses cAMP as cofactor) 
composed by two regulatory subunits and two catalytic subunits. As a tetramer, this protein 
stays blocked, but when the concentration of cAMP is high, it binds to the regulatory 
subunits promoting the release and activation of the catalytic subunits (Wang et al., 2014; 
Smith et al., 2018). In the Vap-Vip system, vipC1 and vipC2 gene products might be 
catalytically active alone or forming homodimers (or even higher multimeric states) but 
they block each other if both are present. Also, after duplication of vipC, or other genes, 





mutations can provide novel features, which are then exposed to negative or positive 
selection (Bridgham et al., 2008). These new acquired properties could lead ultimately to 
different genes that plays distinct roles depending on the species. This could be the case 
also for the gain of vapB in some Aspergilli, where after the initial duplication event of 
vipC, evolution could take a different but parallel direction. This vapB gene could have 
evolved differently under distinct requirements and genomic environments (species), 
leading to the generation of new genes with different functions. This would support why 
vapB (or vipC1/2) plays a role in development in A. nidulans but it modulates the stress 
response in A. fumigatus, although the scope of all their implications are not yet known.  
The functional diversification  after a duplication event, or the gene loss as an energy 
saving mechanism, (Gladieux et al., 2014; Qian et al., 2014), could have been the two forces 
that have driven the evolution of the Vap-Vip system among Aspergillus species. 
In the phylogeny of Aspergilli, although most of the different Vap-Vip proposed 
systems tend to cluster together, they are also represented in more distant species (Figure 
12). This implies that genomic rearrangement, such as the aforementioned generations or 
losses of components of the vap-vip system occurred at different points during the 
evolution. The analysis of more species is necessary to get a comprehensive picture of the 
actual scenario and evolution of these genes in Aspergilli. 
Out of the 34 different strains of A. fumigatus (23 environmental and 11 clinical 
isolates) that were investigated for the presence of components of this system, 75% possess, 
apart of vapA gene, two copies of vipC but no vapB. The remaining 25%, in addition to 
these three genes, harbour the vapB gene. Interestingly, all the tested strains have two 
different copies of vipC but only in 25% of them the presence of vapB is conserved (Figure 
12). It seems that the duplication of vipC confers an evolutionary advantage since all the 34 
different strains of A. fumigatus, environmental and clinical isolates, have the vipC2 gene. 
On the other hand, the gain of vapB only in certain strains suggests that the contribution of 
this gene to the system is subtle and expendable, although it cannot be excluded additional 
unknown functions. This fact raises the question of why does A. fumigatus have two 
different alternatives of the Vap-Vip system, what is the function and which is the impact 
of these two variants in the different strains. 
In the saprophytic fungus and genetic model organism A. nidulans, this complex 





Bayram et al., 2014), but its function in other members of this genus had not been 
investigated before. The most conserved element of this system, vapA, was used in an 
interspecific assay to check whether the gene from A. fumigatus can complement its 
deficiency in the deletion mutant of A. nidulans. As shown in the Results section 3.2.4, 
AfuVapA can restore the increased brlA transcript levels as a result of the An∆vapA 
deletion, although the expression levels of vapA in A. fumigatus seems to be lower than in 
A nidulans. While in A. nidulans VapA-GFP, expressed under native promoter, is 
detectable by microscopy as single foci in the plasma membrane (Sarikaya-Bayram et al., 
2014), in A. fumigatus it can only be detected after enrichments (pull-down experiments) 
(Figure 15). Importantly, AfuVapA is a putative membrane-bound protein, which normally 
are proteins difficult to extract and detect under normal conditions. By the use of detergents 
and other extraction methods, AfuVapA-GFP expressed under native promotor could not 
be detected neither by western hybridization nor fluorescence microscopy in A. fumigatus 
AfS35. It could also be that the function of these proteins in both fungi is not that similar, 
is influenced by the genomic environment or is totally different, even if there is some 
phenotypic recovery. To further check this hypothesis, the complementation strains with 
the remaining genes needs to be generated and assessed, and also in the reciprocal way, 
from A. nidulans to A. fumigatus. 
In order to address the function of these proteins in A. fumigatus, the loss of genes 
was artificially produced by deleting the corresponding genes to make the knockout strains. 
During the next sections, the impact of the Vap-Vip system over key cellular processes in 
this saprophyte and human opportunistic pathogen will be discussed. 
 
4.2 Modulation of the stress response by the Vap-Vip system 
According to this study, previous published data in A. nidulans and the proposed 
model (Figure 40), this complex, as a whole regulatory unit, does not seem to be essential 
for the survival of the cell in A. fumigatus strain AfS35. Deletion mutant of its components 
are still able to grow and produce spores. This affirmation can be inferred from the fact that 
the deletion of all its subunits recovers the WT phenotype under almost any circumstance. 
This suggests also that this complex, in WT conditions, with all its components intact, 
remains blocked. In line with this hypothesis, where the Vap-Vip system integrates 





membrane-bound protein, and the VipC1/VipC2 methyltransferases, would be the catalytic 
subunits. The single deletion of vapA usually have a minor effect or no effect under every 
tested conditions, suggesting that in the absence of VapA, VipC1 and VipC2 might be 
blocking each other. In addition, VapA could be also involved in the transmission of the 
signal to the catalytic part, directly or through another protein(s), which supports the no 
effect-phenotype of the vapA deletion strain. The unbalancing of this system by deletion of 
any of the methyltransferases, vipC1 or vipC2, but especially vipC2, alone or combined 
with the deletion of any other member of the complex, seems to activate it (or ‘unblock’ it), 
leading to phenotypical changes. These different kind of mutations would be enough to 
disrupt the complex, which could result in the release from VapA of one of the 
methyltransferases and its subsequent activation. This unblocked system could be also 
capable to respond to different stimuli, which would result in a further activation of the 
methyltransferases as it will be shown during the coming sections. 
Under basal conditions, unbalancing of this complex results in several phenotypical 
differences and developmental defects such as irregular radial growth, larger colonies or a 
more remarkable white halo surrounding the colony, probably associated with less 
conidiation. A magnification of these phenotypes was observed when the different mutant 
strains were grown under distinct stressing conditions (Figure 22), suggesting that it is the 
buffer capacity to stand hostile situations rather than a general stress response what it is 
affected. 
However, in the case of the MSB-induced oxidative stress, and the sorbate-mediated 
weak acid response, the situation seems to be different. The destabilisation of the Vap-Vip 
system, mainly by deletion of vipC2, leads to a clear effect of resistance specifically against 
MSB-induced oxidative stress and not H2O2 nor diamide (Figure 17). This can be partially 
explained due to the distinct mode of action of these ROS-generating chemicals, which 
triggers different cellular responses. Diamide is a thiol-oxidizing agent that imbalance the 
GSH/GSSH redox system by the fast oxidation of GSH (glutathione) to GSSH (glutathione 
disulfide).  H2O2, by increasing the intracellular peroxide (O22-), generates highly reactive 
hydroxyl radicals (OH•) and promotes the oxidation of the sulphur-containing amino acids 
(Toledano et al., 2003). In contrast, menadione alters the redox equilibrium reducing the 
NADH and NAD(P)H pools, which is particularly important since these two cofactors are 
needed in their reduced state to regenerate several free radical scavengers (Piper, 1999; 





release the iron from metal-containing proteins like [4Fe-4S]-proteins, culminating in the 
production of OH• radicals (Toledano et al., 2003; Pócsi et al., 2005).  
The responsive set of genes that are activated upon treatment with these three 
different ROS-generating compounds are only partially overlapping (Pócsi et al., 2005). 
Also in yeast there are several references that supports that these chemicals trigger distinct 
elements of the oxidative stress response (OSR) (Flattery-O’Brien et al., 1993; Saito et al., 
2004; Thorpe et al., 2004). The destabilisation of the Vap-Vip system could be triggering 
downstream elements that ultimately affects specifically the genes related to the MSB-
dependent OSR. According to the model, where VipC1 and VipC2 are blocking each other, 
the loss of one of them, especially vipC2, would lead to the release from VapA and 
activation of the other, promoting changes, directly or indirectly, over the gene expression 
and resulting in this effect of resistance. The additional deletion of vapA together with any 
of the methyltransferases will resemble the methyltransferase single deletion-phenotype. 
Remarkably, and only in this case, the complete inactivation of the Vap-Vip system, 
achieved by the triple deletion mutant, did not recover the WT phenotype. The deletion of 
the whole complex also displayed resistance against menadione, which might be suggesting 
an additional suppressive role of this complex towards the OSR and only upon MSB 
stimulation. The hypothesis of the dual inhibition when both methyltransferases are present 
fails to explain why when both are absent, there is still an effect of resistance. The most 
likely explanation for this particular stress would involve the action of additional regulatory 
elements that are part of a more complex and imbricated network with multiple bypass 
pathways and overlapping points (Figure 40).  
It has been reported a pro-oxidant effect of certain carboxylic acids such as sorbic 
acid (Piper, 1999). However, disruption of the Vap-Vip system in A. fumigatus strain 
AfS35, by deletion of vipC2 alone or together with vapA, not only did not promote 
resistance, but slightly increased the sensitivity against this chemical (Figure 20). Similarly 
than before, an explanation could be that both compounds, MSB and sorbate, trigger 
different cellular responses in the cell. In contrast to MSB, sorbic acid potentiates the 
damages caused by ROS derived from the respiratory chain, activating a completely 
different set of genes (Mira et al., 2010 a). Also, the stress response to carboxylic acids is 
much more complex and involves the activation of many different downstream elements 





Interestingly, the contribution of the Vap-Vip system to the MSB-induced OSR and 
the weak acidic response against sorbic acid in A. fumigatus strain A1160 is exactly the 
opposite. This strain has the second variant of the Vap-Vip system: in addition to the other 
three genes, it also possesses a copy of vapB. Deletion of either vapB or vipC2 increases 
the sensitivity against MSB and the resistance against sorbic acid in the A1160. On top of 
this, we have also an intermediate situation in which the deletion of vipC2 in the AfS77 
strain, which also has the second Vap-Vip variant, did not have any effect over the MSB-
induced OSR nor the weak acid stress response (Figure 18 and 21). 
Altogether, this results indicate that these might be strain specific effects although 
this opposite correlation between the AfS35 and A1160 strains suggest an implication of 
the Vap-Vip system over these two cellular stress responses. It could be that under different 
backgrounds, gene gain and loss events could have had different implications. The role of 
the Vap-Vip system in the modulation of the adaptive stress response to hostile conditions 
is determined by the genomic environment, and it has a different impact depending on the 
stimuli. However, in order to validate this hypothesis, more deletion mutants and 
experimental evidences need to be generated in different strains. These findings point out 
once more the enormous variability that exist, not only at the molecular but also at the 
physiological level, between different isolates of A. fumigatus, which fits with the data 







Figure 40: The Vap-Vip system modulates the MSB-induced oxidative stress response 
(A) In WT conditions, this intact Vap-Vip system remains blocked and inactive. (B) The loss of 
the putative scaffold membrane-bound protein, VapA, does not alter the active/inactive state of 
the methyltransferases since VipC1 and VipC2 are blocking each other. (C-D) When the 
methyltransferase balance is altered by deletion of vipC1 or vipC2, especially vipC2, this complex 
acquires the active state which is able to respond to stimuli and detach from VapA. This activated 
methyltransferase most likely promotes changes in the gene expression which leads to this MSB-
resistance phenotype in A. fumigatus strain AfS35. The double arrows represent that there might 
still be certain intercommunication between VapA and the methyltransferase even in the active 
state. Additional unknown factors (white circles with a ‘?’) that might be involved in alternative 





4.3 Vap-Vip system and the control of secondary metabolism 
The production of a dark pigmentation in the bottom of the colony in the ∆vipC2 
strain has been shown (Figure 24). Deletion of vipC2 disrupts the Vap-Vip system making 
it capable to respond to light and govern secondary metabolism. Although there is already 
an effect in the ∆vipC2 strain on the secondary metabolism in darkness, where darker 
compounds are produced (Figures 24 and 25), light activates further VipC1 and alters the 
production of fumiquinazolines and other metabolites (Figures 27 and 28). VipC1 promotes 
changes in the gene expression, presumably through epigenetic modifications, increasing 
the fmqA and fmqC transcript levels, which results in an accumulation of fumiquinazolines’ 
intermediates such as FQA, FQC/FQD and FQF (Figure 28 and 29). The gene cluster that 
encodes for the fumiquinazolines biosynthetic machinery has recently been reported to be 
positively regulated by an epigenetic modifier, the valproic acid, in A. fumigatus. The 
treatment with this compound promotes an increase in the expression levels of all the 
components of the cluster, fmqA-E, resulting in an accumulation of fumiquinazoline C 
(FQC) (Magotra et al., 2017). This published data supports an epigenetic control of this 
gene cluster for the fumiquinazolines’ production, which might be also the case when 
unbalancing the Vap-Vip methyltransferase system. Disturbing this equilibrium, when 
vipC2 is absent, might lead to epigenetic changes which alter gene expression and enhances 
fumiquinazolines production upon the right stimuli. 
Furthermore, when the ∆vipC2 strain was analysed, there were more differentially 
expressed peaks in the HPLC-MS chromatogram, apart from those corresponding to the 
fumiquinazolines’ intermediates. The FQ’s are colourless molecules as it can be inferred 
by their UV-spectrum. These two observations and the fact that the ∆vipC2 strain 
accumulates dark pigments in the centre of the colony when grown under constant 
illumination, and to a minor extent also in darkness, strongly suggest that there must be 
additional secondary metabolite pathways affected. HPLC-MS analysis of the vipC2 
deletion strain grown under darkness conditions, probably with different extraction 
methods, should be performed to confirm those differences on plate. Altogether, it can be 
said that unbalancing of the Vap-Vip system by deletion of vipC2, leads to alterations in 
the gene expression, presumably through epigenetic modifications, that results in the 
enhanced production of fumiquinazolines, pigments, and other secondary metabolites 





The increased expression of the master regulator of asexual development, brlA, in the 
vipC2 deletion strain has been shown. The production of certain fumiquinazoline 
intermediates have been associated to asexual development. Whereas FqA and FqF are 
found also in vegetative tissue, FqC localization, for instance, is predominantly 
conidiophore-specific (Lim et al., 2014; Lind et al., 2018). Recent studies have confirmed 
the role of brlA as a master regulator of secondary metabolism and other cellular processes. 
It regulates not only developmental SMs as the fumiquinazolines, but also the vegetative 
SMs (Lind et al., 2018). brlA deletion strains are still able to produce FqF but fail to produce 
all the other Fq moieties. Also, in the ∆brlA mutant, the transcript levels of all the 
components of the fumiquinazolines gene cluster were almost undetectable (Lim et al., 
2014). These findings are also in line with a recent report that shows that rtfA deletion 
mutants display an increased conidiation, correlating with higher brlA levels in 
A. fumigatus. Interestingly, an upregulation of fmqA transcript and an accumulation of FqC 
was also described for the ∆rtfA strain in this study (Myers et al., 2017). 
As mentioned above, in this study, an overexpression of the fmqA and fmqC has been 
observed (Figure 29). FmqA and FmqC catalyse the production of the first fumiquinazoline 
precursor, FqF, and the intermediate, FqA, respectively. This correlates with the 
fumiquinazoline intermediates that have been identified accumulating in the ∆vipC2 strain, 
FQA and FQF (peak 1 and 3, respectively in the Figure 28). Giving the fact that brlA is also 
upregulated in the vipC2 deletion mutant (Figure 30), it raises the question whether it is 
VipC1 directly exerting an effect on the fumiquinazolines cluster or is it a brlA-mediated 
mechanism. It could even be possible that VipC1, through epigenetic modifications, is 
controlling both, brlA expression and fumiquinazolines production by regulation of the 
expression of their biosynthetic genes. The deletion of vipC2 in a ∆brlA background will 
be necessary to place the methyltransferase(s) upstream or downstream of BrlA in the 







Figure 41: Vap-Vip system in the control of secondary metabolism 
(A) In WT conditions, this intact Vap-Vip system remains blocked and inactive, being unable to 
react to the stimuli. (B) Loss of the VipC2 encoding gene leads to the deregulation of this system 
switching to active state. Active VipC1 can then alter the secondary metabolism and pigments 
production even without stimulus. (C) Light can activate further VipC1 leading to a more intense 
and localized pigmentation, and to the upregulation of fmqA and fmqC with the subsequent 






Figure 42: Interplay between the Vap-Vip system and BrlA in the control of the biosynthesis 
of the fumiquinazolines 
In WT conditions, this intact Vap-Vip system remains blocked and inactive, presumably attached 
to the fungal plasma membrane (left panel). Disruption of the complex by deletion of vipC2 leads 
to the release and activation of VipC1 which results in an upregulation of brlA. The observed 
upregulation of the fmqA and fmqC genes and subsequent accumulation of fumiquinazolines might 
be a BrlA-dependent mechanism, a direct VipC1 effect, or a synergic combination of both where 
even other unknown factors could be involved (right panel). 
 
This is an effect specific of the AfS35 strain since deletion of vipC2 in the AfS77 or 
A1160 backgrounds did not produce any pigmentation in the bottom of the colony. 
However, as mentioned, we cannot exclude that other secondary metabolite pathways are 
being affected. To further test this hypothesis and since some of the differentially produced 
compounds can be colourless, HPLC-MS analysis of these deletion strains in different 





4.4 Vap-Vip system and the anti-azole drug resistance 
Deletion of vipC1, vipC2, or vipC2 together with vapA leads to a voriconazole-
resistant phenotype (Figure 31). Furthermore, the vipC2 deletion strain, which shows the 
greatest effect, also displays resistance against itraconazole (Figure 36). Overexpression of 
multidrug resistance (MDR) transporter genes is one of the most common mechanisms in 
antifungal drug resistance (Meneau et al., 2016). The observed effect of resistance in the 
absence of vipC2 could be explained, at least partially, due to the higher expression levels 
of two drug efflux transporters: abcA (AFUA_2G15130) and abcB, also known as cdr1B 
(AFUA_1G14330) (Figure 37). AbcB have been described to exert a positive effect over 
the resistance against voriconazole in A. fumigatus AfS35 and Af293, and also against 
itraconazole but only in the Af293. For AbcA, though, a minor effect of resistance against 
voriconazole but only in the Af293 has been reported (Fraczek et al., 2013; Paul et al., 2013, 
2017). It could be that overexpression of AbcA together with AbcB promotes a synergic 
effect that results in this azole-resistance effect in the vipC2 deletion strain. 
Recently, other non-cyp51 deletion mutation in the Afssn3 gene that leads to the 
increased expression of MDR efflux transporters and the subsequent azole resistant-
phenotype has been discovered in A. fumigatus (Long et al., 2018).  
Two different scenarios are possible. One in which either VipC1 or VipC2 is acting 
as direct or indirect inhibitor of the expression of abcA and abcB, and where VapA would 
have a minor trivial role. Thus, when they are not present, expression levels of abcA and 
abcB go up and therefore, these mutant strains become resistant. This explanation would 
need additional elements involved since the vipC1 and vipC2 double deletion or the triple 
deletion mutant do not display any effect of resistance. The second scenario, according to 
our previously proposed model, is that VipC1 and VipC2 are blocking each other and only 
when one of them is absent, the other gets activated and alters gene expression, for instance, 
increasing abcA and abcB products upon azole stimulation. This hypothesis would explain 
why when both are absent or when both are present, there is no effect of resistance. The 
fact of the different contributions of both methyltransferases to this effect and to the Vap-
Vip system could be the result of many additional factors, for instance, different protein 
levels or stoichiometry, different degree of activity or affinity, not fully overlapping targets, 





Figure 43: Effect of the Vap-Vip system over the anti-azole drug response 
(A) In WT conditions and without azole stimulation no effect in the abcA and abcB expression 
levels is observed. (B) Upon voriconazole treatment, mutant systems, and not the WT, are able to 
get activated by the stimulus. The activated methyltransferases, VipC1 or VipC2, are able to induce 
changes in the gene expression, directly activating the transcription of abcA and abcB or indirectly 
through an unknown factor, and leading to the effect of resistance. ∆vipC1, ∆vipC2 and 
∆vapA/vipC2 strains become resistance to voriconazole but only ∆vipC2 gets resistant to 
itraconazole. Whereas for the secondary metabolism control, the deletion of vipC2 is sufficient to 
induce the production of pigments and the upregulation of brlA, for instance. It seems that the Vap-






These observations together with the fact that the double deletion of vapA and vipC1 
does not have any effect, suggest that it is not the absence of vipC2 itself, but the presence 
of vipC1 (without vipC2) the key element of this mechanism of resistance. To have one of 
the methyltransferase and only one, especially vipC1, is what it confers resistance upon 
voriconazole stimulation in A. fumigatus strain AfS35 (Figure 43).  
This phenotype is also strain specific since no effect of resistance was observed in 
other A. fumigatus backgrounds upon deletion of vipC2 (Figure 34). As for the secondary 
metabolism and the stress response, this differential effect supports the heterogeneity 
among isolates, and the distinct roles and impact of the Vap-Vip system in the adaptive 
response depending on the genomic environment and the stimuli. 
4.5 The Vap-Vip system as an environmental adaptive tool in A. fumigatus 
  
Aspergillus fumigatus is widely known for its extremely broad capacity of adaptation 
to different kind of niches. Among of the habitats where A. fumigatus can be found are 
compost piles, immunosuppressed humans, or even there are cases reported where some 
isolates have been identified inside plants, as endophytes (Kusari et al., 2009; Li et al., 
2012; Magotra et al., 2017). Its ability to grow and decompose the decaying organic matter, 
but also to colonize and infect immunocompromised hosts, is the result of a complex and 
highly evolved environmental adaptive response.  
Adaptation is the consequence of a sophisticated sensing machinery, a proper 
interpretation of environmental cues and the establishment of a rapid and coordinated 
response depending on the stimuli. The availability of nutrients and oxygen, pH, 
temperature and the presence of harmful compounds are just some examples of the 
situations A. fumigatus have to regularly deal with during its life cycle. The development 
of new mechanisms that increases the tolerance upon certain environmental factors is key 
in the evolution of this adaptive response. A competent adaptive response is determinant 
for the success of the fungus, as pathogen inside the host, but also as saprophyte in the 
natural environments (Van De Veerdonk et al., 2017). 
In the case of a saprophytic fungus as the genetic model organism A. nidulans, it is 
reasonable to think that the different environments where it can be found are less diverse. 
In this fungus, the Vap-Vip system configuration that possess is implicated in the 





the stress response or anti-azole resistance (Figure 19 and 35) as it is in A. fumigatus. It 
seems that the genetic configurations of the Vap-Vip system in the facultative opportunistic 
pathogen, A. fumigatus is more prone to regulate the adaptive response.  
It has been shown that after a gene duplication event, the accumulation of mutations 
can provide new different functions to the duplicated gene (Bridgham et al., 2008; 
Kaltenegger et al., 2015). If these new features suppose an evolutionary advantage upon 
certain conditions in some species, the probability of fixation of this gene will be higher. 
These new properties might have different impact for the fungus depending on the 
environment and specific niches, as it could be the case of vipC2 among the different 
A. fumigatus strains. By contrast, this new gene variant may get lost completely over the 
time in other environments and species if its contribution is not relevant, as it could have 
happened for vapB. 
The gain or loss of genes encoding to different components of this system modulates 
the stress responses upon certain stimuli, which might have supposed an evolutionary 
advantage to survive under different conditions. This fact, makes this complex a very 
versatile and dynamic genetic tool, by which the fungus could lose or gain genes due to 
selective external pressures to increase the adaptation capacity to different environments. 
There are several examples reported about other pathogenic fungi and microorganisms, 
even within Aspergillus, that have used the gene loss and duplication as an evolutionary 
mechanism of adaptation (Carbone et al., 2007; Powell et al., 2008; Albalat et al., 2016; 
Coulombe-Huntington et al., 2017; Li et al., 2017).  
The gain of genes that contribute to the adaptation to different conditions is a 
widespread mechanism that allows the colonization of new environments. One common 
strategy is the incorporation of foreign specialized genes by lateral or horizontal gene 
transfer (HGT). Lateral gene transfer is a major force that has driven the genome evolution 
in prokaryotes in response to environmental adaptations (Ochman et al., 2000). This 
phenomenon is more likely to occur between close related organisms and among species 
sharing similar ecological niches (Smillie et al., 2011), although recent evidences have 
shown that HGT can happen across different life domains. There are even cases reported 
of cross-kingdom HGT, for example one extremophilic eukaryote that have acquired genes 
from bacteria and archaea (Schönknecht et al., 2013). In fungi, for instance, there are 





participated as donor organisms. Fungal species have received foreign genomic material 
from other fungi, for example, the transmission of the whole sterigmatocystin gene cluster 
(~54 kb, 23 genes) from Aspergillus nidulans to Podospora anserine (Slot et al., 2011). 
Another example is the case of some Trichoderma in which nearly half of its genes were 
obtained via HGT from plant-related filamentous fungi (Druzhinina et al., 2018). In 
addition to the aforementioned bacteria or archaea origin of these lateral genomic 
exchanges, there are also cases reported from plants to fungi (Richards et al., 2009; Gao et 
al., 2014) or even from viral sources (Liu et al., 2010) (Figure 44). 
 
 
Figure 44: Horizontal gene transfer and sexual development as generation processes of 
genomic variability 
The recipient fungal cell can acquire foreign genomic material from different donor 
sources such as bacteria, plants and other fungi, via horizontal gene transfer (HGT). 
Genomic rearrangements during sexual development might have contributed as well to 





The fact is that HGT is a quick mechanism by which genetically unrelated organisms 
can exchange genes for rapid environmental adaptation. The transfer of genes, group of 
genes or even an entire chromosome can have an important role on niche specification, 
pathogenic state or shift in metabolic capabilities (Fitzpatrick, 2012). The gain of vapB via 
HGT could have taken place at some point during the evolution of certain species as a 
response to a specific environmental requirement. There are other cases reported in which 
the genetic exchange of methyltransferases encoding genes has been recognised as an 
important mechanism of adaptation in eukaryotes and prokaryotes (Chen et al., 2017).  
HGT can be especially important in a fungus like A. fumigatus, that grows in the 
natural environments and it can also behave as a human opportunistic pathogen, being the 
most common fungal agent of invasive aspergillosis (>90% of infections). But it is also 
important in other fungi that share identical genetic Vap-Vip configurations as A. fumigatus 
and present similar biological strategies, both saprophytic and pathogenic. Two examples 
of this are A. flavus, the second most abundant agent of fungal infections within this genus 
(Hedayati et al., 2007; Paulussen et al., 2017), and A. terreus, another well know saprophyte 
that can cause fungal infections in humans (Steinbach et al., 2004; Castón et al., 2007). 
Furthermore, the development of new bioinformatics tools and algorithms to explore the 
genome aiming to find potentially horizontal transferred genes (HTG) have reported in 
A. fumigatus and A. flavus more than 270 and 500 HTGs, respectively (Nguyen et al., 
2015). It could be possible that HGT of components of the Vap-Vip system played an 
important role in these versatile organisms, where adaptation to the changing environments 
is essential for their success. 
Another important factor to be considered as a relevant mechanism to generate 
genomic variability is the genomic rearrangements that occur during sexual development. 
A. fumigatus is a heterothallic fungus that can undergo sexual development under very 
tightly regulated conditions if it gets into contact with a strain of opposite mating type 
(O’Gorman et al., 2009). Genomic exchanges during sexual development together with 
mutation and selection over the time could have favoured the generation of new gene 







Figure 45: Vap-Vip system as an environmental adaptive weapon in A. fumigatus 
In WT conditions, this system with all its components is blocked, unable to be activated by any 
stimuli. In this proposed model, VipC1 and VipC2 would be blocking each other. The unbalancing 
of this Vap-Vip system, achieved mainly by deletion of at least one of the methyltransferases (MTs), 
enables the complex to receive the signal. Deletion of one of the methyltransferases also favours 
the release of the other MT from VapA, which promotes already phenotypic changes. If it acts as a 
single monomeric unit or, by contrast, it forms homodimers o higher homo-multimeric complexes 
remains unknown. The stimulus, that can be from different nature, will activate further the 
methyltransferase leading to changes in the gene expression that ultimately will affect the fungal 







Taken together, our examination of the adaptive response of A. fumigatus revealed 
the presence of a novel genetic mechanism by which the fungus can increase the tolerance 
to hostile situations. This seems to be a silent system that stays as a backup pathway against 
stressful conditions and gets activated only under specific signals. Gene gain and loss within 
this system allows a more controlled and fine-tuning response against environmental 
signals (Figure 45). The deciphering of all these molecular networks will contribute further 
to the understanding of the biology of Aspergillus fumigatus. Future identification of novel 
mutations within this, or similar silent system that can lead to alterations in key cellular 












“Loss is nothing else but change, and change is Nature’s delight” 
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Table 11: Corresponding gene names of the proteins listed in Table 6 
Aspergillus 
species vapA vapB vipC 
A. niger 
CBS513.88 An01g02280 - An03g06140 
A. niger 
ATCC1015 ASPNIDRAFT_206311 - ASPNIDRAFT_204025 
A. luchuensis 
CBS106.47 ASPFODRAFT_56314 - ASPFODRAFT_50818 
A. kawachii 
IFO4308 AKAW_09859 - AKAW_09010 
A. tubingensis 
CBS134.48 ASPTUDRAFT_116905 - ASPTUDRAFT_60922 
A. brasiliensis 
CBS101740 ASPBRDRAFT_53135 - ASPBRDRAFT_68748 
A. carbonarius 
CBS141172 ASPCADRAFT_208237 - ASPCADRAFT_210496 
A. aculeatus 
CBS172.66 ASPACDRAFT_30244 - ASPACDRAFT_76600 
A. clavatus 
NRRL1 ACLA_014240 - ACLA_043750 
A. wentii 
CBS141173 ASPWEDRAFT_50435 - ASPWEDRAFT_177709 
A. ruber 
CBS135680 EURHEDRAFT_382284 - EURHEDRAFT_417012 
A. glaucus 
CBS516.65 ASPGLDRAFT_29766 - ASPGLDRAFT_52781 
A. terreus 




CBS795.97 ASPVEDRAFT_157455 ASPVEDRAFT_44586 ASPVEDRAFT_57483 
A. sydowii 
CBS593.65 ASPSYDRAFT_55012 ASPSYDRAFT_92287 ASPSYDRAFT_94584 
A. nidulans 
FGSC A4 AN0186.2 AN8616.2 AN8945.2 
A. flavus 












Z5 Y699_00945 Y699_07755 
Y699_05784 
Y699_09459 
N. fischeri NFIA_076080 - NFIA_095550 NFIA_062190 
A. fumigatus 













A discrepancy exists between the database entry for AFUB_034310 and the genomic 
sequence obtained from gDNA amplification due to the predicted/annotated vs 
experimentally determined. Annotated genomic sequence is much smaller and does not 
correspond with the VipC2 encoding gene, therefore, the protein does not correspond 
neither, and BLAST analyses fail to identify it. Primers targeting the vipC2 gene, 
HA17/HA18 (from A. fumigatus Af293), were used to amplify its coding sequence from 
genomic DNA in A. fumigatus A1160 and PCR product was sequenced. Both, the size in 
gel, and the sequence of the PCR product were identical as the vipC2 gene from the Af293. 
When the 5’ and 3’ UTR regions of the AFUB_034310 annotated gene were inspected, the 
whole genomic sequence corresponding to the experimentally determined vip2 gene was 
found. According to BLAST analyses, A1160 strain does not seem to have the vipC2 gene 
(or protein) but experimental evidences indicate that it is wrongly annotated. The new 
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°C  Degree Celsius  
aa  Amino acid(s)  
ABC ATP- binding cassette 
ABPA Allergic bronchopulmonary aspergillosis 
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Af/Afu Aspergillus fumigatus 
Amp Ampicillin 
Amp B Amphotericin B 
An Aspergillus nidulans 
ARAF Azole-resistant Aspergillus fumigatus 
Asex Asexual  
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LM  London medium  
L-Trp L-Tryptophan 
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mAbs  Milli absorbance units  
MAP  Mitogen-activated (kinase)  
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ml  Millilitre  
MM  Minimal medium  
mM  Millimolar  
mm  Millimetre  
MMS Methyl methanesulfonate 
mRNA  Messenger RNA  
MS Mass spectrometry 
MS/MS  Tandem mass spectrometry  
MSB Menadione sodium bisulfite 
MSX L-methionine sulfoximine 
MT(s) Methyltransferase(s) 
mU  Milli-units  
MUSCLE Multiple sequence comparison by log- expectation 
NAD(H)  Nicotinamide adenine dinucleotide  
NADP(H)  Nicotinamide adenine dinucleotide phosphate  
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P-BLAST Protein-BLAST 
PCR  Polymerase chain reaction  
pg  Pico gram  
phleoRM  Phleomycin recyclable resistance marker  
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